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Abstract 
 
If humanity is to reduce the rate of climate change, it is essential that our societies switch to a 
more sustainable production of fuels and chemicals, which in turn depends on technological 
development. Oleochemical production via microbial catalysts – such as the yeast 
Saccharomyces cerevisiae – can use a considerably broader range of renewable substrates 
compared to the conventional production processes. Additionally, it enables optimization of the 
catalytical properties of the chosen host via metabolic engineering. Oleochemicals are derived 
from fatty acids (FAs), whose biosynthesis depends on the conversion of a substrate to cytosolic 
acetyl-CoA – the precursor for FA synthesis. FA synthesis additionally requires large amounts 
of the reducing cofactor NADPH. The primary aim of this thesis was to develop and evaluate 
metabolic engineering strategies with potential to positively influence FA production of S. 
cerevisiae, mediated via an increased supply of acetyl-CoA or NADPH. 
     A major portion of the thesis is focused around a heterologous metabolic pathway to produce 
acetyl-CoA based on the activity of a phosphoketolase (XFPK) and a phosphotransacetylase 
(PTA). This pathway theoretically allows to reduce carbon and energy losses compared to the 
native yeast system. We identified several efficient XFPK candidates with potential to generate 
a high flux through the pathway. Furthermore, we show that two endogenous proteins – Gpp1 
and Gpp2 – efficiently degrade the XFPK-formed produced acetyl-phosphate (AcP) to acetate, 
accumulating during cultivation. We show that this limits the benefit of the heterologous 
pathway, likely due to increased proton decoupling and ATP consumption during acetate 
activation. When we co-expressed XFPK and PTA, deletion of GPP1 appeared to be required 
to enable a significant flux towards acetyl-CoA during growth on glucose, reducing acetate 
accumulation. While a 25% increase in FA production was observed at the end of the glucose 
phase, the final titer was reduced by 20% compared to the control. We suggest that PTA 
expression negatively affects FA production during ethanol consumption due to low level of 
AcP during such conditions, leading to net flux from acetyl-CoA to AcP. Therefore, we propose 
that ethanol formation should be avoided in order to optimize XFPK/PTA use. 
     Regarding cofactor supply, we investigated if increasing activity of Stb5 – a transcriptional 
activator of genes involved in the pentose phosphate pathway (PPP) and NADPH production – 
could influence FA synthesis positively. STB5 overexpression had a beneficial effect on FA 
production in the glucose phase, an effect shown to be independent of flux through the PPP. 
However, final titers were affected negatively, and transcriptomic analysis indicates that 
mechanisms were activated in cells to counteract a Stb5-imposed redox imbalance. This 
suggests that an effective drain of NADPH – e.g. during product formation – is required to 
prevent systemic negative effects of STB5 overexpression. 
     The results produced within the scope of this thesis will serve as an aid in future metabolic 
engineering strategies targeting compounds relying on acetyl-CoA or NADPH. 
 
Keywords: Sustainability, oleochemicals, fatty acids, Saccharomyces cerevisiae, acetyl-CoA, 
NADPH, metabolic engineering, phosphoketolase, transcription factor.  
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1 Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.1 Oleochemicals - from a global to a cellular perspective 
 
A global perspective 
 
When I initiated writing this thesis in Gothenburg 2018, my attention was effectively brought 
to the topic of climate change, as the high temperatures and lack of rain observed in Sweden 
during May to July were extreme. As of 2017, the global temperature has increased by 0.9°C 
relative to the average 1951-1980 temperature, and across the globe extreme weather conditions 
are notably more common. Climate change is an inevitable result of rising levels of greenhouse 
gas (GHG) emissions, of which CO2 already by 1950 had surpassed the highest recorded level 
during the last 420.000 years [1] – approximately 300 ppm – and in 2016 crossed the 400 ppm 
mark (https://climate.nasa.gov/vital-signs/carbon-dioxide/). Therefore, a rapid reduction of 
GHG emissions is imperative.  
     In order to create a sustainable society with reduced GHG footprint, the global economy 
must undergo a major transformation. The prevailing economic model can be described as 
linear – it is highly dependent on manufacturing processes where non-renewable resources such 
as fossil fuels are used as raw material and our waste is largely dumped or burnt. A paradigm 
shift would be to fully move into a circular economy, which seeks to reduce resource 
consumption and maximize recycling of waste-streams [2]. Consumption will inevitably 
continue, which is why production routes must shift toward sustainable operation. The so-called 
bioeconomy describes a system in which “the basic building blocks for materials chemicals and 
energy are derived from renewable biological resources” [3]. 
 
Oleochemicals – applications and production 
 
A product group that today exclusively relies on biomass for production is oleochemicals. 
Oleochemicals are aliphatic molecules that are used to produce a diverse range of products, 
from consumer goods such as cosmetics, shampoo and detergents to industrial lubricants, 
emulsifiers and transportation fuels [4]. The common precursor to build such chemicals are 
fatty acids (FAs), which are in abundance in biological lipids, such as vegetable oils and animal 
fat. As an illustration of the applicability and demand for FAs, the annual growth of the world-
wide vegetable oil market was a remarkable 4.5% during the last decade (2008-2017), largely 
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due to a growing biofuel and oleochemical production [5]. The growth is predicted to be closer 
to 2% over the next decade, but vegetable oils will still represent one of the fastest growing 
commodities. Even if the raw material required for production of oleochemicals and biofuels 
technically is renewable, vegetable oil production is considered environmentally unsustainable 
in the short-term perspective. This is due to the extensive time required to repay the high 
“carbon debt” associated with the establishment of oil crops such as palm and soy in areas 
which currently hold rainforests. As an example, it is estimated that the time to repay the carbon 
debt from palm biodiesel produced from crops established in Indonesian or Malaysian peatland 
rainforests is 423 years [6]. During this time, the net emission of GHGs from using such biofuels 
exceed that of the fossil-based fuels they replace. For example, the expanse of efficient palm 
oil crops causes deforestation in tropical regions, which by itself leads to a vast increase in 
GHG emissions, biodiversity loss and soil degradation over time [7].  
 
The microbial catalyst and fatty acid biosynthesis 
 
A way to limit the requirement of oil crops in oleochemical production, and thereby reduce 
environmental impact, is to rely on microbial catalysts. Fermentation-based oleochemical 
production offers a great advantage over the traditional chemical conversion of vegetable oils, 
as a broad range of plant substrates potentially can be utilized. For example, the carbohydrates 
in lignocellulosic material such as wood and grass represent an abundant substrate stream, and 
these type of plants can be cultivated in various climate types [8]. A microbial catalyst can be 
precisely engineered to catalyze multiple steps in a bioconversion process, as traits and 
enzymatic capabilities from different species can be transferred into a representative host. For 
example, lignocellulose degradation observed by fungal species as well as the biosynthesis of 
alkanes observed by certain cyanobacteria can theoretically be combined into a single host.  
     In this context, the yeast Saccharomyces cerevisiae has for long been a model organism for 
the eukaryote cell, resulting in both detailed information about its biology and an arsenal of 
tools to manipulate its genome being available. Furthermore, it is a robust organism tolerating 
harsh cultivation conditions such as low pH and it is resistant to phage-contamination, which 
commonly affects bacterial hosts. Consequently, S. cerevisiae is a commonly observed 
microbial host for bioconversion processes, such as the large-scale production of succinic acid 
by BioAmber, isobutanol by GEVO and farnesense by Amyris [9]. During the last five years, 
S. cerevisiae has been intensely explored and developed as catalyst for oleochemical production 
[10], such as free FAs [11-16], fatty alcohols [13, 14, 17], phospholipids [16], triacylglycerols 
[18], long/short chain FA species [19-22], alkanes/alkenes [14, 23-25], specialty lipids [26-28] 
FA ethyl esters [13, 29-33] and wax esters [34, 35]. 
     In brief, oleochemical production in S. cerevisiae is dependent on the degradation of 
substrate molecules to the central metabolite acetyl-CoA. Acetyl-CoA is a thioester comprised 
of a molecule of acetic acid bound to the thiol “coenzyme A”, which is utilized as an acyl-group 
carrier within the cell [36]. The formed acetyl-CoA can subsequently be used as precursor in 
the resource-intensive synthesis of FAs. The production of one molecule of octadecanoic acid 
– a FA comprising 18 carbon molecules – requires consumption of 9 acetyl-CoA, 8 molecules 
of the molecular energy equivalent ATP and 16 molecules of the reducing cofactor NADPH. 
The enzymes responsible for FA synthesis are acetyl-CoA carboxylase (Acc1), converting 
acetyl-CoA to malonyl-CoA [37] and the fatty acid synthase (FAS): a large enzyme complex 
comprised of two separate proteins, Fas1 (β) and Fas2 (α), which each has multiple catalytic 
domains. The FAS utilizes acetyl-CoA as a priming unit and malonyl-CoA as an extender unit 
during FA elongation [38]. FA synthesis is a highly controlled cellular process and has been 
shown to be regulated at the transcriptional level [39], via post-translational phosphorylation 
[40, 41] as well as feed-back inhibition mediated by acyl-CoA [42].  
1. Introduction 
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1.2 Objectives 
 
As previously mentioned, plenty of resources have been invested into the area of developing S. 
cerevisiae as a host for oleochemical production. Nevertheless, the intricacy of biological 
systems offers numerous alternative solutions with the ability to improve a particular aspect of 
a process. Moreover, even though the process of FA synthesis is highly researched in S. 
cerevisiae, there are aspects which remain unstudied. The research laying the ground for this 
doctoral thesis has focused on three separate aspects with potential to positively influence FA 
synthesis and/or to generate a better understanding of the FA synthesis process: 1) precursor 
supply of acetyl-CoA, 2) cofactor supply of NADPH, and 3) enzyme regulation. A short 
background and a description of the objective of these areas of study are presented below. 
 
Precursor supply: Acetyl-CoA 
 
The native route for cytosolic acetyl-CoA supply in S. cerevisiae is carbon- as well as energy-
inefficient, limiting the theoretical yield of any acetyl-CoA derived product. As high product-
on-substrate yield is one of the most important factors for a successful biorefinery, there has 
been a high research focus on shifting to alternative, heterologous routes for cytosolic acetyl-
CoA supply. The route that theoretically is among the most promising in terms of optimal yield 
is based on a coordinated expression of a phosphoketolase (XFPK) and a phosphotransacetylase 
(PTA), as the route bypasses both carbon and energy loss [43]. Previous research, utilizing a 
XFPK from Aspergillus nidulans in S. cerevisiae in order to enhance acetyl-CoA derived 
product formation, presented conflicting results with regards to the efficacy of the introduced 
heterologous route [32, 44, 45]. Efficient enzyme catalysis is essential if carbon fluxes should 
be successfully diverted within the cell. In Paper I we screened several heterologous 
phosphoketolase candidates for functional expression in S. cerevisiae and high catalytic 
efficiency. This enabled us to identify several efficient enzyme candidates, whose expression 
however had a negative impact on yeast growth. A growth defect represents a significant 
drawback in biorefinery applications, as it is likely to reduce both yield and productivity of a 
process. For this reason we characterized effects of expression of the most efficient XFPK 
identified in Paper I from Bifidobacterium breve (Xfpk(BB)), results presented in Paper II. 
Ultimately, we evaluated how co-expression of XFPK and PTA species affected growth and/or 
FA production in different yeast strains, the results of which are enclosed and discussed within 
the thesis (Chapter 3.4).  
 
Cofactor supply: NADPH 
 
NADPH is the abbreviation for the reduced form of nicotinamide adenine dinucleotide 
phosphate (NADP+), which is utilized by cells as a reducing agent in biosynthetic reactions. 
NADPH biogenesis, and in particular flux through the oxidative pentose phosphate pathway 
(PPP), is required to be a highly regulated process due to the global effect the redox state has 
on cellular metabolism. NADPH supply is considered to be increased in response to a higher 
demand, for example observed under levels of oxidative stress and an increased biosynthetic 
requirement [46]. In a reversed approach we evaluated if it was possible to enhance FA 
biosynthesis, a process that requires large amounts of NADPH, by forcing the cell to increase 
its NADPH supply. The transcription factor (TF) Stb5 has been shown to be an activator of 
multiple genes related to the PPP and NADPH production in response to oxidative stress [47]. 
In Paper III we evaluated if overexpression of STB5 could be utilized as a metabolic 
engineering strategy to positively influence FA synthesis. In the same paper, we studied what 
effects overexpression had on physiology as well as global transcription. 
1. Introduction 
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Enzyme regulation: FAS 
 
Lysine acetylation is a common post-translational modification which has emerged as an 
important regulator of many metabolic enzymes [48]. Henriksen et al. conducted an acetylome 
study of S. cerevisiae, identifying more that 4000 unique acetylation sites on proteins [49]. Yet, 
there have been few reports validating the potential regulatory function of acetylation sites in 
S. cerevisiae. Acetyl-CoA acts as the donor for protein acetylation, and the intracellular acetyl-
CoA levels have been shown to correlate with the degree of protein acetylation [50]. Among 
the enzymes found to be acetylated by Henriksen et al, Acc1 and Fas1/Fas2 were reported to 
have multiple acetylation sites. As these enzymes are located at the branchpoint of metabolism 
of acetyl-CoA, the donor for protein acetylation, it is possible that protein acetylation could be 
a regulatory determinant of function. This has been shown to be the case for the human fatty 
acid synthase [51]. The identification of post-translational regulatory sites on enzymes poses 
an opportunity to deregulate connected cellular processes. With the overall aim to enhance FA 
synthesis in S. cerevisiae in mind, in Paper IV, three acetylation sites in Fas2 were targeted for 
investigation for a putative regulatory role in FA synthesis. 
 
1.3 Thesis structure 
 
Chapter 2 is dedicated to the presentation of relevant background to the topics of this thesis. It 
covers important features of S. cerevisiae metabolism, such as an overview of the central carbon 
metabolism and important physiological responses. Furthermore, due to the central role of 
acetyl-CoA, FA synthesis and redox metabolism in this thesis, aspects such as biosynthetic 
pathways and regulation of these processes are discussed in greater detail. The last subchapter 
gives an overview of the cell factory concept and metabolic engineering principles and 
methodology. 
     The three following chapters are initiated with an introduction of previous work with 
relevance for the undertaken subproject, and proceed to present the results and connected 
discussion of the studies conducted within the scope of the chapter. Chapter 3 covers the results 
of Paper I-II, in which heterologous enzymes with ability to influence acetyl-CoA supply were 
evaluated for functionality and impact of expression on S. cerevisiae physiology. The last 
subchapter (Chapter 3.4) also contains results which are not part of a manuscript. Chapter 4 
presents results of Paper III in which the effect of overexpression of the transcription factor 
Stb5 was evaluated. Lastly, Chapter 5 presents the study where the potential regulatory 
function of acetylation sites in Fas2 was evaluated, covering Paper IV.  
     Chapter 6 concludes the thesis presenting key conclusions and future perspectives of each 
individual project described within this thesis. 
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2 Background 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Saccharomyces cerevisiae, baker’s yeast, has been a key player in the development of the 
scientific fields of microbiology, biochemistry and genetics. Long before this scientific 
revolution in biology, yeast constituted a “kitchen-aid” for thousands of years for bread baking, 
wine making and beer brewing. This is due to its excellent ability to break down sugar 
molecules while producing ethanol and carbon dioxide – the intoxicating and bread-lifting 
agents of brewed liquids and bread, respectively. 
     The first conceptional understanding of the chemical process of fermentation was made by 
Antoine Lavoisier in 1789, who proposed that sugar was converted into alcohol and carbon 
dioxide during wine fermentation [52]. Yet, it was not until the 1836-1837 that it was 
recognized that organisms were responsible for this conversion process, independently shown 
by Charles Cagniard-Latour, Friedrich Kütsing and Theodor Schwann [52]. Louis Pasteur 
studied the physiology of yeasts in the late 1850s, established their role in fermentation, and 
determined the differences in how sugar was processed by the yeasts during aerobic and 
anaerobic conditions [53]. The first pure yeast cultures were isolated in 1883 by Emil Christian 
Hansen, at the time employed by the Carlsberg Laboratory in Copenhagen, thereby initiating a 
revolution in the brewing industry as consistent flavor and quality of the products could be 
obtained [54].     
     This basic metabolic trait of yeast is still the foundation for bread and alcohol fermentations 
in industry. Nevertheless, the accomplishments in microbiology, biochemistry and genetics 
have propelled the birth of scientific disciplines which allow to engineer biological systems. 
This has helped to optimize yeast as an industrial organism, not only for the “task” millions of 
years of evolution led it to execute, but also for completely new purposes. In the field of 
metabolic engineering, genetic traits are manipulated or introduced into a host organism with 
the aim to influence its metabolism - the networks of biochemical reactions occurring within 
cells. This has enabled the creation of “cell factories”, which can efficiently convert simple raw 
materials such as sugars into complex chemicals.  
     In order to improve the interpretations of the topics of this thesis, the following subchapters 
present the basis of central carbon metabolism in yeast and specific metabolic branches with 
special connection to the projects of this thesis. Lastly, the concept of the cell factory and 
metabolic engineering principles will be presented. 
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2.1 Central carbon metabolism of Saccharomyces cerevisiae  
 
Glycolysis 
 
A hexose sugar molecule is within the cell primarily transformed through the process of 
glycolysis – a coordinated action of numerous enzymes with specificity for the particular 
intermediary metabolites, an overview of which is found in Figure 1. The elucidation of the 
main reactions of glycolysis was made possible after Eduard Buchner in 1897 showed that a 
cell-free extract of yeast could still ferment sugars. It was thus shown that glycolysis was a 
process not directly dependent on living cells but rather chemical catalysis made possible by 
proteins [54]. Glycolysis was recognized as a general biochemical pathway, and the details of 
the pathway were studied and fully described both in yeast and muscle cells by the first half of 
the twentieth century [55]. 
     Altough S. cerevisiae may consume different types of hexose sugars, the preferred substrate 
is glucose – the dominant carbohydrate in plant biomass – which can be readily fermented at 
high rates even under anaerobic conditions [56]. The two glucose-isomers mannose and 
fructose as well as the hexose galactose are fermentable carbon sources for S. cerevisiae. 
However, while the two former are readily fermented, yeast growth rate on galactose is about 
a third of that observed for growth on glucose and mainly of respiratory character [57]. Hexose 
sugars are imported by facilitated transport via a family of hexose transporters (HXT). These 
differ with respect to substrate specificity, affinity for glucose and transcriptional and 
posttranscriptional regulation [58, 59]. 
     Once imported into the cell, glucose as well as mannose and fructose are first phosphorylated 
by the action of hexokinases (encoded by HXK1 and HXK2) in an ATP dependent process, 
yielding glucose-6-phosphate (G6P), mannose-6-phosphate (M6P) and fructose-6-phosphate 
(F6P), respectively.  Galactose is converted to G6P through the so-called “Leloir pathway”, via 
formation of galactose-1-phosphate and glucose-1-phosphate. G6P and M6P are converted into 
F6P by glucose-6-phosphate isomerase (encoded by PGI1) and phosphomannose isomerase 
(encoded by PMI40), respectively. Another molecule of ATP is consumed when F6P is 
converted into fructose-1,6-bisphosphate (F1,6BP) by 6-phosphofructo-1-kinase (encoded by 
PFK1 and PFK2). F1,6BP is thereafter cleaved into two three-carbon compounds: 
glyceraldehyde-3-phosphate (GAP) and dihydroxyacetone phosphate (DHAP) by fructose-1,6-
bisphosphate aldolase (encoded by FBA1). Triose phosphate isomerase (encoded by TPI1) 
catalyzes the interconversion of DHAP and GAP, completing the so-called “investment-phase” 
of glycolysis with formation of two molecules of GAP. 
     The “energy generation phase” is initiated by the conversion of GAP to 1,3-
bisphosphoglycerate (1,3BPG) under NADH-formation through the action of glyceraldehyde-
3-phosphate dehydrogenase (encoded by TDH1, TDH2 and TDH3), commonly referred to as 
GAPDH. One molecule of ATP is subsequently released when 1,3BPG is converted into 3-
phosphoglycerate (3PG) via phosphoglycerate kinase (encoded by PGK1). Phosphoglycerate 
mutase (encoded by GPM1) coverts 3PG into 2-phosphoglycerate (2PG). Phosphopyruvate 
hydratase, also known as enolase (encoded by ENO1 and ENO2), subsequently converts 2PG 
into phosphoenolpyruvate (PEP). In a final step, pyruvate kinase (encoded by PYK1 (CDC19) 
and PYK2) catalyzes the conversion of PEP to pyruvate while producing an additional molecule 
of ATP. In summary, the enzymatic processing of one molecule of glucose results in two 
molecules each of pyruvate, NADH and ATP, without any requirement of molecular oxygen. 
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Figure 1. Central carbon metabolism: glycolysis (pink box), the oxidative (yellow box) and non-oxidative (green 
box) part of the PPP, and the pyruvate branchpoint of respiratory or fermentative growth (lower right corner). 
Glycerol synthesis/utilization pathway is also shown in the “Glycolysis box”, indicated in grey. 
 
The pentose phosphate pathway 
 
As shown in Figure 1, an important route diverting carbon from glycolysis is the pentose 
phosphate pathway (PPP). The pathway generates NADPH and precursors for nucleotide and 
amino acid synthesis, the sugars ribose-5-phosphate (R5P) and erythrose-4-phosphate (E4P), 
respectively. The PPP has two distinct branches: an oxidative branch that comprises three 
enzymatic reactions of which two produce NADPH, and a non-oxidative branch that comprises 
four reactions and rearranges the carbon molecules of the sugar phosphates into C3-C7 
compounds. 
     The first step of the oxidative branch of the PPP is catalyzed by glucose-6-phosphate 
dehydrogenase, encoded by ZWF1, and produces 6-phosphogluconolactone (6PGL) and one 
molecule of NADPH when G6P is oxidized. Subsequently, 6-phosphogluconolactonase, 
encoded by SOL3 and SOL4, acts upon 6PGL to produce 6-phosphogluconate (6PGC). The last 
step of the oxidative PPP is catalyzed by 6-phosphogluconate dehydrogenase, encoded by 
GND1 and GND2, that oxidizes 6PGC further into ribulose-5-phoshate (Ru5P) and CO2 
resulting in an additional molecule of NADPH. The enzymatic reactions of the oxidative PPP 
are largely considered unidirectional, and the regulation of flux into the pathway is reviewed in 
more detail in section 2.4, describing NADPH synthesis routes in greater detail. 
2. Background 
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     The non-oxidative part of the PPP, on the other hand, is comprised of reversible 
interconversions of C3-C7 sugar phosphates connecting intermediates of the PPP with those of 
glycolysis. The Ru5P formed from the oxidative PPP can either be converted by ribose-5-
phosphate ketol-isomerase (encoded by RKI1) to R5P or ribulose-5-phosphate 3-epimerase 
(encoded by RPE1) to xylulose-5-phosphate (X5P). The two pentose sugars R5P and X5P can 
be recombined into one C7 and one C3 sugar phosphate, namely seduheptulose-7-phosphate 
(S7P) and the glycolytic intermediary GAP. The reaction is catalyzed by a transketolase 
(encoded by TKL1 and TKL2), activity of which is dependent on the cofactor thiamine 
diphosphate (ThPP) [60]. A transaldolase (encoded by TAL1 and NQM1) can further rearrange 
S7P and GAP into F6P and E4P, which can be degraded in glycolysis or utilized in aromatic 
amino acid and vitamin B synthesis, respectively. Transketolases furthermore catalyze the 
interconversion of E4P and X5P into F6P and GAP. 
     A majority of the above described enzymes of the canonical PPP were described in the first 
half of the 20th century, and a draft version of the complete pathway was presented in 1955 
[61]. However, as late as in 2011, the PPP enzyme sedoheptulose-1,7-bisphosphatase (encoded 
by SHB17) was characterized in yeast. It catalyzes a non-reversible formation of S7P from 
sedoheptulose-1,7-bisphosphate (SBP), that in turn is formed via interconversion of DHAP and 
E4P catalyzed by the glycolytic aldolase Fba1 [62]. Thus, Shb17 constitutes an additional link 
between glycolysis and the PPP (not shown in Figure 1). 
 
Fate of pyruvate and the Crabtree effect 
 
The pyruvate produced from glycolysis has different destinations within the yeast cell. The 
molecule is located at a branch-point of dissimilatory and assimilatory metabolic pathways and 
simultaneously between respiratory and fermentative metabolism [63], illustrated in Figure 1. 
If destined for respiratory assimilation, pyruvate is imported into the mitochondria and 
subsequently oxidized within the tricarboxylic acid (TCA) cycle to produce CO2 along with 
reducing equivalents for the respiratory chain. Furthermore, pyruvate can be carboxylated via 
pyruvate carboxylase (encoded by PYC1) into oxaloacetate in an ATP-dependent anaplerotic 
reaction. Conversely, during fermentative growth, the majority of the pyruvate molecules are 
decarboxylated by cytosolic pyruvate decarboxylase (encoded by PDC1, PDC5 and PDC6) to 
acetaldehyde and CO2. The acetaldehyde is then reduced to ethanol in a reaction primarily 
catalyzed by alcohol dehydrogenase 1 (encoded by ADH1) [64]. 
     Respiratory dissimilation of glucose via the mitochondrial pathways is more energetically 
favorable in terms of ATP yield compared to fermentative conversion of glucose into ethanol. 
In S. cerevisiae, pure fermentation results in 2 ATP per consumed molecule of glucose without 
any consumption of oxygen, while it is estimated that 18 ATP can be formed through respiration 
[65]. The additional ATP formed via respiration stem from oxidative phosphorylation when 
electrons are donated from NADH to ultimately form molecular oxygen in the mitochondrial 
electron transport chain. During fermentative growth and ethanol formation, acetaldehyde is 
instead utilized as an electron acceptor of NADH without any concurrent ATP production. The 
reductive formation of ethanol allows the yeast cell to grow while maintaining redox balance 
in conjunction with NADH-producing glycolysis [66].  
     In contrast to facultative anaerobic species, which exclusively perform fermentation if 
oxygen is lacking, S. cerevisiae diverts a majority of provided glucose towards ethanol 
formation even in the presence of oxygen if glucose is present in excess – a phenomenon 
referred to as the Crabtree effect [67]. Two distinct effects have been observed, one “short-
term” and one of “long-term” character. The short-term effect refers to the immediate onset of 
alcoholic fermentation after addition of an excess of sugar to a sugar-limited culture [63]. The 
effect is believed to represent a saturation of respiratory metabolism, and is commonly referred 
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to as “overflow metabolism”. Exposure to elevated glucose levels triggers a transcriptional 
downregulation of a majority of genes encoding enzymes of the TCA cycle and respiratory 
chain [68]. Such repression effectively blocks respiratory routes for pyruvate assimilation, and 
is believed to be the cause of “long-term” Crabtree effect, occurring at high growth rates [69].  
    The Crabtree effects is counterintuitive if solely considering the theoretical ATP yield as a 
determining factor for mode of growth. However, an advantage emerges if considering that 
ATP production can be performed at a higher rate by using aerobic fermentation, permitting a 
higher growth rate. This phenomenon is clearly demonstrated by the lower growth rate of S. 
cerevisiae on non-fermentable carbon sources such as ethanol [70]. A higher growth rate would 
provide a selective advantage in settings when there is a competition for limited resources, 
referred to as the rate/yield trade-off (RYT) hypothesis, described by Pfeiffer et al. [71]. 
Furthermore, by constraining a stoichiometric model by the allocation of protein mass, Nilsson 
and Nielsen recently showed that aerobic fermentation is more catalytically efficient than 
respiration, i.e. more ATP can be produced per unit of protein [72].  
      An alternative hypothesis suggests that the Crabtree effect evolved in yeast as a mechanism 
to defend sugar rich resources, as the produced ethanol is antiseptic and limits growth of 
sensitive species, a theory termed the “make-accumulate-consume” (MAC) strategy [73]. In 
favor of this, the resurrection of the last common ancestor of the ethanol-forming 
dehydrogenase Adh1 and the ethanol-consuming Adh2 kinetically resembles Adh1 [74]. Thus, 
ancestral yeast was highly unlikely to perform aerobic fermentation as produced ethanol could 
not be consumed afterwards. Furthermore, the Adh-duplication event is estimated to coincide 
with 1) the time point of the duplication of other genes involved in controlling flux from hexose 
to ethanol (e.g. PDC) and 2) the Cretaceous age, during which an excess of fruits and 
fermentable sugars became available [74].  
     As aerobic low-yield metabolism exists also in other biological systems, such as bacterial 
and human systems [75], it has been argued that RYT likely is a more influential factor 
compared to MAC [76]. More recently, de Alteriis et al. argued that the Crabtree effect, as well 
as the corresponding Warburg effect commonly observed in cancer cells, could have evolved 
as a protection against the phenomenon “sugar-induced cell death” (SCID) and ATP-depletion 
[77]. It has also been suggested that an upper limit of energy dissipation is the trigger of the 
Crabtree/Warburg effect [78], which the authors hypothesize is a type of ‘safety valve’ to 
prevent cells from damage. Thus, the evolutionary background to the Crabtree effect is still 
under discussion. 
 
2.2 Acetyl-CoA biosynthesis and cellular utilization 
 
Acetyl-CoA is a key intermediate in central carbon metabolism. It acts as fuel in the 
mitochondrial TCA cycle, a process that in part generates energy for the cell, in part produces 
essential precursors for amino acid and nucleotide synthesis. Acetyl-CoA also represent the 
precursor for fatty acid and isoprenoid synthesis localized to the cytosol and it is the degradation 
product of β-oxidation, i.e. fatty acid degradation, in the peroxisomes [79]. Furthermore, acetyl-
CoA acts as the acetyl-donor in protein acetylation, a post-translational event occurring in 
mitochondria, nucleus as well as cytosol [50]. Clearly, this multifaced metabolite is of particular 
importance in cellular metabolism, and several aspects of its biosynthesis and metabolism are 
presented in this section. An overview of S. cerevisiae acetyl-CoA and C2 carbon metabolism 
is shown in Figure 2. 
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Figure 2. Acetyl-CoA synthesis, transport and utilization in S. cerevisiae. The two major routes for acetyl-CoA 
synthesis in yeast are 1) via the PDH-complex in the mitochondria, and 2) the “PDH-bypass” in the cytosol, 
comprising the activity of Pdc/Ald/Acs-enzymes. Acetyl-CoA can also be formed via degradation of fatty acids 
in the peroxisomes and through acetate activation by Ach1. Adapted from Galdieri et al. [80]. 
 
Acetyl-CoA biosynthesis 
 
There are two major routes for acetyl-CoA synthesis in S. cerevisiae separated into different 
subcellular compartments: the mitochondria and the cytosol.  
     In the mitochondria, pyruvate is first required to be imported from the cytosol via the 
mitochondrial pyruvate carriers (encoded by Mpc1, Mpc2 and Mpc3). The functional carrier is 
reported to be a complex of primarily Mpc1/Mpc2 in respiratory conditions and Mpc1/Mpc3 in 
fermentative conditions [81]. Acetyl-CoA is then directly synthesized from pyruvate in an 
irreversible oxidative decarboxylation catalyzed by the pyruvate dehydrogenase (PDH) 
complex. The complex is composed of three catalytic subunits encoded by five structural genes 
(PDA1, PDB1, LAT1, LPD1 and PDX1), and requires participation of five coenzymes (FAD, 
NAD+, ThPP, CoA and lipoic acid) to function [63]. The PDH complex is regulated on multiple 
levels, including transcriptional control of LPD1 expression via glucose catabolite repression 
and Hap2/3/4-mediated activation, and post-translational inactivation of the complex by 
phosphorylation [82, 83]. The formed acetyl-CoA is fed into the TCA cycle via a condensation 
reaction with oxaloacetate, catalyzed by the mitochondrial isoforms of citrate synthase 
(encoded by CIT1 and CIT3) [84].  
     In the cytosol, acetyl-CoA is formed from pyruvate in a three-step process, commonly 
referred to as the “PDH bypass” [63]. It is initiated with the decarboxylation of pyruvate to 
acetaldehyde catalyzed by the Pdc enzymes. The two last enzymatic steps coincide with 
utilization of ethanol (see Figure 2). After glucose is consumed during aerobic fermentation, 
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S. cerevisiae undergoes through a diauxic shift, a process during which the growth temporarily 
is ceased while the cellular protein composition is remodeled to match respiratory metabolism. 
This involves a de-repression of genes encoding enzymes required for ethanol consumption, 
the glyoxylate cycle, gluconeogenesis and mitochondrial function [85, 86]. The non-
fermentable carbon sources produced during the exponential phase (ethanol, glycerol and 
acetate) can thereafter be consumed, albeit at a lower growth rate compared to exponential 
growth on glucose [70]. When growing on ethanol, cytosolic acetyl-CoA formation is initiated 
by the oxidation of ethanol to acetaldehyde while NAD+ simultaneously is reduced to NADH, 
a reaction mainly catalyzed by alcohol dehydrogenase 2 (encoded by ADH2) [64, 87]. 
Acetaldehyde is thereafter oxidized further to acetate. There are three cytosolic acetaldehyde 
dehydrogenases in S. cerevisiae; Ald2, Ald3 and Ald6. Of these, the NADPH-dependent Ald6 
is responsible for the vast majority of the acetate formation [88]. Ald2 and Ald3 are instead 
involved in b-alanine synthesis – an intermediate in pantothenic acid and coenzyme A synthesis 
(discussed in more detail later in this subchapter)[89]. 
     Cytosolic acetyl-CoA is formed from acetate via the action of acetyl-CoA synthetase 
(encoded by ACS1 and ACS2). Expression of ACS1 is subjected to glucose repression while 
ACS2 is constitutively expressed, hence, a deletion mutant of ACS2 fails to grow in high 
concentration of glucose [90]. Acs1 is believed to have a shared distribution between the cytosol 
and peroxisome, while Acs2 likely resides in the cytosol, the nucleus, and possibly in the 
endoplasmic reticulum (ER) [91-94]. Two equivalents of ATP are required for the synthesis of 
cytosolic acetyl-CoA, as ATP is hydrolyzed to AMP [43]. This processes reduces the 
respiratory ATP yield of ethanol and acetate compared to direct consumption of pyruvate via 
the TCA cycle. 
    An alternative way for acetyl-CoA formation relates to diffusion of undissociated acetate – 
produced via the PDH bypass – over the mitochondrial membrane. The gene ACH1 encodes as 
a mitochondrial enzyme, which first was considered to be a acetyl-CoA hydrolase [95, 96], but 
later was found to have a much greater preference for transferring CoA from various acyl-CoA 
species to organic acids, such as acetate [97]. While the reaction is not considered influential 
under normal circumstances, it has been shown to be important for growth on acetate and if 
alternative routes for mitochondrial acetyl-CoA supply are inactivated [97, 98]. Furthermore, 
the less pronounced acetyl-CoA hydrolase catalytic properties of Ach1 have been shown to be 
essential for growth in a strain lacking pyruvate decarboxylase [99]. 
     Lastly, acetyl-CoA formation is also dependent on biosynthesis of CoA, which is not 
consumed but instead recycled once an acetyl- and other acyl-groups are shuttled forward in 
metabolic pathways. CoA is a thiol which in S. cerevisiae can be synthesized de novo in a 13-
step pathway, starting from pyruvate and valine, additionally requiring ATP, b-alanine and 
cysteine as substrates throughout the synthesis process [100, 101]. Alternatively, the 
intermediate pantothenate (vitamin B5) can be imported via the high-affinity transporter Fen2 
[102], leaving five reactions to be catalyzed (encoded by CAB1-CAB5) in a metabolic pathway 
that is believed to be universal among organisms [103]. Cab1 catalyzes the step that is 
considered to be rate limiting in CoA-biosynthesis, in which pantothenate is phosphorylated 
while consuming ATP, and the enzyme is strongly inhibited by acetyl-CoA [104]. 
Subsequently, a heterometric protein complex consisting of Cab2-Cab5 and the nonessential 
proteins Sis2 and Vhs3, which bear resemblance to Cab3, catalyze the remaining steps of CoA 
formation [105]. 
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Acetyl-CoA utilization and the TCA/glyoxylate cycles 
 
In contrast to metabolites such as ethanol, acetaldehyde and acetate, acetyl-CoA formed in the 
cytosol cannot travel freely between different subcellular organelles by means of diffusion. 
However, acetyl-CoA can readily move back and forth between the cytosol and the nucleus, 
referred to as the nucleocytosolic pool, which is biochemically separated from the 
mitochondrial pool [94]. The acetyl-CoA can be linked to carnitine by the catalytic action of 
carnitine acetyltransferases (CATs) [106], and thereafter transported to the mitochondrial 
compartment via the transporter protein Crc1 [107], shown in Figure 2. There are three known 
CATs in S. cerevisiae: Cat2, localized to the mitochondria and peroxisomes [108], and Yat1 
and Yat2, localized to the outer mitochondrial membrane and cytosol, respectively [92, 106, 
109]. Through this transport system, acetyl-CoA formed in the peroxisomes and cytosol can be 
fully oxidized in the mitochondrial TCA cycle. However, the shuttle system requires that 
carnitine is supplemented, as S. cerevisiae in contrast to many other eukaryotic species lacks 
the biosynthetic enzymes required for carnitine biosynthesis [106, 110]. The transcription of 
genes related to the carnitine shuttle are subjected to glucose repression [108, 109]. This fact, 
and the observation that carnitine supplementation fails to support growth of strains in which 
the PDH bypass was inactivated even in glucose-limited conditions [111], strongly suggest that 
the carnitine shuttle system exclusively transfers acetyl-CoA units into the mitochondria.  
     During growth on minimal media using C2 carbon sources as substrate, the carbon contained 
in acetyl-CoA has to find its way into the mitochondria irrespective of the carnitine shuttle 
system described above. This requires the action of the glyoxylate cycle, which can be 
described as an anabolic variation of the TCA cycle occurring in the cytosol and peroxisomes 
[112-119]. The main features and the differences between the two pathways are highlighted in 
Figure 3. The glyoxylate cycle bypasses two CO2-emitting reactions occurring in the TCA 
cycle (catalyzed by isocitrate dehydrogenase (Idh) and a-ketoglutarate dehydrogenase (Kgd)) 
while it invests two molecules of acetyl-CoA per cycle, yielding one molecule of C4 
dicarboxylic acid as the end product. Similar to the mitochondrial cycle, the glyoxylate cycle 
is initiated by the condensation of acetyl-CoA with oxaloacetate (C4) catalyzed by Cit2, 
localized to the peroxisomes [120]. Citrate (C6) is converted via aconitate to isocitrate by 
aconitase (encoded by ACO1), which also catalyzes the corresponding reaction in mitochondria. 
Isocitrate is cleaved to succinate (C4) and glyoxylate (C2) by the glyoxylate cycle-specific 
enzyme isocitrate lyase (encoded by ICL1). Glyoxylate is further condensed with another 
molecule of acetyl-CoA, catalyzed by malate synthase (encoded by MLS1 and MLS2). Similar 
to the TCA cycle, malate dehydrogenase (encoded by MDH1 in mitochondria and MDH2 and 
MDH3 in the glyoxylate cycle) transforms malate into oxaloacetate, which completes the cycle. 
The formed succinate is imported into mitochondria via a succinate/fumarate symporter 
(encoded by SFC1), and subsequent conversion of cytosolic fumarate to malate catalyzed by 
fumarase (encoded by FUM1 for both mitochondrial and cytosolic form), is required for growth 
of S. cerevisiae on C2 compounds [121]. Cytosolic oxaloacetate can then be used to fuel the 
mitochondrial TCA cycle or gluconeogenesis via a decarboxylation and ATP-dependent 
formation of the glycolytic intermediate PEP catalyzed by phosphoenolpyruvate carboxykinase 
(encoded by PCK1). Finally, via activity of Pyk1/2, the MPC transporters and the PDH 
complex, PEP is converted into mitochondrial acetyl-CoA, closing the route of cytosolic to 
mitochondrial acetyl-CoA supply in the absence of carnitine. 
     In accordance with its essential role during growth on C2 carbon sources, activity of the 
glyoxylate cycle is suppressed by glucose, and activated when glucose is removed [112, 122, 
123]. The nature of glucose-mediated regulation is complex, and the repressive effect is 
transmitted by interlinked regulatory interactions and signaling pathways, briefly reviewed by 
Kayikci and Nielsen [124]. The mechanism of transcriptional repression of gluconeogenesis 
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genes is dually regulated by the kinase Snf1. At high glucose concentrations, Snf1 is inactive 
and remains in the cytosol. At glucose limited conditions, Snf1 is activated by phosphorylation 
at which it transfers to the nucleus where it phosphorylates the transcriptional repressor Mig1. 
The phosphorylation releases Mig1 from the promoter of genes involved in utilization of 
alternative carbon sources, including the transcriptional activator Cat8 [125]. Cat8 is in turn 
activated by Snf1-mediated phosphorylation, and is required for transcriptional activation of 
majority of the genes encoding enzymes required for C2 utilization, such as ADH2, ALD6, 
ACS1, ICL1, MLS1, MDH2 and SCF1 [126-128]. 
 
 
Figure 3. Major differences of the glyoxylate cycle and TCA cycle. The TCA cycle is located to the 
mitochondria and results in the complete oxidation of acetyl-CoA and formation of two molecules of CO2. The 
enzymes of the glyoxylate cycle are located in the cytosol and peroxisomes, and result in the formation of one 
molecule of succinate (C4) derived from 2 molecules of acetyl-CoA. 
 
Acetyl-CoA and protein acetylation 
 
Acetyl-CoA furthermore has an important role in the post-translational modification (PTM) of 
proteins. It acts as the donor of in protein acetylation, occurring on the ε-amino group of lysine-
residues. The modification is reversible, and the addition and removal are catalyzed by lysine 
acetyltransferases (KATs) and deacetylases (KDACs, also commonly referred to as histone 
deacetylases, HDACs), respectively [94]. The by far most studied protein acetylation events are 
those of histones – the nuclear proteins that package DNA into structural nucleosome units. 
Addition of an acetyl-group to a lysine residue neutralizes its positive charge, thereby relaxing 
interaction of histones with the negatively charged DNA while other proteins such as RNA-
polymerase gains access [129]. In this way, histone acetylation-status is a vital regulator of gene 
transcription. 
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     Along with advances in the area of proteomics, it is today widely recognized that protein 
acetylation also has an important regulatory role over non-histone enzymes. The number of 
unique acetylation sites detected in human (~2500) compares with that observed for the well-
known regulatory PTM phosphorylation (~2200) [130]. Also yeast proteomic studies show the 
broad scope of protein acetylation. Henriksen et al detected more than 4000 unique acetylation 
sites in S. cerevisiae [49], and 3160 were detected in the oleaginous yeast Yarrowia lipolytica 
[131]. Interestingly, acetylation has in various studied organisms frequently been found to occur 
on central metabolic enzymes [48], in which modifications rapidly could influence catalytic 
activity. For example, the acetylation patterns of metabolic enzymes in the prokaryote 
Salmonella enterica was shown to coordinate carbon source utilization and metabolic flux 
[132]. Furthermore, there is a high degree of conservation of the acetylation sites of metabolic 
enzymes from prokaryotes to eukaryotes [49, 133]. This implies that protein acetylation could 
have an important, preserved role also in metabolic regulation. 
     One enzyme that has strong connection to acetyl-CoA metabolism and has been shown to 
be deactivated by acetylation is acetyl-CoA synthetase (Acs). This feed-back regulation has 
been confirmed for S. enterica as well as in mammalian AMP-forming Acs, which if acetylated 
require activation by NAD+-dependent deacetylases – known as sirtuins – for proper function 
[134-137]. The lysine residues that are subject to regulation in the S. enterica Acs are conserved 
in S. cerevisiae Acs1 and Acs2, corresponding to Lys675 and Lys637, respectively [79, 80]. 
Sirtuins have been suggested to have an important role in the metabolism of short chain fatty 
acids in yeast. This is based on the observation that a strain lacking both sirtuin genes HST3 
and HST4 exhibits a severe growth impairment when grown on acetate or propionate, but not 
on glucose or a mixture of glycerol and ethanol [138]. No direct evidence of regulatory 
acetylation of Acs1 and Acs2 in yeast have so far been presented, however. Furthermore, there 
have been few attempts to evaluate the role of the individual acetylation sites detected in 
acetylome studies. To determine which of all detected acetylation sites that mediate a regulatory 
function constitutes a great challenge.  
     The concentration of acetyl-CoA has been shown to correlate with the acetylation status of 
proteins in the nucleus as well as mitochondria [50, 94, 139]. Acs2 is indicated to be the main 
source of acetyl-CoA for histone acetylation, and the acetyl-CoA concentration is at its highest 
in exponential phase, reflected in a higher degree of histone acetylation in this phase [94, 139]. 
In a yeast strain where PDA1 was deleted (rendering the mitochondrial PDH-complex 
nonfunctional) the acetylation of mitochondrial proteins was significantly reduced while the 
total cellular acetyl-CoA levels decreased by 30% [50]. Methods for quantification of acetyl-
CoA can currently not distinguish between the mitochondrial and the nucleocytosolic fractions. 
However, as mitochondria occupy as little as 1-2% of the cellular volume during exponential 
phase growth on glucose [140], a reasonable assumption is that the mitochondrial acetyl-CoA 
concentration under normal conditions is about 20-30 times higher than that of the cytosol. This 
agrees with the observation that mitochondrial proteins in particular are found to have multiple 
acetylation sites and have a higher basal level of acetylation compared to cytoplasmic proteins 
[49, 50].  
     Lysine residues are progressively acetylated non-enzymatically in vitro in the presence of 
increasing concentrations of acetyl-CoA [50]. This suggests that protein acetylation may 
depend on non-enzymatic processes also in vivo. This is especially likely in the mitochondria 
where no KAT have yet been identified, acetyl-CoA is present in high concentration, and the 
relatively alkaline pH of 8.0 is permissive for such reactions to occur [141-143]. Recent studies 
have shown that the two homologs SIRT3 and Hst4 in human and yeast mitochondria, 
respectively, are likely to have a role in suppressing acetylation levels of mitochondrial proteins 
which otherwise would accumulate fast and interfere with protein activity [144, 145].  
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2.3 Fatty acid biosynthesis and regulation 
 
Biosynthesis of fatty acids 
 
Acetyl-CoA acts as an important building block for cellular constituents, such as sterols and 
fatty acids (FAs), which both constitute essential components of the cell membrane. The overall 
reaction principles of FA biosynthesis (FAB) are conserved from bacteria to eukaryotes, while 
the enzymatic machinery differs on a structural level. In brief, the synthesis is based on a cyclic 
process, in which thioester-intermediates are extended by two carbons at a time through steps 
of 1) condensation, 2) reduction, 3) dehydration and 4) reduction. An overview of the synthesis 
process is depicted in Figure 4. 
     The cyclic FAB process requires acetyl-CoA and malonyl-CoA as substrates. Malonyl-CoA 
is directly derived from acetyl-CoA in a carboxylation reaction catalyzed by acetyl-CoA 
carboxylase (encoded by ACC1), which is dependent on ATP and biotin. The reaction is 
considered to be rate limiting in the synthesis of FAs.  
     In yeast and other eukaryotic organisms, the fatty acid synthase (FAS) is built from one or 
two distinct polypeptides – in S. cerevisiae encoded by FAS1 (β) and FAS2 (α). These 
polypeptide(s) comprise all enzymatic domains required for de novo FAB, a system referred to 
as type I FAS [146]. In the bacterial FAB machinery, each enzymatic domain is instead 
represented by an individual protein, a system referred to as type II FAS [147]. In S. cerevisiae, 
the Fas1/Fas2-complex producing the main pool of FAs is located to the cytosol, but yeast also 
encodes a mitochondrial system of type II essential for respiratory growth due to the 
mitochondrial requirement for lipoic acid [148]. The operative FAS is a large complex 
consisting of α6β6 dodecamers, with six catalytic chambers in each of which eight enzymatic 
reactions or transfers are catalyzed [38], as described below. 
     In order for FAS to function, it must be activated via addition of a phosphopantetheine 
prosthetic group (the “pantetheine arm”) of CoA to the acyl-carrier protein (ACP, located on 
Fas2), catalyzed by the phosphopantetheine transferase (PPT, located on Fas2). ACP has a 
central role throughout the synthesis process, shuttling substrate intermediates to all the 
catalytic centers of the FAS chamber. After activation, acetyl transferase (AT, located on Fas1) 
loads the acetate primer from acetyl-CoA onto the SH-terminus of the ACP pantetheine arm. 
The elongation cycle is initiated when the acetate primer (or the growing acyl-intermediate) is 
transferred to Cys1305 of the ketoacyl synthase (KS, located on Fas2). The empty ACP 
subsequently moves to the malonyl/palmitoyl transacylase domain (MPT, located on Fas1), 
acquiring a malonate from malonyl-CoA. The ACP shifts back to the KS domain which 
catalyzes a condensation reaction between the acetate and malonate units, releasing the CO2 
which initially was captured during malonyl-CoA formation by Acc1. Thereafter, ACP shuttles 
the 3-ketoacyl intermediate sequentially to the ketoacyl reductase domain (KR, located on 
Fas2), the dehydratase domain (DH, located on Fas1), and the enoyl reductase domain (ER, 
located on Fas1), producing a saturated hydrocarbon chain elongated by two carbons at the end 
of each cycle. The two reductase reactions require NADPH as electron donor, resulting in the 
consumption of two molecules of NADPH per elongation cycle. 
     When the length of the FA typically reaches 16 or 18 carbons, elongation termination occurs 
when ACP directs the acyl-chain to the MPT domain, where it is transferred to the SH-group 
of CoA and the FA is released as an acyl-CoA thioester – the form required for cellular 
metabolic utilization of FAs [38]. Acyl-CoAs are not readily soluble in the cytosol, and have 
been found to be non-covalently and reversibly bound with high affinity by the acyl-CoA 
binding protein Acb1 [149]. The protein is evolutionary well-conserved, and is believed to 
transport and deliver acyl-CoAs to utilizing systems in all eukaryotic cells [150, 151].  
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Figure 4. Fatty acid biosynthesis in S. cerevisiae. Adapted from Bergman et al. [152]. 
 
The fate of fatty acids 
 
     The acyl-chains have multiple destinations within cells. Of fundamental importance is the 
formation of membrane lipids, where the FAs are used to produce amphiphilic phospholipids 
with the ability to form bilayers. Around 75-80% of the FAs are desaturated by the Δ9 
desaturase Ole1, residing in the endoplasmic reticulum (ER). This feature is essential to 
maintain membrane fluidity [153, 154]. The FA elongation system, also located to the ER, is 
responsible for elongating the FAS-produced C16-18 FA species up to a length of C26 [155]. FAs 
can be stored for utilization at a later stage, in the form of sterol esters (SE) and triacyl glycerol 
(TAG) which accumulate in lipid droplets [156].  
     Once the cell requires FAs, either for membrane synthesis or as energy source, the storage 
lipid or phospholipid bound FAs can be released through the action of lipases [157, 158]. Both 
lipase-produced and exogenously fed free FAs are required to be activated to acyl-CoA species 
by acyl-CoA synthases (encoded by FAA1-FAA4 and FAT1) prior to metabolic utilization 
[159]. Thus, strains devoid of acyl-CoA synthases cannot utilize FAs as a sole carbon source, 
and during regular growth conditions such cells, and even the double mutant faa1∆faa4∆, 
excrete free fatty acids (FFAs) into the media [160]. Acyl-CoA species can be degraded via β-
oxidation, a peroxisomal processes which essentially consists of the reversed reactions 
compared to FAB: cyclic steps of 1) oxidation, 2) hydration, 3) oxidation and 4) thiolytic 
cleavage. Acetyl-CoA is the end-product of β-oxidation, and therefore be considered to be a 
third major route for acetyl-CoA formation in yeast (shown in Figure 2).  
     As FAs are required for membrane synthesis, production of FAs occurs throughout all 
growth phases. However, the proportion of lipid species are dynamically changing with growth 
phases, in particular after entering the diauxic shift and moving into ethanol phase [161]. 
Storage lipids (TAG/SE) are depleted during an initial lag-phase, and throughout exponential 
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phase the level of storage lipids remains low. Storage lipid formation increases when the cells 
enter the diauxic shift, and are again mobilized when cells enter the post-diauxic shift. The 
increased proportion of storage lipids observed during the diauxic shift is related to the transient 
quiescent phase observed at glucose depletion, where the synthesis of membrane lipids is not 
required [161]. 
 
Regulation of fatty acid biosynthesis  
 
Synthesis of one molecule of octadecanoic acid (C18) consumes 9 molecules of acetyl-CoA, 8 
molecules of ATP (during malonyl-CoA formation), and 16 molecules of NADPH. Due to this 
high energy and cellular resource requirement, FAB is a process bound to be highly regulated. 
Transcriptional activation and repression, product inhibition and post-translational mechanisms 
have all been shown to influence FAs synthesis [39, 42, 162, 163]. 
     Transcription of ACC1 and FAS1/FAS2 is controlled in coordination with many genes 
involved in phospholipid synthesis via the inositol-responsive upstream activating sequence 
(UASINO)-mediated system. The system was initially characterized for regulation of the gene 
INO1, encoding inositol-3-phosphate synthase responsible for production of the lipid precursor 
inositol. The UASINO regulatory element is a 10 bp long sequence that serves as the binding site 
for the transcriptional activator complex Ino2/Ino4 [164, 165], and has been identified in the 
promoters of ACC1 and FAS1/FAS2 [39, 166, 167]. The transcriptional repressor Opi1 interacts 
with Ino2, thus inhibiting transcription of genes preceded by UASINO-containing promoters 
[168]. This repression is dependent on the cellular level of the phospholipid precursor 
phosphatidic acid (PA). At high concentrations of PA, Opi1 localizes to the endoplasmic 
reticulum (ER), where the PA stabilizes Opi1 interaction with the ER-membrane protein Scs2 
[169]. 
     In addition to the Ino2/Ino4 mediated transcriptional activation, FAS1 and FAS2 are 
positively co-regulated by the general regulatory factors Rap1, Abf1 and Reb1 [170]. The Fas1 
protein product also directly influences expression of FAS2, possibly to counteract an 
unbalanced ratio of Fas1 to Fas2 protein [171]. 
     Acyl-CoA species are the direct product of FAB and have been found to impact the activity 
of Acc1 as well as the FAS complex. The activity of Acc1 was shown to be significantly 
reduced in the presence of exogenously added FAs, while the repression was not observed in a 
strain devoid of acyl-CoA synthase activity. This led to the conclusion that the repression is 
mediated by the acyl-CoA species [172]. It is not completely clear how the enzymatic 
repression is mediated in yeast. Nevertheless, in vitro studies of a purified acetyl-CoA 
carboxylase homolog from rat showed that palmitoyl-CoA efficiently inhibits enzyme activity 
via an allosteric mechanism preventing the formation of an active enzyme complex [173]. 
Furthermore, this inhibitory effect was distinctly reduced in the presence of an acyl-CoA 
binding protein [174]. With regard to regulation of FAS activity, palmitoyl-CoA and stearoyl-
CoA are effective inhibitors of the enzyme [162]. The inhibition is considered to be an effect 
of a limited dissociation of the acyl-CoA species from the enzyme following to synthesis [175]. 
Such a situation is likely to occur when Acb1 becomes saturated. On the contrary, acyl-CoA 
pools are observed to be enlarged in a strain overexpressing Acb1, thus stimulating FA 
synthesis [149]. The Acb1-acyl-CoA complex also has a role in regulating gene expression, as 
a strain devoid in Acb1 or expressing an Acb1 mutant unable to bind acyl-CoA esters results in 
an increased expression of ACC1, FAS1 and FAS2 among other genes involved in phospholipid 
synthesis [176].  
     Acc1 is also regulated by phosphorylation by the kinase Snf1, resulting in enzyme inhibition 
[41, 163]. Acc1 represents the rate-limiting step in the formation of FA synthesis, and is the 
same time a critical regulator of nucleocytosolic acetyl-CoA levels and therefore acetylation 
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dynamics [177]. Phosphorylation events catalyzed by Snf1 are dependent on the interaction of 
Snf1 with several factors, such as one of three regulatory subunits (Sip1, Sip2 or Gal83), and 
the stimulatory factor Snf4 [178]. Sip2 has been found to be acetylated by the acetyl transferase 
NuA4, a modification that strengthens its interaction with Snf1, which in turn inactivates Snf1 
[179, 180]. The level of Sip2 acetylation correlates with the nucleocytosolic acetyl-CoA 
concentration and is lowered in a snf1∆ mutant, rendering Acc1 non-inhibited and acetyl-CoA 
levels low [177, 181]. In this way, it is believed that acetylation of Sip2, activity of Snf1 and 
Acc1, and nucleocytosolic acetyl-CoA levels form a homeostatic mechanism which would 
maintain acetyl-CoA concentration within acceptable limits [80]. 
     Acc1 and Fas1/Fas2 have also been demonstrated to be acetylated at multiple residues [49]. 
Due to the central role of acetyl-CoA in FA synthesis as well as protein acetylation, it is 
tempting to assume that acetylation could have a direct regulatory role of FAB-related enzymes, 
analogous to that observed for acetyl-CoA synthetase in cells of bacterial and human origin. 
Indeed, in human cells, acetylation of the FAS has been associated with an increased level of 
protein ubiquitinylation and, as a result, its subsequent degradation [51]. However, no study 
prior to this has been conducted to determine a regulatory role of acetylations detected on the 
FAB-related enzymes in S. cerevisiae.  
 
2.4 Cellular redox balances and cofactor biosynthesis 
 
Cellular degradation of sugars, energy generation and biosynthesis of cellular constituents are 
all processes that are dependent on “redox chemistry”. In a redox-dependent chemical reaction, 
an electron is transferred from one molecule to another, thereby changing the oxidation state of 
an atom in each molecule. A molecular entity that passively functions as an electron donor or 
acceptor in enzymatic catalysis, and otherwise remains unaffected, is referred to as a redox 
cofactor or coenzyme. Redox cofactors permit the cell to separate the occasion of donation and 
final utilization of electrons. An example is when electrons are donated to NADH during 
glycolysis while NADH ultimately transfers electrons to the respiratory chain or to 
acetaldehyde in respiratory and fermentative conditions, respectively. 
 
Redox couples and balances 
 
The two chief redox couples in central carbon metabolism are the nicotinamide adenine 
dinucleotide (phosphate) pairs NAD+/NADH and NADP+/NADPH. However, many other 
important redox couples exist, for example FAD/FADH2 and GSSG/2GSH, the former 
important in cellular processes such as the TCA cycle and the latter in oxidative stress response, 
respectively [182]. NAD(H) and NADP(H) have distinct tasks within biological systems, where 
NAD(H) predominantly acts in catabolic reactions, while NADP(H) is involved in biosynthetic 
reactions [66]. As the cofactors merely shift between a reduced and an oxidized state, an 
important feature to consider is the ratio of the two partners at a given time point. The ratio is 
a measurement of the availability of cofactors within the system, and it regulates the ability to 
perform redox-dependent reactions within a cell. 
     As neither NAD(P)H nor NAD(P)+ directly can traverse the organelle membranes, the redox 
balances are distinct in mitochondria and the cytosol. Furthermore, NAD+ and in particular 
NADH are often found in protein-bound form, which is considered kinetically and 
thermodynamically irrelevant [183]. Conventional analytical methods cannot distinguish 
between the cytosolic and mitochondrial redox pools, nor between free and protein-bound 
cofactors.  In order to determine the free cytosolic NAD+/NADH ratio, Canelas et al. designed 
a redox sensor based on a bacterial mannitol-1-phosphate-5-dehydrogenase expressed in the 
yeast cytosol, allowing to estimate the ratio through measurement of the metabolites mannitol-
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1-phosphate and fructose-6-phosphate [184]. Through this method (and assuming the cytosolic 
pH to be between 6.5-7.0), the NAD+/NADH ratio was estimated to be between 100-300 in 
aerobic, glucose limited chemostats – more than 10-fold higher than what was measured with 
a spectrophotometric whole-cell method. The high cytosolic ratio of NAD+/NADH permits 
oxidative reactions to take place, including the glycolytic reaction catalyzed by glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) with a ∆G°=6,3 kJ mol-1 [185]. On the contrary, the 
NADPH/NADP+ ratio is required to remain high to be able to drive anabolic reactions. 
Analogous to the method developed by Canelas et al., Zhang et al. designed a metabolite sensor 
to monitor the cytosolic NADPH/NADP+ ratio in yeast, based on a bacterial shikimate 
dehydrogenase with high specific activity [186]. By measuring dehydroshikimate and 
shikimate, the S. cerevisiae NADPH/NADP+ ratio was estimated to be around 22 and 16 in 
batch and chemostat culture, respectively. 
 
Nicotinamide adenine dinucleotide synthesis  
 
A summary of important synthesis routes and cytosolic/mitochondrial transport mechanisms of 
NAD(P)+/NAD(P)H couples in yeast is depicted in Figure 5. NAD+ can be synthesized de novo 
from tryptophan or regenerated by NAD-degradation products in a “salvage pathway”. In the 
de novo pathway, nicotinic acid mononucleotide (NAMN) is formed from tryptophan in 6 
enzymatic steps (catalyzed by enzymes encoded by BNA1-BNA2 and BNA4-BNA7) and one 
non-enzymatic reaction. At this point, the de novo and the salvage pathways converge, and 
through the action of two additional enzymes (encoded by NMA1/NMA2 and QNS1), NAD+ is 
formed from NAMN [187, 188].  
     NADP+ (and NADPH) synthesis in turn depends on phosphorylation of NAD+ (and NADH). 
There are two NAD(H) kinases residing in the cytosol of S. cerevisiae, which primarily 
phosphorylate NAD+ into NADP+, encoded by UTR1 and YEF1, where Utr1 appears to have 
the most important physiological role [189-191]. Furthermore, mitochondria also contain a 
NADH kinase, encoded by POS5, which has preference for NADH as substrate [192]. Pos5 has 
a vital role in mitochondrial protection toward oxidative stress, and a pos5∆ mutant shows 
respiratory defects, while a pos5∆ utr1∆ genotype results in a lethal phenotype [191]. 
 
 
 
Figure 5. An overview of biosynthetic reactions influencing the redox status of S. cerevisiae. The dashed bars 
indicate genes involved in redox shuttles of the connected NAD(P)H species. 
2. Background 
 20 
NADH-forming reactions 
 
One of the most important NADH forming reactions in the cytosol is that catalyzed by GAPDH, 
resulting in 2 NADH per glucose, while activities of the TCA cycle produce 4 NADH per 
pyruvate entering the cycle in the mitochondria. The NADH produced by glycolysis in the 
cytosol is in anaerobic conditions and in glucose excess re-oxidized through the formation of 
ethanol. Glycerol formation, on the other hand, allow the cell to establish redox balance with 
excess NADH generated from the assimilation of sugar to biomass [66]. When glucose is 
consumed in a completely respiratory manner, e.g. in a glucose-limited chemostat, the NADH 
produced in the cytosol must be transferred to the electron transport chain. S. cerevisiae 
possesses three mitochondrial NADH:ubiquinone oxidoreductases which oxidize NADH and 
transfer electrons to ubiquinone. NDI1 encodes a version whose catalytic site faces the 
mitochondrial matrix, oxidizing NADH produced via the TCA cycle. In contrast, NDE1 and 
NDE2 encode proteins with catalytic activity facing the cytoplasmic side of the mitochondrial 
outer membrane, and thus can act as a direct transfer of cytosolic NADH to the respiratory 
chain [193]. Furthermore, a redox shuttle based on ethanol-acetaldehyde diffusion over the 
mitochondrial membrane and mitochondrial alcohol dehydrogenase (encoded by ADH3) has 
been shown to be essential for growth in a ndi1∆ mutant [194]. Additionally, the mitochondrial 
NAD+ carrier protein (encoded by NDT1) allows for transport of cytosolic NAD+ into the 
mitochondria [195]. 
 
NADPH forming reactions and regulation 
 
Cytosolic NADPH generation in S. cerevisiae as well as in other eukaryotes is dependent on 
the oxidative PPP. Two molecules of NADPH are formed per G6P being converted into R5P 
and CO2, resulting from the enzymatic activity of the dehydrogenases Zwf1 and Gnd1/Gnd2. 
The importance of the oxidative PPP on NADPH supply is supported by the observations of 
zwf1∆ mutant strains, which become hypersensitive toward oxidative stress [196-198] and – at 
least in some strain backgrounds, such as S288C – methionine auxotrophic [199]. NADPH is 
the essential reducing component of the glutathione antioxidant protection system [200] and 
three molecules of NADPH (four in total, if considering the requirements of thioredoxin 
reductase) are required in order to convert organic sulfate to hydrogen sulfide [201, 202], which 
is required for methionine biosynthesis. It is therefore widely considered that the 
hypersensitivity to oxidative stress and methionine auxotrophy of the zwf1∆ phenotype both are 
the result of a reduced availability of NADPH. The observation that methionine prototrophy is 
restored in response to an availability of NADPH from an alternative source, i.e. by 
overexpressing the NADP+-dependent acetaldehyde dehydrogenase encoded by ALD6, 
supports the latter hypothesis [203]. Ald6, as well as the isocitrate dehydrogenase encoded by 
IDP2, constitute additional cytosolic routes for NADPH generation. Ald6 is essential for 
growth on glucose in a zwf1∆ strain [203], while Idp2 has a more pronounced impact on 
NADPH generation during growth on non-fermentable carbon sources, when the glucose-
mediated transcriptional repression of the gene is relieved [204].  
     In the mitochondria, there are several NADP+-utilizing dehydrogenases: ALD4 and ALD5 
encode mitochondrial acetaldehyde dehydrogenases, MAE1 encodes malic enzyme, which 
catalyzes an oxidative decarboxylation of malate to pyruvate, and IDP1 encodes a 
mitochondrial isocitrate dehydrogenase. Among these, the acetaldehyde dehydrogenases, in 
particular Ald4, have a critical role in providing NADPH in mitochondria in the absence of 
Pos1 [205]. As previously mentioned, the mitochondrial pool of NADPH is distinct from that 
in the cytosol. However, the mitochondrial transporter protein Yhm2, which exports citrate and 
imports a-ketoglutarate, is suggested to function as a NADPH-redox shuttle in yeast. The 
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export of citrate to the cytosol may result in the generation of cytosolic NADPH, providing that 
the citrate is converted to a-ketoglutarate (see Figure 3). Thus, the Yhm2 transport reaction 
yields a net export of reducing equivalents from mitochondria to the cytosol, supported by an 
observed decrease in cytosolic NADPH/NADP+ ratio in a yhm2∆ mutant [206].  
     One of the most important flux diversions which can be made to influence the NADPH 
supply is the branchpoint of glycolysis and the oxidative PPP. ZWF1 is considered to be 
constitutively expressed on various carbon sources [196, 207]. However, the flux through the 
node is not static, and is believed to be of a flexible type [208]. For example, roughly 16.2% of 
all the glucose consumed in an aerobic batch culture are shuttled via the oxidative PPP, while 
the corresponding number is 44.2% in an aerobic, glucose-limited chemostat, closely 
corresponding with the increased requirement of NADPH for biomass synthesis [209]. Zwf1 
activity in crude cell free extracts is inhibited by NADPH, indicating that the NADPH 
concentration or the NADPH/NADP+ ratio dictates the flux entering the oxidative PPP [210]. 
Furthermore, overexpression of YNO1 in S. cerevisiae – encoding an NADPH oxidase – caused 
a 10-fold increase in superoxide levels, while no such increase was present in a zwf1Δ mutant. 
This further supported the idea that the flux through the oxidative PPP dynamically increases 
in response to the NADPH demand [211]. 
     However, the discussed flux diversion is not solely dependent on the activity of Zwf1. This 
is exemplified by the processes set in motion by oxidative stressors, leading to a dynamic 
redirection of glycolytic flux towards the oxidative PPP. This metabolic reconfiguration is 
initiated via the inhibition of GAPDH in response to oxidative perturbation, occurring within 
seconds of exposure and thus effectively blocking the glycolytic flux and increasing the 
intracellular concentration of G6P [212]. Exposure to oxidative stress also activates gene 
expression of multiple genes within the oxidative and non-oxidative PPP, as well as other genes 
encoding NADPH-producing enzymes, mediated by the transcription factor Stb5 [47, 213]. 
However, such regulation is bound to be slower than a metabolic reconfiguration due to the 
requirement of mRNA and protein synthesis. 
 
2.5 Engineering of yeast metabolism 
 
The cell factory 
 
The production of ethanol and penicillin by S. cerevisiae and the filamentous fungus 
Penicillium chrysogenum, respectively, are well-established industrial processes. They both 
represent examples of how microorganisms can be utilized as cell factories, catalyzing the 
conversion of simple carbohydrate substrates into specific metabolic products of commercial 
interest. Industrial penicillin-producing strains are today estimated to produce more than 
100.000-fold more than the first confirmed penicillin-producing isolate [214]. Both of the 
above-mentioned processes exploit the natural substrate-to-product spectrum of the production 
organism, and the discussed optimization of the penicillin production process were primarily 
made via untargeted mutagenesis and optimization of cultivation parameters.  
     The rapid progress made in the field of genomics and genetic engineering over the recent 
decades now allows for a transfer of traits between organisms in a precise fashion. This has 
vastly expanded the industrial microorganism production portfolio, as attractive metabolic 
pathways of organisms which for example are problematic to culture or genetically modify can 
be inserted into a more suitable production host. As a result, research fields such as synthetic 
biology and metabolic engineering are now blooming, and researchers aim to design, create and 
study customized organisms with a precise tasks [215]. For example, pathway architecture can 
be modified to achieve a better yield of an established production process, or a newly unraveled 
metabolic pathway can be installed to enable commercial production of a high-value chemical.  
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     One of the greatest challenges societies of today face is to find substitutes for the 
conventional oil and natural gas refineries, which provide petroleum for the transportation 
sector and platform chemicals and secondary chemicals for the polymer and solvent industries. 
Not only are these resources physically limited, but they release massive amounts of carbon 
dioxide to our atmosphere when extracted, processed and used. The use of microbial catalysts 
to produce carbon-based chemicals and fuels, e.g. of an oleochemical character, on the other 
hand constitutes a sustainable alternative, as carbon dioxide sequestering plants and organisms 
can act as the feedstock (or even as cell factories themselves) [216]. Furthermore, as discussed 
in Chapter 1, fermentation-based technologies for production of compounds based on FAs 
offer a much broader range of substrates to be utilized compared to the conventional chemical 
conversion of plant- and/or animal-based oils. Microbial communities have conquered virtually 
every environmental niche imaginable and have consequently adapted to metabolize numerous 
food sources - traits which can be transferred between organisms. Thus, current waste products 
from agriculture and forestry industries could be used as substrate for the production of various 
products if microbes can be constructed to catalyze an efficient conversion, for example yeasts 
engineered to utilize cellulose and hemi-cellulose as substrates [217].  
     Some parameters of importance to consider in the design of a cell factory are yield, titer and 
productivity. The yield represents how much product is obtained for a certain amount of 
substrate (e.g. g product/g substrate), and the titer is how much product is obtained per culture 
volume (e.g. g/L). The productivity in turn reflect how efficient the production process is in 
terms of time (e.g. g/L/h). The three parameters will influence an industrial production to a 
smaller or greater extent. For example, if a bulk chemical of lower value is produced, the 
product-on-substrate yield is required to be high, as the cost of the substrate commonly accounts 
for a large proportion of the total production cost. However, even if a process has a high yield 
it might not be optimal from a productivity point of view. For example, if the microbial 
conversion process takes a full week to reach completion, the cost of the production facility 
might outcompete the benefit of a high yield. Finally, final titer is usually a parameter of 
importance in the purification process, where the cost can reach high levels if the concentration 
in the medium is low [218]. 
 
Metabolic engineering principles 
 
As mentioned, metabolic engineering allows us to optimize fermentation processes by 
introducing targeted genetic changes into the microbial catalyst. A schematic overview of the 
metabolic engineering process is shown in Figure 6. It consists of repeated cycles of design of 
modifications to introduce, strain construction, cultivation and sampling, and data analysis. The 
workflow tends to be iterative, as the analysis of the effect of an introduced genetic change 
often will indicate that additional genetic perturbations are required to improve the performance 
of the cell factory.  
     The “Design” step of the cycle commonly makes use of a “rational strategy” based on 
currently available knowledge of the chosen organism, such as metabolic reaction networks and 
known protein properties. The complexity of biological systems however makes this process 
imperfect, as decisions commonly are based on a highly simplified view of metabolism. It is 
becoming more common that the design step is aided by genome scale models of 
microorganisms. These models aim to include a large proportion of the reactions taking place 
within a cell and in the simplest form handle three levels of information: metabolites, reactions 
and genes, from which predictions of metabolic fluxes can be made. The first genome-scale 
model of yeast metabolism was published in 2003, which contained 1145 reactions, 825 
metabolites and 708 genes [219]. From there onwards newer versions have regularly been 
presented with more details (e.g. including more genes/metabolites) and with different types of 
2. Background 
 23 
constraints laid on top of the original network to achieve a better prediction of cellular behavior. 
An example of constraints employed are based on transcriptome data, in which the information 
on gene expression are used to adjust the flux passing through certain reactions. Analogously, 
proteomic, thermodynamic, enzyme kinetic and metabolomic constraints can be implemented 
to achieve better predictions [220].  
 
 
 
Figure 6. Overview of the biorefinery concept and the metabolic engineering cycle.  
Adapted from Bergman et al. [152]. 
 
     The “Build” step of the metabolic engineering cycle entails to introduce the genetic 
change(s) into the host, either by expressing the desired construct from a plasmid or by 
integrating them into the host genome – a step also referred to as strain construction. In 1973, 
Cohen, Boyer and co-workers reported the first event of successfully engineering the bacterium 
Escherichia coli, thus developing the field of recombinant DNA technology. Shortly thereafter, 
techniques became available to modify the yeast S. cerevisiae [221, 222]. As opposed to non-
homologous end joining, yeast preferentially repairs double strand breaks via homologous 
recombination (HR) [223]. As a result, by simply introducing a linear DNA fragments bearing 
homologous sequences to a specific chromosomal location, the fragment will be perceived as a 
double strand break and specifically incorporated into the genome. Conventionally, a type of 
selective marker has been required to be simultaneously incorporated in order to efficiently 
identify mutated cells [224]. With the advent of CRISPR/Cas9 technology – first reported for 
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use in S. cerevisiae six years ago [225] – multiple marker-less modifications can now be 
introduced in a single transformation [226]. 
     Once the desired strains are constructed, the “Test” phase can be initiated. Simply put, it 
entails to cultivate strains in one way or another and take samples which convey information 
about strain performance. First tests are commonly performed in a small-scale setting. There 
are high-throughput systems that allow to cultivate a large number of individual strains (such 
as 48 or 96-well plates) at once and automatically monitor cell density and/or fluorescence. 
Such methods are superior in terms of a first screening of growth but limited for applications 
where larger sampling volumes are required. At a somewhat larger scale, falcon tubes or shake 
flasks are commonly utilized. However, certain cultivation parameters are hard to control in 
small scale cultures. For example, full oxygenation is difficult to achieve by simply swirling 
the culture, especially at higher cell densities. Furthermore, even if buffered medium is utilized, 
the pH is altered throughout the culture period.  
     A highly controlled experiment can be performed in bioreactors, where the parameters 
temperature, pH, and dissolved oxygen can be precisely monitored and adjusted along the 
cultivation. Furthermore, the system can be connected to a sensor analyzing the gas content of 
the exhaust gas, giving important information about the rate of oxygen consumption and carbon 
dioxide formation. The medium composition will still change over time in a batch culture, and 
by introducing genetic changes into strains, the growth rate will also likely be altered from the 
reference strain. By employing a chemostat setup, also the medium composition and growth 
rate can be controlled within the bioreactor. 
 
Metabolic engineering tools and strategies 
 
A central concept in metabolic engineering is to re-direct carbon fluxes within the cell to 
optimize product formation. An increased flux through a pathway of interest can be achieved 
through several different means, but it commonly comes down to increasing the overall enzyme 
activity in a particular pathway. The pathway in turn can either be “endogenous”, meaning that 
it originates from within the concerned host organism, or “heterologous”, meaning that it stems 
from another source that can provide the host with a novel or improved function.  
     The modulation of enzyme activity can be achieved by targeting different levels of 
regulation. One of the most common ways is to enhance the transcriptional level of the target 
genes, generating more messenger RNA (mRNA) which in turn gets translated into proteins. 
This can be accomplished by increasing the total gene copy number in the cell or utilizing strong 
promoters, i.e. the gene regulatory elements present upstream of the gene sequence that recruit 
components of the transcriptional machinery. Frequently, modulation of translational efficiency 
is also utilized as means to increase enzyme activity. In case of expression of heterologous 
genes, codon-optimization can be utilized, which optimizes the nucleotide content of the gene 
sequence to match the most prevalent codon usage in the receiving organism [227]. Addition 
of a short “Kozak consensus sequence” just upstream of the start codon can also be utilized, 
which enhances initiation of translation of the mRNA sequence [228]. The last, and most direct, 
step to influence enzyme activity is to make targeted modifications of the protein sequence to 
influence catalytic activity of the enzyme, for example by enhancing binding affinity of the 
enzyme to its substrate or by abolishing post-translational regulation. Another way is to 
physically bring the enzyme in closer proximity to its substrate, i.e. to enhance the local 
concentration of substrate – by substrate channeling-techniques.  
     Due to the inherent nature of metabolic networks, the product of one reaction is commonly 
the substrate for one or more reactions. Therefore, another common strategy to increase flux 
through a desired pathway is to down-regulate, or completely abolish, flux through competing 
pathways. A down-regulation can be achieved by replacing the native promoter of a gene with 
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a weaker one, or introducing a mutation into a gene which limits the flux through the produced 
enzyme. Furthermore, if the enzyme activity is not essential for cell survival, the activity can 
be completely abolished, either by introducing a premature stop-codon, or by deleting the 
genetic material from the cell completely.  
     A metabolic engineering strategy commonly aims to influence the metabolism of the host at 
many different points simultaneously. Table 1 presents some examples of utilized strategies 
when constructing cell factories. For a more comprehensive overview, the reader is referred to 
reviews on the topic, for example by Lee et al. [229]. 
 
Table 1. Examples of metabolic engineering strategies utilized in yeast. 
 
Strategy Examples of modifications to be introduced Reference 
Optimize/expand     
substrate utilization 
Modify cells to more efficiently take up certain substrate, to co-
utilize substrates, or introducing genes which enable utilization 
of substrates not naturally consumed by the host. 
 
[230] 
Reduce/eliminate   
byproduct formation 
Deletion or downregulation of genes responsible for diverting 
flux from the targeted pathways 
 
[31] 
Increase precursor 
metabolite pool 
Enhancing expression of genes catalyzing reactions upstream 
of the desired target compound to steer the carbon flux toward 
precursor formation (and, consequently, product formation) 
 
[231] 
Rerouting of metabolic 
pathways 
Introduction of a heterologous enzyme which in a more 
beneficial way, e.g. with increased energy or carbon efficiency, 
can produce the sought-after product. 
 
[232] 
Co-factor engineering Increase production of a required co-factor; alter co-factor 
specificity of enzymes; introducing a redox-balance reaction to 
maintain cellular homeostasis.  
 
[233] 
Expanding product 
spectrum 
Introducing heterologous pathways to produce non-native 
chemicals; engineering endogenous enzymes to form new 
products. 
 
[22] 
Enhancing strain 
tolerance 
Development of tolerance (for example in the presence of 
fermentation inhibitors or toxic products). Required 
modification is commonly identified by performing adaptive 
laboratory evolution/genome sequencing, followed transferring 
the suspected causal mutation into desired host. 
[234] 
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3 Prospects and limitations of a phosphoketolase-
based route for acetyl-CoA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1 Engineering acetyl-CoA metabolism 
 
As described in the previous chapter, acetyl-CoA is a central metabolite highly relevant for a 
multitude of cellular processes. Acetyl-CoA is the fuel of the TCA- and glyoxylate cycle, the 
acetyl-donor in protein acetylation, and the immediate precursor for isoprenoid and fatty acid 
synthesis. The role of acetyl-CoA as the precursor for the biosynthesis of various commercially 
interesting products, such as fatty acids (e.g. used as/in dietary supplements, consumer 
products, lubricants, biofuels), isoprenoids (e.g. used as/in flavor and fragrances, dietary 
supplements, vitamins, pharmaceuticals, and biofuels), polyketides (pharmaceuticals), 
polyhydroxyalkanoates (biodegradable polymers), etc., has led to a great interest for 
engineering acetyl-CoA metabolism in S. cerevisiae as well as in other organisms. In this 
section a summary of various strategies explored by the metabolic engineering community to 
influence acetyl-CoA metabolism in S. cerevisiae are presented. 
     The most apparent way to increase acetyl-CoA supply is to increase the flux through the 
natural pathway towards cytosolic acetyl-CoA, namely through the PDH bypass (Pdc/Ald/ 
Acs). An early effort elevate acetyl-CoA levels in yeast through engineering the PDH bypass 
were performed to positively influence the production of the isoprenoid amorphadiene [235]. 
The strategy was based on overexpression of the native target gene ALD6 and expression of a 
mutant acetyl-CoA synthetase from the bacterium S. enterica. By removing an inhibitory 
acetylation site in the Acs (ACSSEL641P), a 4-fold increase in amorphadiene production was 
achieved. A successful extension of this strategy to promote α-santalene synthesis additionally 
utilized overexpression of ADH2, to promote ethanol conversion to acetaldehyde, and a deletion 
of CIT2 or MLS1, to prevent the acetyl-CoA of flowing into the glyoxylate cycle [236].  
     However, the strategies adopted in the above-mentioned studies do not resolve the fact that 
the native route to form cytosolic acetyl-CoA from pyruvate in S. cerevisiae results in loss of 
CO2 and energy. The carbon loss results from the decarboxylation of pyruvate catalyzed by 
Pdc1/5/6, and energy expenditure (ATPàAMP) occur during activation of acetate by Acs1/2. 
As both carbon and energy loss limit the theoretical yield of the biorefinery process, multiple 
studies have investigated acetyl-CoA generating routes with potential to increase the theoretical 
yield of product formation in S. cerevisiae, commonly of heterologous origin. A visual and 
stoichiometric overview of these strategies are shown in Figure 7 and Table 2, respectively. 
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ATP-citrate lyase (ACL) 
 
ATP-citrate lyase (ACL) is responsible for production of cytosolic acetyl-CoA from citrate in 
many higher eukaryotic species, and is a hallmark feature of many oleaginous yeasts [237]. 
Since the citrate originates from mitochondrially produced acetyl-CoA, the pathway is not able 
to circumvent carbon loss. In addition the reaction requires ATP, but forms ADP instead of 
AMP, resulting in a lower net consumption of energy compared to the native yeast pathway. 
The pathway has been utilized in several different metabolic engineering strategies in S. 
cerevisiae to positively influence production of fatty acids, n-butanol and mevalonate [238-
241]. An ACL from Mus musculus was either expressed in a wild type or in strains in which 
mitochondrial forms of isocitrate dehydrogenase were disrupted to increase the citrate 
concentration, and both strategies were found to have moderate positive effects on fatty acid 
production [238]. Lian et al. enhanced titers of n-butanol by two-fold when they expressed the 
ACL from the oleaginous yeast Y. lipolytica [239]. More recently, several ACLs from different 
organisms were expressed and compared in S. cerevisiae. The ACL from the filamentous fungi 
Aspergillus nidulans were shown to have a 4-6 fold higher activity than previously evaluated 
enzymes, including those from M. musuculs and Y. lipolytica. In combination with other 
modifications, the expression of the A. nidulans ACL significantly increased mevalonate 
production in S.  [240], and has subsequently fruitfully been used to enhance FA synthesis [15]. 
 
 
Figure 7. Strategies to produce cytosolic acetyl-CoA in S. cerevisiae via A) the native (PDC/ALD/ACS) or the 
alternative routes PFL/FDH, PO/PTA, PDHcyto, A-ALD, PDHmito+carnitine and ACL and B) a suggestion of 
XFPK/PTA route in combination with endogenous reactions catalyzed by the gluconeogenetic enzyme Fbp1 and 
enzymes from the PPP and glycolysis. Adapted from van Rossum et al. [43]. 
 
Cytosolic expression of pyruvate dehydrogenase complex (PDHcyto) 
 
An alternative way to improve energy efficacy in cytosolic acetyl-CoA synthesis is to express 
a pyruvate dehydrogenase complex in the cytosol (PDHcyto). This solution enables an ATP-
independent synthesis of cytosolic acetyl-CoA from pyruvate. The strategy was published by 
two independent research groups in 2014. The approach of one group involved either co-
targeted the mitochondrial S. cerevisiae PDH complex to the cytosol or heterologous expression 
of PDH from E. coli [239], while the second group utilized a PDH from Enterococcus faecalis 
[242]. Lian et al. claimed that both PDH-expression strategies led to increased acetyl-CoA 
levels, had a positive effect on the production of n-butanol, and supported growth of a PDC-
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negative strain [242]. The researchers however did not comment on the expression of genes 
involved in lipoylation of the PDH-subunit E2, nor did they supplement their cultures with 
lipoic acid. Kozak et al., on the other hand, found that expression of the PDH-subunits from E. 
faecalis exclusively supported growth in an ACS-negative strain providing genes encoding 
putative lipoate ligases (able to activate subunit E2) were expressed and lipoic acid was added 
to the medium. During aerobic and anaerobic batch culture, the growth rate of the modified 
strain was 0.35 h-1 and 0.30 h-1, respectively, while the wild type strain had a growth rate of 
0.42 h-1 and 0.33 h-1 [239]. 
 
Carnitine-dependent export of mitochondrially produced acetyl-CoA (PDHmito+carnitine) 
 
As described, the PDH complex offers an ATP-neutral route to form acetyl-CoA from pyruvate, 
which in minimal media does not contribute to the cytosolic pool due to the impermeability of 
the mitochondrial membrane to acetyl-CoA. Even if carnitine is present and the acetyl-carnitine 
transport is active, the transport machinery appears to be unidirectional, favoring acetyl-CoA 
import to the mitochondria [106, 110, 111]. A recent study successfully evolved yeast for 
carnitine-dependent export of mitochondrial acetyl-CoA to the cytosol [243]. Laboratory 
evolution was performed in an ACS-negative, carnitine supplemented yeast strain that 1) 
constitutively expressed the yeast CATs and 2) contained PDHcyto that could be inactivated at 
omission of lipoic acid. This allowed to create a provisional condition where the strain was 
dependent on mitochondrial synthesis for its cytosolic acetyl-CoA requirements, and thus for 
growth. Adaptive evolution of this strain yielded mutants able to grow on glucose in the absence 
of lipoic acid, but not in the absence of carnitine. Another research group recently reconstructed 
a heterologous route for carnitine biosynthesis from Neurospora crassa in S. cerevisiae, and 
successfully demonstrated synthesis of carnitine when the precursor trimethyl-lysine was 
supplemented [244]. Thus, further development of these ideas could potentially provide a 
platform for a more energy efficient provision of cytosolic acetyl-CoA supply in yeast.  
 
Table 2. Overall stoichiometry of acetyl-CoA formation from glucose 
 
Pathway Stoichiometric function 
Native ½ Glucose + 2NAD(P)+ + ATP + CoA + H2O à  
acetyl-CoA + 2(NAD(P)H + H+) + CO2 + ADP + Pi 
ACL ½ Glucose + 2NAD+ + CoA à acetyl-CoA + 2(NADH + H+) + CO2 
PDHcyto / mito+carnitine 
A-ALD 
PFL/FDH 
½ Glucose + 2NAD+ + ADP + Pi + CoA à  
acetyl-CoA + 2(NADH + H+) + CO2 + ATP + H2O 
PO/PTA ½ Glucose + NAD+ + ADP + Pi + CoA + ½ O2 à  
acetyl-CoA + NADH + H+ + CO2 + ATP + 2H2O 
XFPK/PTA 1⁄3 Glucose + 1⁄3 ATP + CoA à acetyl-CoA + 1⁄3 (ADP + Pi) + 2/3 H2O 
 
Acetylating acetaldehyde dehydrogenase (A-ALD) 
 
Acetylating acetaldehyde dehydrogenase (A-ALD) also provides an ATP-neutral conversion of 
pyruvate to acetyl-CoA and is common in many prokaryotes. The enzyme catalyzes a 
reversible, NAD+-dependent conversion of acetaldehyde to acetyl-CoA, and has in yeast 
previously been expressed to promote the opposite reaction in order to enhance ethanol yield 
from xylose and acetate [245, 246]. Kozak et al evaluated four heterologous, codon-optimized 
A-ALD candidates in an ALD-negative (ald2∆ald3∆ald4∆ald5∆ald6∆) yeast and found that 
all candidates supported relatively fast growth [232]. However, the expression was linked to a 
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decreased biomass formation, believed to be caused by an accumulation of the toxic 
intermediate acetaldehyde in the strains. At the same time, calculations of ∆G´ suggests that an 
accumulation of acetaldehyde indeed is a thermodynamic requirement for the reaction to form 
acetyl-CoA under in vivo conditions. 
 
Pyruvate formate lyase (PFL) 
 
Pyruvate formate lyase (PFL) constitutes an additional ATP-independent route of acetyl-CoA 
formation from pyruvate, a reaction that additionally produces formate. In order to avoid 
negative effects mediated by formate, PFL should be co-expressed with (or expressed in a host 
containing activity of) formate dehydrogenase (FDH), which oxidizes formate to CO2 using 
NAD+ as electron acceptor. The catalytic activity of PFL depends on an activating enzyme 
(PFL-AE), that abstracts a hydrogen atom from its active site – an activity which in turn is 
dependent on flavodoxin as electron donor. The radical makes PFL sensitive toward oxygen 
and the enzyme is therefore most suited for anaerobic processes. PFL and PFL-AE were first 
expressed anaerobically in S. cerevisiae in 2009, during which formate accumulation was 
observed [247]. Kozak et al expressed several PFL candidates with their corresponding PFL-
AE, and observed anaerobic growth on glucose of the candidates from E. coli and Lactobacillus 
plantarum in an ACS-negative strain, reaching 73% of that observed in the ACS-positive 
reference strain [232]. PFL and PFL-AE from E. coli have also been co-expressed with 
flavodoxin and/or ferredoxin proteins from E. coli. The study concludes that the electron donors 
enhance the performance of PFL-expressing strains, and the system as a whole improves the 
growth of a PDC-negative mutant even in aerobic conditions [248]. 
 
Pyruvate oxidase and phosphotransacetylase (PO/PTA) 
 
The flavoprotein pyruvate oxidase (PO) can also catalyze an ATP-neutral conversion of 
pyruvate to acetyl-CoA if co-expressed with a phosphotransacetylase (PTA) – both commonly 
found in bacteria. The PO utilizes an oxygen- and inorganic phosphate-dependent oxidation of 
pyruvate to acetyl-phosphate (AcP), CO2 and H2O2. The PTA in turn catalyzes the reversible 
conversion of AcP and CoA into acetyl-CoA and Pi. Detoxification of the hydrogen peroxide 
commonly occurs in organisms through catalase activity. The biggest difference of the PO-
dependent and PDHcyto/A-ALD/PFL-dependent pathways is the requirement for molecular 
oxygen and the generation of fewer reducing equivalents. A PO from Aerococcus viridans and 
a PTA from S. enterica were recently expressed in a PDC-negative strain of S. cerevisiae that 
substantially improved growth and increased the production of the acetyl-CoA dependent 
products farnesense and 3-hydroxypropanoate (3-HP) [249].  
 
Phosphoketolase and phosphotransacetylase (XFPK/PTA) 
 
The last route to have been used to promote cytosolic acetyl-CoA synthesis in S. cerevisiae, 
and which this thesis largely focused on, is based on the combined action of a phosphoketolase 
(XFPK) and a PTA (described in PO/PTA section). XFPK enzymes can catalyze either one or 
both of the redox-, carbon- and energy-neutral conversions of xylulose-5-phosphate (X5P) and 
fructose-6-phosphate (F6P) according to: 
 
xylulose-5-phosphate + Pi à glyceraldehyde-3-phosphate + acetyl-phosphate 
fructose-6-phosphate + Pi à erythrose-4-phosphate + acetyl-phosphate 
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Phosphoketolases (EC 4.1.2.9 and EC 4.1.2.22) are ThPP dependent enzymes with important 
metabolic roles in some species of fungi, in heterofermentative and facultative 
heterofermentative lactic acid bacteria (LAB),  and in bifidobacterial species [250]. In 
particular, the F6P-specific XFPK is considered to be a taxonomic marker for the 
Bifidobacteriaceae family, due to its central role in the so-called “bifid-shunt” [251]. From the 
XFPK-produced AcP, PTA can catalyze the following reversible reaction: 
 
acetyl-phosphate + CoA ßà acetyl-CoA + Pi 
 
Both the XFPK and the PTA reaction (in direction of acetyl-CoA formation) are 
thermodynamically favorable during standard biochemical conditions, with ∆GR°´= -49.9 to        
-63.2 kJ mol-1 for the XFPK-catalyzed reactions, and ∆GR°´= -9.8 kJ mol-1 for the PTA reaction 
[252]. As indicated in Figure 7B, The XFPK/PTA route can in combination with activity of 
enzymes of the non-oxidative PPP, glycolysis and the gluconeogenic enzyme fructose-1,6-
bisphosphatase theoretically enable complete carbon conservation in the production of acetyl-
CoA from fructose-6-phosphate [253]. However, glucose must initially be phosphorylated by 
hexokinase – a reaction which consumes ATP – to yield F6P in S. cerevisiae. This results in a 
negative ATP yield when XFPK/PTA is used to produce acetyl-CoA from glucose (Table 2). 
Therefore, some carbon must pass through glycolysis to produce ATP, preventing complete 
carbon conservation. 
     The XFPK/PTA route was initially introduced into yeast in combination with A-ALD to 
enhance ethanol fermentation from xylose [245]. Thereafter it has been successfully 
implemented to enhance production of acetyl-CoA-derived compounds such as 
polyhydroxybuturate (PHB) and fatty acid ethyl esters (FAEE) [32, 45]. The XFPK used in the 
studies by de Jong et al. and Kocharin et al. originates from A. nidulans, and the flux through 
the heterologous enzyme had previously been confirmed in S. cerevisiae by 13C-based 
metabolic flux analysis [44]; however, the activity of the enzyme was not directly evaluated. 
 
Comparative advantage of the XFPK/PTA route in acetyl-CoA and fatty acid formation 
 
As shown in Table 2, the different routes for acetyl-CoA formation differ with respect to acetyl-
CoA, ATP, NAD(P)H and CO2 yield on glucose [43].  
     The ATP yield of the native route is negative (–1 ATP), as the ATP produced in glycolysis 
per ½ glucose is hydrolysed to AMP, that cellularly corresponds to a consumption of two 
equivalents of ATP. As discussed in the previous section, the XFPK/PTA by-passes the ATP-
producing steps of glycolysis, and hence the route has a negative ATP-yield (-1/3 ATP per 1/3 
glucose), while all other routes have a neutral (ACL) or positive ATP-yield on glucose. The 
XFPK/PTA pathway is on the other hand the only route for acetyl-CoA formation 
circumventing production of CO2, which also is an important factor to consider in optimizing 
product-on-substrate yield.  
     Furthermore, the XFPK/PTA route is alone in offering a redox-neutral synthesis of acetyl-
CoA, a fact which influences the attainable yield of various compounds [43]. An NADH surplus 
obtained in glycolysis and through the various acetyl-CoA forming pathways needs to be re-
oxidized to obtain redox balance. Thus, if NADH is not consumed during product formation it 
is required to be oxidized via other processes, such as respiration which in turn generate large 
amounts of ATP. In order to optimize a production process using a cell factory a slightly 
positive ATP yield on glucose is optimal, which can be used for cellular maintenance. 
Conversely, a large positive ATP yield will on the other hand divert glucose toward biomass 
formation, resulting in a decreased product-on-substrate yield. 
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     An additional aspect to consider in the specific case of production of fatty acids is the 
requirement of NADPH. The native PDH bypass supplies 1 NADPH per acetyl-CoA formed 
through the action of Ald6, while the remaining pathways depend on a re-routing of carbon 
through the oxidative PPP for cytosolic NADPH generation.  
     The undesirable effects of the requirement to re-oxidize surplus NADH through respiration 
and completely rely on the oxidative PPP to generate NADPH become obvious when inspecting 
the calculation of the theoretic yield of different acetyl-CoA formation pathways for production 
of the fatty acid palmitic acid. While the NADH-producing pathways with neutral or positive 
ATP yield slightly decreases the yield compared to the native pathway (0.194 vs. 0.203 
molproduct/molsubstrate), the XFPK/PTA pathway increases the yield to near 87% of the theoretical 
maximum (0.226 vs. 0.261 molproduct/molsubstrate) [43]. However, the highest yield is calculated 
to be obtained if a combined approach is employed, where the XFPK/PTA pathway should be 
used to produce 65% of the acetyl-CoA while the remaining 35% should stem from an ATP-
independent pathway, corresponding to 89% of the maximum yield [43]. 
 
3.2 Evaluating different phosphoketolases (Paper I) 
 
With the potential benefits the XFPK/PTA pathway could offer fatty acid synthesis, we set out 
to optimize and study certain aspects of the pathway. Stochiometric analysis is unquestionably 
a useful tool to understand the prospects as well as limitations of a certain pathway in a 
metabolic engineering scenario. However, such analyses assume that there is no limitation in 
enzyme fluxes and no interfering reactions. Reality unfortunately often tells a completely 
different story, where thermodynamic constraints, enzyme kinetics and competing cellular 
reactions greatly influence a metabolic pathways functionality.  
     Our initial goal was to find XFPK candidates with high catalytic activity and different 
substrate specificities. For example, since F6P is present at higher concentration in cells during 
growth on glucose [254], a higher flux through the XFPK could likely be achieved by utilizing 
an enzyme with high specificity toward F6P. As previously mentioned, XFPK enzymes with 
preference for X5P are common in heterofermentative lactic acid bacteria and enzymes with 
preference for F6P are common in bacteria of the Bifidobacteriaceae family. The recombinant 
pathway thus has potential to be increased considerably by investigating enzyme candidates 
from such sources. We decided to compare nine different enzyme candidates, including the 
XFPK from A. nidulans previously observed to positively influence production of metabolites 
depending on acetyl-CoA. Of the eight remaining candidates, three were from the 
Bifidobacterium genus – B. adolecentis, B. breve, B. lactis – and five from the Firmicute 
phylum: Clostridium acetobutylicum, Leuconostoc mesenteroides, Lactobacillus 
paraplantarum, and two candidates from Lactobacillus plantarum. The enzyme selection was 
in part based on that XFPK function had been verified by previous studies [245, 253, 255-260]. 
Furthermore, we wanted to test candidates from different bacterial families, and to include 
enzymes evaluated in published metabolic engineering strategies for benchmarking. The 
enzyme nomenclature used throughout the thesis follows the initial of the genus and the species-
specific name of the origin of the enzyme, e.g. Xfpk(BB) for the phosphoketolase from B. breve. 
     Figure 8 shows a percent identity matrix of the investigated XFPK candidate amino acid 
sequence. As expected, the degree of similarity of the enzymes from the Bifidobacterium genus 
was high (minimum of 85% identity), while the distance was larger for most candidates falling 
within the Firmicute phylum (identity between 52-68%), and a comparison between the two 
mentioned bacterial groups returns an identity between 43-48%. Most dissimilar to all other 
XFPK candidates is the enzyme from A. nidulans, with a maximum of 37-41% homology. 
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     Plasmids carrying the codon-optimized XFPK sequences were transformed into the URA3-
lacking laboratory yeast strain CEN.PK 113-5D [261]. The parent plasmid pSP-GM1 [262] was 
co-transformed and evaluated alongside with the other strains as a control. 
 
 
 
Figure 8. Percent identity matrix of investigated phosphoketolase candidates.  
     To find functionally expressed enzymes and to distinguish different levels of affinity of 
enzyme candidates to X5P and F6P, respectively, used an in vitro assay based on a modified 
version of the established ferric hydroxamate method [263]. Enzymatically produced AcP is in 
the reaction converted to ferric acetyl hydroxamate, appearing as a brownish coloration 
quantifiable at 505 nm, as indicated in Figure 9A. Crude cell-free extracts from strains 
expressing the nine XFPKs were either provided with F6P or R5P and inorganic phosphate as 
substrates. R5P was used as a substitute for X5P due to a market shortage, but as crude cell-
free extracts and not purified enzymes were utilized, we relied on the endogenous yeast 
enzymes Rki1 and Rpe1 to interconvert R5P to X5P, as indicated by a previous study [253]. 
     The calculated specific activities were normalized to the total protein content of the added 
crude cell-free extracts, and the combined results of the X5P and F6P assay are shown in Figure 
9B. Seven out of the nine evaluated candidate XFPKs formed significant levels of AcP 
compared to the control pSP-GM1 using both X5P (assumed to be formed from R5P) and F6P 
as substrates. Two tested candidates did not display activity in either of the two assays, namely 
Xfpk(AN) and Xfpk(LPP). The highest activity was observed for Xfpk(CA) and Xfpk(LM), 
both showed a specific activity using X5P as substrate close to 1.0 U / mg total protein, while 
their corresponding specific activity using F6P as substrate was considerably lower – around 
0.2 U / mg total protein. Xfpk(BB) together with Xfpk(BA) showed the highest activity on F6P 
– close to 0.5 and 0.4 U / mg total protein, respectively. Furthermore, these enzymes displayed 
a relatively high activity toward X5P, approximately 0.8 and 0.6 U / mg total protein for 
Xfpk(BB) and Xfpk(BA), respectively. In terms of total measured specific activity, Xfpk(CA), 
Xfpk(LM) and Xfpk(BB) all summed up to around 1.2 U of XFPK-activity/mg total protein. 
Candidate Xfpk(BL), previously expressed in yeast [245], had a sum of roughly 0.5 U / mg 
total protein. 
    As Xfpk(AN) was expressed with positive results in previous metabolic engineering 
strategies [32, 45], the negative results of Xfpk(AN) and Xfpk(LPP) were potentially due to an 
inherent insensitivity of the enzyme assay. During the optimization of the assay, we did observe 
a “bleaching” of the AcP standard curve when it was incubated with a mixture of protein 
extracts compared to when protein extract was left out (data not shown), indicating that the AcP 
was being degraded. The degradation effect should have been low due the addition of 
phosphatase inhibitor NaF to the reaction mixture. However, reaction rates of XFPK-candidates 
with lower activity could possibly have been matched by that of the (NaF-inhibited) 
endogenous phosphatases. 
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Figure 9. In vitro enzyme assays of XFPK activity. A) Physical outcome after 30 min incubation of assay 
reagents with crude XFPK-expressing cell-free yeast extracts, where formed AcP is converted to brownish ferric 
acetyl hydroxamate. B) Specific activities of the nine tested Xfpk enzymes with respect to substrates X5P 
(supplied as R5P) and F6P. Adapted from Bergman et al. [264]. 
  
     Due to the observation that AcP was degraded in the presence of crude cell-free extracts, 
(clearly observed during a parallel development of an in vitro assay to detect PTA activity, 
during which NaF was omitted from the reaction, see section 3.4), we researched recent patent 
literature and found that the endogenous glycerol-3-phosphatases encoded by GPP1 and GPP2 
likely were responsible for a large proportion of the hydrolysis of AcP to acetate [265].  
     In order to determine the validity of this claim, we constructed gpp1∆, gpp2∆ and 
gpp1∆gpp2∆ deletion mutants and used crude cell extracts prepared thereof in a phosphatase-
assay, where AcP was provided as the sole substrate. Indeed, we observed that yeast possesses 
an efficient enzymatic pathway to degrade AcP, and that a large proportion of this activity could 
be attributed to the Gpp1 and Gpp2 phosphatases (Figure 10). After 60 min of incubation, the 
AcP signal was completely lost in the wild type strain CEN.PK 113-5D. A single deletion of 
GPP2 had little impact on the overall AcP degradation, retaining 12% of the original AcP 
concentration after 60 minutes, while the corresponding value for the gpp1∆ mutant was 66%. 
In comparison, 93% of the original AcP amount was retained after 60 min incubation with the 
gpp1∆gpp2∆ sample. 
 
 
Figure 10. AcP degradation in crude cell-free extracts of CEN.PK113-5D and corresponding gpp1∆, gpp2∆ and 
∆gpp1/∆gpp2 deletion strains monitored over time. Adapted from Bergman et al. [264]. 
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Based on an efficient natural conversion of XFPK-produced AcP to acetate, also indicated by 
Sonderegger et al. [245], we hypothesized we could determine which XFPK candidate had the 
highest in vivo activity by monitoring acetate levels over time. We selected the three XFPK 
candidates that showed relatively equal and high total activities in the in vitro enzyme assay – 
Xfp(LM), Xfpk(CA) and Xfpk(BB) – as well as Xfpk(AN) for further evaluation. 
     The strains carrying pSP-GM1 and XFPK-harboring plasmids were cultivated in shake flask 
cultures until stationary phase was reached in all strains. The maximum specific growth rate 
(µ(max)), maximum levels of acetate accumulation, and complete acetate and OD600 profiles 
are shown in Figure 11A and B. XFPK expression indeed led to an increase in acetate 
accumulation in all strains with expected high enzymatic activity, where Xfpk(BB) showed a 
2.4-fold increase compared to the control. The fact that strains expressing Xfpk(BB) appeared 
to have a higher in vivo activity than strains expressing Xfpk(LM) and Xfpk(CA), even though 
they all showed a similar total activity level in vitro, is likely related to its higher activity on 
F6P. F6P is present at higher intracellular concentrations than X5P during glucose consumption 
[254], and the total substrate pool should thus be larger for enzyme with higher preference for 
F6P. No significant difference in acetate accumulation was however observed in the strain 
encoding Xfpk(AN), however, indicating that the use of the enzyme candidates with higher 
activity has potential to significantly enhance acetyl-CoA derived product formation.  
 
 
  
 
 
Figure 11. A) Maximal acetate accumulation and maximum specific growth rate measured in cultivations of 
Xfpk-expressing strains. B) Acetate and OD600 profiles during whole cultivation. The strains were cultivated in      
minimal media with 2% glucose in biological triplicates. Adapted from Bergman et al. [264]. 
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     Phosphoketolase expression of enzyme candidates with higher activity was also coupled to 
a decreased growth rate, reduced biomass formation and prolonged diauxic shift. Xfpk(BB) – 
likely to have the highest in vivo activity based on the acetate production profile – also displayed 
the most negatively influenced growth profile, with a final biomass yield and µ(max) of 
approximately 75% of that observed for the control.  
     Acetate is a weak organic acid, which dissociates into a negative anion and a proton at the 
near neutral pH conditions in the cell. In order to keep pH homeostasis, these ions are required 
to be actively pumped out of the cell via ATP-dependent transport processes. At low pH, the 
non-dissociated form of the acetic acid will form, that may passively diffuse back into the cell. 
This creates a futile cycle were ATP is consumed, referred to a proton or weak organic acid 
uncoupling [218]. Furthermore, in order to consume the Gpp1/Gpp2-produced acetic acid when 
glucose is depleted, ATP is required for its activation into acetyl-CoA. Thus, the cell is likely 
to encounters a situation which demands increased cellular utilization of ATP. Simultaneously, 
XFPK-dependent diversion of flux from glycolysis should result in a loss of ATP production, 
as steps of the ATP-generating portion of lower glycolysis will be bypassed.   
 
3.3 Characterizing effects of phosphoketolase expression (Paper II) 
 
Based on the initial observations of how XFPK expression influenced yeast growth, we decided 
to characterize the effects of expression in greater detail in Paper II. Common within the field 
of metabolic engineering is to introduce multiple genetic modifications simultaneously and 
evaluate the combined effects on cellular behavior and productivity. Using this approach, 
aspects of how the individual genetic changes influence the cell factory might be overlooked. 
In particular, expression of heterologous enzymes should be of particularly high concern, as 
these are likely to influence cellular physiology in unforeseen ways. For example, the XFPK 
product AcP is a to yeast non-native compound that potentially can be utilized by native 
processes or enzymes in an unconstrained manner. The ability of Gpp1 and Gpp2 to degrade 
the compound is one example, but potentially other effects could also influence the behavior of 
the cell. For example, the attenuated formation of acetate after glucose depletion (Figure 11B) 
indicates that AcP is present at elevated concentrations within the cell for a significant amount 
of time. In bacteria, AcP is considered a key contributor to protein acetylation and the 
compound has been shown to acetylate proteins non-enzymatically in vitro [266]. Thus, 
elevated levels of AcP may potentially influence yeast gene expression and metabolism [80]. 
     The characterization was performed by cultivating the control strain and XFPK expressing 
strain (xfpk(BB)) in bioreactors, allowing us to control parameters such as gas flow, stirring 
speed, pH and temperature during batch culture, and even growth rate during chemostat culture. 
The strains were initially cultivated in batch mode with 2% glucose at pH 5, and after the 
cultures had reached the ethanol phase, glucose-limited chemostat mode was initiated with a 
dilution rate of D=0.1 h-1 and a glucose concentration in the feed of 7.5 g L-1.  
     Based on continuous measurements of cell dry weight, OD600 and HPLC during exponential 
phase of the batch phase and steady state chemostat conditions, the physiological parameters 
listed in Table 3 were calculated.  
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Table 3. Physiological parameters calculated for control and strain xfpk(BB) in batch and chemostat mode. 
 
  Batch Chemostat 
Strain Control xfpk(BB) Control xfpk(BB) 
µ(max) (h-1) 0.353 ± 0.008 0.266 ± 0.006 0.104 ± 0.002 0.103 ± 0.003 
Y(x/s) (gCDW/gGlucose) 0.135 ± 0.00 0.123 ± 0.00 0.479 ± 0.01 0.409 ± 0.01 
q(Glucose) (mmol gCDW-1 h-1) -14.42 ± 0.36 -12.19 ± 0.39 -1.18 ± 0.06 -1.36 ± 0.03 
q(EtOH) (mmol gCDW-1 h-1) 21.46 ± 0.75 17.26 ± 0.52 - - 
q(Acetate) (mmol gCDW-1 h-1) 0.61 ± 0.04 1.38 ± 0.03 - - 
q(Glycerol) (mmol gCDW-1 h-1) 1.13 ± 0.03 0.62 ± 0.04 - - 
q(Pyruvate) (mmol gCDW-1 h-1) 0.13 ± 0.01 0.15 ± 0.00 - - 
q(Succinate) (mmol gCDW-1 h-1) 0.02 ± 0.0 0.01 ± 0.0 - - 
q(CO2) (mmol gCDW-1 h-1) 30.01 ± 0.32 28.16 ± 0.97 2.91 ± 0.19 3.34 ± 0.09 
q(Biomass) (mmol gCDW-1 h-1) 14.37 ± 0.31 10.81 ± 0.25 4.13 ± 0.31 4.07 ± 0.25 
q(O2) (mmol gCDW-1 h-1) -5.49 ± 0.53 -7.63 ± 0.76 -2.61 ± 0.20 -3.35 ± 0.12 
Carbon balance 107% ± 2% 107% ± 2% 99% ± 3% 92% ± 1% 
 
Strains were grown in biological quadruplicates in minimal media with 2% glucose during batch phase and 
0.75% glucose in the feed in chemostat conditions, pH 5. Values shown correspond to averages of quadruplicate 
measurements ± standard deviation. 
 
     Similar to our observations from shake flask cultivations, µ(max) and biomass yield were 
reduced in strain xfpk(BB), approximately 20% and 10% lower compared to the control, 
respectively. The glucose uptake rate was reduced by 15% in strain xfpk(BB), which 
complicates a direct comparison of the calculated metabolic fluxes. Thus, in order to visualize 
how the relative carbon fluxes differed between the two strains, the q-values in Table 3 were 
normalized to glucose uptake rate and entered into a schematic figure of yeast metabolism, 
shown in Figure 12. Thus, even though the flux toward CO2 is decreased in xfpk(BB) in Table 
3, the value in Figure 12 suggests a slight relative increase (38.5% versus 34.7%). If the CO2 
stemming from respiratory activity is estimated as the difference between the total amount and 
that produced from pyruvate decarboxylation in the cytosol (e.g. half of the normalized carbon 
flux toward ethanol), it indicates that the respiratory activities are increased by approximately 
50%. This correlates well with an observed increase in O2 consumption: q(O2) was calculated 
to be 5.5 mmol gCDW-1 h-1 for the control and 7.6 mmol gCDW-1 h-1 for xfpk(BB), indicating 
that XFPK expression leads to a higher respiratory demand during growth on glucose. 
     Glycerol formation was significantly reduced in strain xfpk(BB) compared to the control, 
possibly due to a reduced requirement to re-oxidize a surplus of NADH as XFPK redirects flux 
from lower glycolysis. Expression led to an increased pyruvate excretion (50% when 
considering the normalized fluxes), indicating a lower flux into the mitochondria or over 
pyruvate decarboxylase. The most pronounced increase in flux in strain xfpk(BB) was observed 
for acetate, where approximately 3.8% of the total carbon was directed towards acetate 
formation, compared to 1.4% in the control. The higher rate of acetate formation indirectly 
implies that XFPK-activity is present, as AcP is degraded by Gpp1 and Gpp2. 
 
3. Prospects and limitations of a phosphoketolase based route for acetyl-CoA 
 38 
 
 
Figure 12. Carbon fluxes (in % C-moles) of exponentially growing strains normalized to glucose uptake rate. 
Flux towards respiration is estimated as the difference between flux toward CO2 and half the flux toward 
ethanol. Fluxes corresponding to below 0.1% of the total flux are not shown in the figure. The strains were 
grown in biological quadruplicates with 2% glucose at pH 5. Adapted from Bergman et al. [267]. 
 
When behavior of xfpk(BB) and the control were compared in steady state conditions (Table 
3, right panel), no accumulation of fermentative products were detected in any of the strains, 
supporting that the growth was fully respiratory. As indicated in Table 3, the biomass yield 
was reduced by 15% in strain xfpk(BB), matched by an increased CO2 production rate and O2 
consumption. As acetate was not accumulated in the strains, it is unlikely that the lower biomass 
yield observed in strain xfpk(BB) was due to an additional ATP expenditure on cellular 
maintenance. Rather, the flux diversion of glucose from glycolysis – leading to a lower ATP 
yield on glucose – in combination with the ATP requirement to activate the Gpp1/2-formed 
acetate to acetyl-CoA was the cause of the reduced biomass formation. 
     The flux passing through the Xfpk(BB) enzyme during batch conditions can be estimated as 
the difference in acetate flux between xfpk(BB) and the control strain, corresponding to a 
moderate amount of 2.4% of the total carbon entering the cell (Figure 12). However, this 
estimate assumes that the acetate pool is left “untouched” until all glucose is depleted. Co-
consumption of glucose and acetate is not considered to be typical for S. cerevisiae, but it has 
been observed previously for CEN.PK strains [268]. 
     During chemostat conditions, the difference in acetate flux could not be used to estimate 
flux through Xfpk(BB), as no fermentative metabolites accumulated. The rate of O2 
consumption and CO2 production for the control strain were in good agreement with that of a 
previous study cultivating CEN.PK 113-7D in glucose at the same conditions [269]. The same 
study also reported on the corresponding flux values when the strain was grown on an equal 
molar concentration of acetate as carbon source. Thus, we can hypothetically consider that the 
substrate source of Xfpk(BB) was a mixture of glucose and acetate, and the proportion of each 
substrate a linear combination of the gas flux observed under glucose and acetate conditions. 
This corresponds to a situation where approximately 12% of the carbon respired is provided in 
the form acetate, which indirectly would stem from XFPK activity. As acetate produced by 
Xfpk in the chemostat represents an initial loss of ATP when glucose is activated by hexokinase 
(compared to the situation were acetate is provided as substrate directly), the calculated value 
of 12% is likely an overestimation.  
3. Prospects and limitations of a phosphoketolase based route for acetyl-CoA 
 39 
     In order to determine the influence of proton decoupling of the produced acetate on the 
negative growth characteristics seen in strain xfpk(BB), we set out to investigate the growth 
profiles of both strains at pH 4 and 6 at which the HA-form of acetic acid should be present at 
85% versus 5% (pKa=4.76). pH-controlled batch cultivations were conducted in biological 
duplicates with 2% glucose. An overview of the complete cell and acetate accumulation profiles 
are shown in Figure 13. For both strains, the maximum acetate concentrations obtained at pH 
6 were about two to three-fold of those seen at pH 4 (Figure 13, right graph). Under both pH 
conditions, maximum acetate accumulation in xfpk(BB) was more than two-fold higher than 
the control, the CO2-production rate was higher for xfpk(BB) compared to the control at both 
pHs, while xfpk(BB) had a higher O2 production rate compared to the control at pH 4 (see 
supplementary data file to Paper II). 
 
Figure 13. Biomass and acetate accumulation of control and phosphoketolase expressing strain (xfpk(BB)). 
Strains were cultivated in biological duplicates in pH-controlled (pH 4 and pH 6) batch cultivations in minimal 
medium with 2% glucose. Error bars are ± standard deviation. Adapted from Bergman et al. [267]. 
 
     During exponential growth on glucose an increased pH had a minor negative influence on 
µ(max) in both strains, and the biomass yield for the control strain was near to unchanged. In 
contrast, at pH 6, the biomass yield was significantly increased for xfpk(BB) compared to its 
pH 4 counterpart, from 89% to about 95% of that of the control in glucose phase – indicating a 
more energy efficient growth. As the maximum specific growth did not increase, this suggests 
that the parameter is dependent on other expression-related effects, likely by the flux diversion 
from glycolysis. After glucose was depleted from the media, an increase in pH reduced the 
biomass yield of the control, resulting in a final biomass yield drop to about 80% compared to 
growth at pH 4. At the same time, xfpk(BB) grew faster at pH 6 than that at pH 4, reaching a 
growth rate almost equal to the control at pH 6, with a concurrent significant biomass yield 
increase (Figure 13, left graph) The positive effects of an increased pH observed for strain 
xfpk(BB), suggest that proton decoupling influenced the physiology of strain xfpk(BB) at lower 
pH, and that an increased pH reduced the ATP burden related to ionic transport. 
     We also investigated how Xfpk(BB) expression influenced the intracellular level of sugar 
phosphates during batch and chemostat conditions. Multiple sugar phosphates taking part in 
reactions of glycolysis and PPP – including the direct substrates and co-products forming during 
AcP formation – were quantified using an LC-MS approach. The absolute levels of the 
quantified amount of the metabolites during chemostat mode are shown in Figure 14 expressed 
as µmol per g cell dry weight (µmol/gCDW). The observed trends in sugar phosphate 
concentrations associated with phosphoketolase expression were found to be similar during 
batch and chemostat cultivations. Even though the glucose uptake rate was about 10-fold lower 
in the chemostat versus the batch cultivation, the intracellular concentrations only decreased by 
about 50% (data not shown, see supplementary data file to Paper II) 
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Figure 14. Quantification of sugar phosphates in the control strain and xfpk(BB) grown in glucose-limited 
chemostats (D=0.1). Strains were cultivated in biological quadruplicates. Significant changes are indicated with 
asterisks (* p<0.05), error bars equal ± standard deviation. Adapted from Bergman et al. [267]. 
 
Some of the most notable changes in sugar phosphate concentrations are a strong decline in the 
XFPK substrate X5P, a 75% reduction compared to control, while F6P was more moderately 
affected – corresponding to a 25% reduction compared to the control. The intracellular F6P 
levels were confirmed to be approximately 3-fold higher than those of X5P in the control strain, 
indicating that the Xfpk(BB) consumes close to equal amounts (0.45 µmol/gCDW) of both 
substrate pools. Considering that X5P is present in lower concentration in vivo, it correspond 
well with our observed in vitro activities of Xfpk(BB), suggested to be approximately 3:2 for 
X5P:F6P (Paper I / Figure 9). 
     The XFPK-products GAP and E4P showed a 2- and 5.4-fold increase compared to the 
control, respectively, giving further confirmation of in vivo activity and dual substrate 
specificity. The large gap between molar difference of consumed substrate (450 pmol/gCDW) 
and formed product (15-30 pmol/gCDW) can likely be explained by thermodynamic forces 
ensuring that the intracellular pools of GAP and E4P remain low. For example, GAP is 
isomerised to DHAP by triose phosphate isomerase (Tpi1) – a reaction with an equilibrium 
ratio of about 1:20 [185] – which is in agreement with the 2-fold increase of DHAP 
concentration observed in strain Xfpk(BB). Significant changes in sugar phosphate 
concentrations were also observed for Ru5P and S7P which are located in proximity to the 
substrates/products within the metabolic network (see figure Figure 1). The common product 
of the two phosphoketolase catalyzed reactions is acetyl-phosphate, which unfortunately could 
not be quantified with the utilized method, but its continuous formation was indirectly measured 
as enhanced levels of acetate in the batch phase (Figure 12).  
     As a last aspect of characterization, we also studied the global transcriptional response of 
Xfpk(BB) expression in yeast by conducting RNAseq analysis of the chemostat cultivated 
strains, and performing a differential expression analysis. 2,024 genes with an adjusted p-value 
smaller than 0.01 and absolute log2 fold change (|LFC|) larger than 0.1were identified. From 
this group, differentially expressed genes (DEGs) with a |LFC|>0.5, |LFC|>1.0 and |LFC|>1.5 
corresponded to 447, 120 and 47, respectively. Figure 15 highlight DEGs involved in the 
central carbon metabolism with a padj<0.01. 
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Figure 15. Transcriptional responses to phosphoketolase expression of central carbon metabolism genes 
expressed as log2-fold changes (padj<0.01). Extent and type (down/up) of the fold change is indicated by 
shading of blue (down) and red (up) color. Samples were taken from glucose-limited chemostats in biological 
quadruplicates. Adapted from Bergman et al. [267]. 
 
Xfpk(BB) expression had a large influence on gene expression in central carbon metabolism. 
Genes encoding enzymes catalyzing reactions in glycolysis were in general weakly 
downregulated. Pyruvate decarboxylase genes PDC1 and PDC6 and alcohol dehydrogenases 
ADH1 and ADH2 were downregulated, possibly an effect to reduce flux through acetate. ACS1, 
responsible for the activation of acetate to acetyl-CoA in the cytosol, was counterintuitively 
weakly downregulated in strain Xfpk(BB). However, as no extracellular acetate was detected 
in any of the strains, the activation of acetate does not appear to be limiting in the chemostat. 
     Multiple DEGs related to utilization of non-fermentable carbon sources – such as acetate – 
were found. In part, CIT2 and MLS1 – catalyzing the condensation of cytosolic acetyl-CoA 
with oxaloacetate and glyoxylate, respectively – were together with other key enzymes in the 
glyoxylate cycle and gluconeogenesis strongly upregulated. A vast majority of genes encoding 
TCA-cycle enzymes located in the mitochondria were upregulated, as well as ACH1, whose 
protein product can activate acetate directly to acetyl-CoA in the mitochondria and has in 
Influence of 
Xfpk(BB) 
expression in 
steady state 
conditions 
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important role in growth on acetate [97]. And even though the carnitine-shuttle system cannot 
be utilized during growth on minimal media [270], the genes related to acetyl-CoA/carnitine 
transport across intracellular membranes (CRC1, YAT1, YAT2 and CAT2) were all upregulated. 
     A gene set analysis highlights that cellular processes such as mitochondrial translation, ATP 
synthesis coupled transport, cristae formation, mitochondrial respiratory chain complex IV 
assembly and aerobic respiration were distinctly upregulated (data not shown, see 
supplementary data file to Paper II). These changes further confirm that strain Xfpk(BB) and 
an increased respiratory demand, likely due to the net ATP loss from a flux diversion from 
glycolysis and the ATP requirement of metabolizing acetate instead of pyruvate. 
     Also, within the PPP, a majority of genes were identified as differentially expressed. 
However, paralogs encoding iso-enzymes for certain catalytic steps were regulated in different 
directions. If the FPKM values obtained for these paralogs are added together, the net effect is 
an upregulation of GND- and TKL-transcripts while the other changes are considered 
insignificant (p<0.01, two-sided T-test). As most of the observed expression changes related to 
the glyoxylate cycle, gluconeogenesis, TCA cycle and respiration can be traced back to a co-
consumption of acetate, we wondered if the “acetate trigger” was responsible also for the 
changes in PPP gene expression. On the contrary, growth on acetate has correlated with a 
downregulation of several genes within in the PPP when compared to growth on glucose, 
hypothesized as a response to produce NADPH via other sources, such as Idp2 [269]. Thus, the 
observed net positive GND/TKL-expression change could potentially be an effect of altered 
intracellular levels of sugar phosphates, but studies investigating the transcriptional regulation 
with respect to metabolite levels are lacking to support this. 
     An interesting observation is that expression of multiple genes related to uracil biosynthesis 
were highly upregulated while the gene URA3 was strongly downregulated in xfpk(BB). The 
host strain is auxotrophic for uracil, and a copy of the native URA3 gene is expressed from the 
2µ-plasmid to ensure vector-retention during cultivation in minimal media. Thus, it appears as 
if the cell actively keeps the plasmid present at a low-copy number in order to minimize the 
damage of the heterologous phosphoketolase. Indeed, when including the xfpk(BB) sequence 
in the genome sequence to which the RNAseq reads are aligned to, it shows that xfpk(BB) was 
expressed at levels lower than the 60 most highly expressed yeast genes even though expressed 
from the TEF1 promoter on a multicopy plasmid, while the native TEF1 gene was expressed 
among the top 20 genes. This suggest that a higher flux through the enzyme could be possible 
if expressed in a way that ensures that toxicity induced by acetate is minimized.  
 
3.4 Insights of combined phosphoketolase and phosphotransacetylase 
expression 
 
The characterization of XFPK expression in yeast conducted in Paper II highlighted the need 
to prevent acetate formation in order to overcome growth-related effects from weak organic 
acid uncoupling. In Paper I we showed how this can be achieved by deleting GPP1 and/or 
GPP2. In order to complete the heterologous pathway, an efficient phosphotransacetylase 
(PTA) able to convert the formed AcP to acetyl-CoA is required. This subchapter presents 
unpublished results covering the search for an efficient PTA and insights from co-expression 
of XFPK and PTA. 
     Initially, we attempted to conduct an in vitro assay to find efficient PTA candidates. This 
work was conducted before we were aware of the function of Gpp1/Gpp2 in breaking down 
AcP. To establish a working method, we used a yeast strain carrying plasmid pSP-GM1 
encoding a PTA from Salmonella enterica (Pta(SE)) and a negative control strain carrying an 
empty plasmid (NC). We started by employing a method developed by Klotzsch et al. in which 
AcP, CoA and enzyme are provided to the same reaction, followed by continuous detection of 
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thioester bond formation at 233 nm [271], which we however failed to implement successfully. 
We then tested if the ferric hydroxamate method [263] described in Chapter 3.2 could be 
utilized as an alternative to detect PTA activity. All the components of the Klotzsch-reaction 
(buffers, AcP, CoA and protein extract) were incubated at 37°C for 30 min, after which the 
components of the ferric hydroxamate method converting AcP to ferric acetyl hydroxamate 
were applied to the samples. This resulted in an end-point read-out on how much AcP had been 
consumed (corresponding to a decrease in brownish coloration), results of which are shown in 
Figure 16. 
     The method returned the opposite results to what we expected. The results clearly 
demonstrated the endogenous ability of yeast to degrade AcP, as nearly all added AcP had been 
consumed in NC-samples. Compared to the XFPK assay performed in Paper I, the Klotzsch-
reaction to detect PTA activity did not contain the phosphatase inhibitor NaF. These were the 
experiments conducted leading us to understand how efficient the native ability to degrade AcP 
was, and the unfavorable effect it should have on pathway efficacy. 
 
Figure 16. A) Ferric acetyl hydroxamate method to detect AcP in samples incubated with crude-cell free 
extracts from strains expressing PTA from Salmonella enterica (Pta(SE)) or not (NC). A) B) Evaluation of CoA 
addition. Confirmation that Pta(SE) prevents AcP degradation exclusively in the presence CoA. 
 
     Even though we concluded that the ferric hydroxamate method was suitable to monitor 
activity of the PTA, it could nonetheless be clearly demonstrated that the enzyme interacted 
with AcP and prevented its breakdown when both AcP and CoA were added (Figure 16A). 
However, as shown in Figure 16B, the protective role of PTA on AcP stability was completely 
dependent on the presence of CoA – an example of cooperative binding. It is interesting to 
speculate if a PTA-dependent protective effect in AcP-degradation could be achieved in vivo, 
but likely the effect is related to the high concentrations of CoA provided in the in vitro reaction 
(in equimolar amounts to AcP: 10 mM). 
     The observation that high degree of AcP remained in the Pta(SE) samples even after 30 min 
furthermore indicated that the equilibrium of the reaction favors AcP formation. Even though 
the acetyl-CoA forming reaction is thermodynamically favorable at standard conditions 
(∆GR°´=-9.8 kJ mol-1), the intracellular concentrations of reactants and products might not 
support the formation of acetyl-CoA in vivo. Additionally, due to the reversibility of the 
reaction, host organisms commonly regulate the pathway flux by means of allosteric mediators 
such as NADH, ATP, pyruvate and PEP, all of which are strong inhibitors of the acetyl-CoA 
forming reaction of PTA in E. coli [272]. These effectors are likely to influence enzyme activity 
also in a heterologous host. 
     Due to the problems encountered trying to establish an in vitro assay, we decided to move 
ahead with the Pta(SE) candidate enzyme that had previously been utilized successfully in a 
PO/PTA-dependent strategy [249]. We began to evaluate the performance of the wild type 
versus the mutant strain gpp1∆gpp2∆, either carrying the control plasmid pSP-GM1 or plasmids 
containing Xfpk(BB) or Xfpk(BB)/Pta(SE). Figure 17 summarizes the impact of the different 
modifications on A) µ(max), B) acetate formation and C) overall growth profiles.  
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     Co-expression of XFPK/PTA in the wild type strain had a slight negative impact on growth 
when compared to expression of XFPK alone, both in terms of growth rate and final biomass 
yield (Figure 17A (blue bars) and 17C). As a large proportion of the AcP in the wild type strain 
is hydrolyzed directly into acetate, the equilibrium reaction might however favor AcP formation 
from acetyl-CoA, creating a futile cycle that in turn reduces biomass formation. Indeed, there 
is no significant difference in the maximum amount of acetate accumulation in the strain 
expressing XFPK or XFPK/PTA (Figure 17B), indicating that the endogenous pathway has a 
much higher capacity than PTA to consume AcP. 
 
 
 
 
Figure 17. Cultivation of CEN.PK 113-5D (WT) or gpp1∆gpp2∆ (∆∆) carrying an empty plasmid (Control), a 
plasmid encoding Xfpk(BB), or a plasmid encoding Xfpk(BB)/Pta(SE). The figures show the influence of A) the 
maximum specific growth rate µ(max) B) maximum level of acetate accumulation and C) growth profiles. The 
strains were grown in biological duplicates (shake flasks) in minimal media with 2% glucose. 
 
       The growth profile of the gpp1∆gpp2∆ deletion strain clearly shows a significant effect of 
blocking glycerol formation: a severely reduced maximum specific growth rate (0.1 h-1 versus 
0.32 h-1 of the wild type) and a strongly prolonged lag-phase (Figure 17A (orange bars) and 
17C). Glycerol formation is considered to have an important role in osmoregulation and redox 
control, primarily in anaerobic conditions, but also at high glucose concentrations when the 
respiratory system is repressed [66, 273]. Previous studies of a gpp1∆gpp2∆ deletion mutant 
indeed support that the phosphatases have an important role during anaerobic growth, an effect 
linked to a disturbed NADH/NAD+ ratio [274]. A double deletion of the glycerol-3-phosphate 
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dehydrogenases GPD1 and GPD2, also resulting in a glycerol deficient phenotype, was 
similarly reported to generate a severe growth defect also during aerobic growth [275]. 
Expression of XFPK or XFPK/PTA in the gpp1∆gpp2∆ strain moderately increased its growth 
rate and/or shortened the lag phase, possibly due to the redirection of carbon from lower 
glycolysis which should otherwise elevate the NADH-induced stress.  
     Interestingly, the acetate formation in the gpp1∆gpp2∆ strain background is severely 
elevated compared to the wild type, by approximately 80% (Figure 17B), an observation that 
was also made by Nissen et al. when they cultivated a gpd1∆gpd2∆ strain aerobically [275]. 
The elevated acetate level is likely to contribute to the impairment of growth of the strains. 
Expression of XFPK or XFPK/PTA in the gpp1∆gpp2∆ strain only moderately increased the 
maximum acetate levels, approximately by 10% to the reference strain, which is a reduction 
compared to the acetate increase observed upon XFPK expression in the wild type strain, which 
was closer to 50%. However, the large overall increase in acetate production in itself defeats 
the purpose of deleting the genes.  
    In view of the severely impaired growth and high acetate production of the double deletion 
mutant, it would be more useful to choose a strategy where only one of the two phosphatases 
were deleted. As indicated in Figure 10, GPP1 would be the preferred candidate for deletion 
although it would still result in a partial drain of the XFPK-formed AcP toward acetate. Indeed, 
this approach was adopted by Meadows et al., who utilized the dual route of XFPK/PTA and 
A-ALD to promote acetyl-CoA formation and ultimately farnesene synthesis in a ∆gpp1 yeast 
host [276].      
     Thus, as a last experiment we expressed Xfpk(BB) alone or in combination with  PTA from 
Clostridium kluyveri (Pta(CK)) – the same enzyme utilized by Meadows et al. [276] – in a yeast 
background carrying a deletion of GPP1, and evaluated the influence of the pathway on FA 
synthesis. Further, in order to enhance FA synthesis, we performed the experiment in a host 
that was devoid of the acyl-CoA synthetase genes FAA1 and FAA4. This makes the strain unable 
to activate free fatty acid (FFA) species which as a consequence get secreted into the growth 
medium [12, 160]. 
     We decided to investigate FFA synthesis at two stages of growth: at the end of exponential 
phase and after 72 h, when strains should have entered stationary phase. Figure 18A shows the 
OD600 reached after 72 h of cultivation time. The deletion of GPP1 in the faa1∆faa4∆ 
background had a negligible effect on final biomass yield. Xfpk(BB) expression in the strains 
had negative effect on growth, both in the wild type and gpp1∆ strain background. This is 
expected, as AcP still can be hydrolyzed to acetate by Gpp2 and possibly other intracellular 
phosphatases, albeit at a lower rate. Xfpk(BB)/Pta(CK) expression in the wild type exhibited 
the most hampered growth, possibly due to the formation of a futile cycle. It should be noted 
that all of these strains (marked with asterisks in figure) showed residual levels of the 
fermentation products ethanol, glycerol and acetate (data not shown), and thus it does not 
represent the final OD600 of the cultures. In particular the level of acetate accumulation in the 
Xfpk(BB)/Pta(CK) was very high – 2.8 g/L – considerably higher than the recorded 
concentration at glucose depletion (1.29 g/L). Furthermore, the biomass increase between the 
two sampling points was only 30%. This suggests that a majority of the energy produced by 
the cell is directly consumed to maintain cellular homeostasis in response to acetic acid stress.  
     Co-expression of Xfpk(BB)/Pta(CK) in the gpp1∆ background on the other hand 
significantly increased the performance in terms of growth. Within 72 h, the strain had 
successfully consumed all of the nutrients in the culture. Likely this effect can be explained by 
an elevated intracellular concentration of AcP that would enable a more efficient channeling 
towards acetyl-CoA and a decreased rate of futile cycling. 
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Figure 18 Cultivation of CEN.PK 113-5D faa1∆faa4 wild type (WT) or with an additional deletion of GPP1 
(gpp1∆) carrying an empty plasmid (Control), a plasmid encoding Xfpk(BB), or a plasmid encoding 
Xfpk(BB)/Pta(CK). The figures show the influence on A) the OD600 at 72 h of culture B) free fatty acid 
accumulation per L medium and OD600 at glucose depletion and C) free fatty acid accumulation per L medium 
and OD600 at 72 h of culture. The strains were grown in biological triplicates in minimal media containing 2% 
glucose. Asterisks (*) indicate that HPLC measurements showed residual amounts of ethanol, glycerol and 
acetate in the culture. 
 
     As indicated by the FFA production in strains carrying the control plasmid, the deletion of 
GPP1 had a slight positive effect on FFA synthesis (Figure 18B). Possibly, this could be related 
to the fact that glycerol-3-phosphate – which is likely to accumulate in the gpp1∆ strain – is a 
substrate for phospholipid and triacylglycerol (TAG) synthesis. Cellularly produced FFAs in 
yeast have been shown to stem from the hydrolysis of neutral lipids and phospholipids [12, 16].  
     When FFA synthesis is considered in the wild type background at glucose depletion (Figure 
18B, blue bars), Xfpk(BB) expression alone had a small positive effect, while co-expression  
with Pta(CK) abolished the effect. The beneficial effect observed for strain Xfpk(BB) agrees 
with the pathway´s ability to redirect carbon from glycolysis – and subsequent ethanol 
fermentation – directly to acetate synthesis. Whereas the acetyl-CoA formed from acetate in 
the Xfpk(BB) strain to a larger degree is utilized by Acc1 and the FAS complex for FA 
synthesis, the surplus likely gets converted to AcP in the Xfpk(BB)/Pta(CK) strain – closing 
the futile cycle. 
     Xfpk(BB) expression in the gpp1∆ mutant led to a minor reduction in FFA synthesis in the 
glucose phase (Figure 18B, orange bars), possibly due to a larger proportion of the carbon 
being trapped in form of AcP during the glucose consumption phase, reducing the immediate 
benefit of the carbon redistribution. A 24% increase in FFA production was observed in the 
corresponding Xfpk(BB)/Pta(CK) strain, indicating a successful diversion of C5 and C6 carbon 
directly toward acetyl-CoA synthesis via the heterologous pathway. The acetate levels at 
glucose depletion in the Xfpk(BB)/Pta(CK) strain were not significantly different from the 
control, while the acetate levels in the Xfpk(BB) background was nearly increased 2-fold, 
indicating that the GPP1 deletion is sufficient to prevent acetate accumulation in a XFPK-
expressing strain when co-expressed with a PTA. 
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     After 72 h of cultivation time, XFPK and XFPK/PTA expression proved to have a negative 
impact on FFA synthesis in both the wild-type and the gpp1∆ background. As such, FFA 
synthesis was reduced by 20 % in the Xfpk(BB)/Pta(CK) gpp1∆ strain compared to the control 
(Figure 18C). When ethanol is metabolized it is converted to cytosolic acetyl-CoA before being 
used for various cellular processes such as respiratory assimilation of the carbon in the TCA 
cycle. During such circumstances, the concentration of AcP produced by XFPK should be low. 
This can be expected as flux through gluconeogenesis and the PPP likely provides a 
significantly lower flux than that of glycolysis during sugar consumption. Thus, the equilibrium 
reaction of PTA would potentially favor AcP formation from acetyl-CoA during growth on 
ethanol.  
     Taken together, this suggests that the optimal setting, in which to use the XFPK/PTA 
pathway to stimulate production of acetyl-CoA derived compounds, is to prevent a two-stage 
fermentation and ensure continuous provision of glucose as substrate throughout the process. 
This can for example be achieved by employing a fed-batch process, in which the glucose is 
slowly fed throughout the whole cultivation to prevent of overflow metabolism. This is a 
common cultivation technique in industrial settings, and indeed, Meadows et al. used a type of 
fed-batch operation to optimize the XFPK/PTA-dependent production of farnesene [276]. 
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4 Influencing fatty acid synthesis via an increased 
NADPH supply 
 
 
 
 
 
 
4.1 Engineering fatty acid metabolism 
 
Various metabolic engineering strategies to positively influence production of fatty acids (FAs) 
and fatty acid derived compounds in S. cerevisiae have been implemented. As presented in 
Chapter 3, one approach has been to increase supply and/or introducing routes which provide 
a more resource-efficient provision of the fatty acid precursor acetyl-CoA. In the following 
subchapter, some of the more general strategies will be briefly introduced, an overview of 
which are shown in Figure 19. Commonly, several of these are combined simultaneously with 
expression of a terminal enzyme to achieve the desired product, e.g. alkanes or fatty alcohols. 
It should be noted that this summary is far from being exhaustive. 
 
Deregulating fatty acid synthesis 
 
The initial step of FA synthesis is the formation of malonyl-CoA from acetyl-CoA, catalyzed 
by Acc1. As mentioned in Chapter 2, activity of Acc1 is negatively regulated by the kinase 
Snf1 [163]. Shi et al. showed that this mode of regulation could be abolished by removing the 
putative Snf1-phosphorylation sites S659 and S1157. While overexpression of the native 
enzyme did not have any significant impact on FA content of the strain compared to the control, 
expression of a gene with both serine residues replaced by alanine (ACC1S659A, S1157A, also 
referred to as ACC1**) enhanced total FA content by 65% [41]. The strategy has thereafter 
been utilized in multiple studies targeting FA-derived compounds, such as FAEEs, TAGs and 
fatty alcohols [18, 21, 26, 277]. 
     Activity of Acc1 and FAS is also suggested to be regulated by acyl-CoA species, likely via 
steric as well as gene regulatory mechanisms (see Chapter 2.3 for more details) [42, 176]. 
Thus, recently a common strategy has been to reduce “product-inhibition” by deleting enzymes 
responsible for free FA (FFA) activation in S. cerevisiae, in particular Faa1 and Faa4. In the 
double mutant faa1∆faa4∆, expression of ACC1, FAS1, FAS2 and OLE1 has been shown to be 
significantly increased [11]. The inability of the yeast to activate the FFA while they are formed 
from various cellular lipases lead to a secretion of FFA to the medium. While not significantly 
influencing intracellular FA concentrations (corresponding to approximately 300 mg/L), 200 
mg/L FFA are excreted in a faa1∆faa4∆ strain, generating a 60% increase in total FA titers 
[12]. In combination with other metabolic engineering strategies, such as prevention of β-
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oxidation and expression of thioesterases (TEs) which release the fatty acid chain from CoA, 
the strategy has been utilized in various studies to achieve high levels of free fatty acids or 
products derived thereof [13, 15, 241, 278]. 
     Another way to influence lipid synthesis is to modify the network regulating their synthesis. 
Feng et al. evaluated the impact of deleting various negative regulators of phospholipid 
synthesis, and observed that the product titer correlated with that of cellular phospholipid 
content, and in particular the deletion of the deacetylase RPD3 resulted in a 2-fold increase in 
the FA-derived product fatty alcohol to 140 mg/L [279]. 
 
 
 
 
Figure 19. Metabolic engineering strategies to influence FA and FA-derived production in S. cerevisiae.  
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Expanding the fatty acid product spectrum 
 
Naturally, S. cerevisiae FAS mainly produces FA species of C16-C18. Many commercially 
attractive products call for FAs of shorter or longer length, such as short-chain hydrocarbons in 
gasoline substitutes, and long-chain FAs in products such as lubricants, cosmetics and 
pharmaceuticals.  
     The FAS complex has been replaced or engineered to promote short/medium chain FA 
(S/MCFA) synthesis (C6-C12) in S. cerevisiae. Co-expression of a human FAS in which the 
native thioesterase (TE) domain had been replaced with a short-chain specific TE (sTE), 
preferentially releasing the FA-chain at an earlier stage during elongation, with a heterologous 
phosphopantetheine transferase enabled production of 111 mg/L of S/MCFAs [19]. The 
rationale for using the hFAS was due to its architectural flexibility, consisting of an X-shaped 
homodimer, in contrast with the highly complex fungal FAS. However, recent engineering 
efforts demonstrated that rational engineering of S. cerevisiae FAS efficiently can generate 
S/MCFAs. By introducing a sTE into Fas2, in combination with mutations in the KS domain 
restricting acyl chain elongation, S/MCFA synthesis reached 175 mg/L [20]. Similarly, by 
overexpressing a FAS-complex carrying three mutations located within 1) the KS domain 
(interfering with chain elongation), 2) the MPT domain (reducing affinity for malonyl-CoA) 
and AT-domain (broadening the acetyl-CoA binding channel), respectively, yeast was 
engineering strain was able to produce 464 mg/L C6-C8 FAs [22].  
     In terms of long-chain fatty acids, a FAS system from the bacterium Mycobacterium vaccae 
was recently introduced to yeast due to its ability to directly produce both long (C16-18) and very 
long (VL: C22-26) FA species. Through expression of the M. vaccae FAS and a long-chain 
specific alcohol reductase from Arabidopsis thaliana in conjunction with various other genetic 
perturbations, a production level of 83.5 mg/L docosanol (C22) was achieved [21]. 
 
Deleting competing metabolic pathways 
 
Another common approach is to prevent FAs from being consumed in competing reactions.     
FAs can be stored as neutral lipids – triacylglycerols (TAGs) and sterol esters (SEs) – in so-
called lipid bodies, before being mobilized and used for growth when needed. The genes 
encoding TAG synthases (DGA1 and LRO1) and acyl-CoA:sterol acyltransferases (ARE1 and 
ARE2) have been found to be non-essential in yeast [280]. Another pathway that consumes FAs 
is β-oxidation, which degrades fatty acyl-CoA species to acetyl-CoA within the peroxisomes. 
A heterodimeric ABC transport complex is responsible for importing long-chain FA species 
into peroxisomes, encoded by PXA1 and PXA2, while enzymes catalyzing FA activation and 
the initial step of degradation within the peroxisome are encoded by FAA2 and POX1, 
respectively [281].  
     The described cellular features are commonly blocked to achieve higher yields of FAs and 
FA-derived products. Elimination of lipid droplet formation and the initial step of β-oxidation 
(dga1∆lro1∆are1∆are2∆pox1∆) generated a 5-fold increase in free FA content [31]. Deletion 
of three genes responsible for fatty acid activation (discussed under section “deregulating fatty 
acid synthesis”) in combination with three genes contributing to β-oxidation 
(faa1∆faa4∆fat1∆pxa1∆faa2∆pox1∆) increased FFA titers to 1.3 g/L [12]. 
     Similarly, in order to enhance titers in a strain already overproducing TAGs, a successful 
strategy included deletion of the SE synthase gene ARE1, TAG-lipase genes TGL3, TGL4, 
TGL5, the three mentioned peroxisomal β-oxidation genes as well as GUT2 – responsible for 
consuming glycerol-3-phosphate required for TAG-synthesis – and led to a TAG content 
corresponding to 25% of the cell dry weight [18]. 
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Engineering NADPH supply 
 
FA synthesis requires large amounts of NADPH – two molecules per elongation cycle, 
corresponding to a cost of 16 NADPH for one molecule of oleic (C18) acid. Consequently, also 
enhancing NADPH supply has been an approach positively influence FA production in S. 
cerevisiae. By introducing a NADP+-dependent GAPDH from Streptococcus mutans, the 
FAEE titer was increased by approximately 20%, to 48 mg/L [30]. A NADP+-producing malic 
enzyme from Mortierella alpina was also expressed to enhance production of fatty alcohols in 
yeast, which only resulted in a 5% (non-significant) increase [13]. 
     A recent study presented a rigorous reprogramming effort to turn S. cerevisiae into a 
lipogenic yeast, which included several NADPH-engineering strategies [15]. In part, flux was 
re-routed through the oxidative PPP via fine-tuned downregulation of PGI1, responsible for 
isomerization of G6P to F6P in glycolysis, while four enzymes within the PPP were 
upregulated: ZWF1, GND1, TKL1 and TAL1, leading to a 28% increase in FFA production. 
Furthermore, the yeast genes YHM2 (encoding a citrate (out) / oxaloacetate (in) shuttle 
transporter in the mitochondrial membrane) and IDP2 (responsible for transforming isocitrate 
to oxaloacetate in the cytosol) were overexpressed to elevate NADPH levels. The final strain 
produced 33.6 g/L FFA in a fed-batch cultivation, which is the highest reported so far by S. 
cerevisiae [15]. 
     An alternative to supplying more NADPH, to decrease its consumption in competing 
pathways is also an option. Metabolic modelling of a fatty alcohol overproducing system 
indicated that 60% of the NADPH produced was consumed by the NADP+-dependent 
glutamate dehydrogenase Gdh1, deletion of which improved fatty alcohol production 3.7-fold 
[17]. 
 
4.2 STB5 overexpression as a metabolic engineering strategy (Paper III) 
 
Among the previous strategies to increase FA synthesis via an enhanced NADPH supply 
discussed above, the re-direction of carbon flux through the oxidative PPP appears to be the 
most successful. This correlates well with the pathway´s ability to produce two molecules of 
NADPH per G6P entering the pathway. Indeed, an elevated flux through the oxidative PPP is 
utilized as cellular protection in response to oxidative stress, and without its integrity, cells 
encounter a redox-collapse [196, 282]. In Paper III we investigated a metabolic engineering 
strategy aimed at elevating intracellular NADPH supply by redirecting flux from glycolysis 
through the oxidative PPP through a mechanism which is naturally activated in yeast upon 
oxidative stress.  
     STB5 encodes a transcription factor (TF) shown to be involved in regulating NADPH 
generation in response to oxidative stress. Using chromatin immunoprecipitation (ChIP) and 
gene expression profiling, Larochelle et al. showed that Stb5 binds to the promoters and 
activates expression of multiple genes within the oxidative PPP, including ZWF1, SOL3, 
GND1, GND2, RKI1, TAL1 and TKL1, upon diamide treatment [47]. Simultaneously, Stb5 
interacted with the promoter of PGI1, whose expression in a stb5∆ mutant increased 
substantially compared to the wild type in response to diamide treatment, indicating that Stb5 
can also act as a transcriptional repressor. In addition to its role in regulating PPP-genes, Stb5 
was found to be an activator of the genes ALD6, ALD4, IDP2, ILV5, ADH6, GOR1, YEF and 
YMR315 – also known to have roles in NADPH-producing reactions [47, 213]. 
     This suggests that an increased flux through the PPP as well an increased pool of NADPH 
potentially could be achieved simply by enhancing the activity of Stb5. Indeed, overexpression 
of STB5 from a low-copy plasmid increased NADPH levels 2.5 times in a BY4727 background 
[213]. Strong overexpression of STB5 prevented the host strain to grow on glucose, but this 
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growth defect was partly relieved when overexpressing a NADPH-consuming butanediol 
dehydrogenase, indicating that STB5 overexpression led to a redox imbalance [283].  
     In the light of these findings, in Paper III we evaluated if promoter replacement of STB5 
could be used as a tool to positively influence FA synthesis. The hypothesis is that it potentially 
could activate several NADPH-producing reactions simultaneously while downregulating flux 
through upper glycolysis. In Figure 20, an overview of central carbon metabolism and some of 
the key targets of Stb5 anticipated to be perturbed are shown. If successful, this strategy could 
represent a flexible and easy-to-implement strategy to boost NADPH supply for various 
reductive biosynthetic processes. 
 
 
Figure 20. Overview of the key targets of the transcription factor Stb5. Positively and negatively regulated 
reactions are highlighted in green and red, respectively. Adapted from Bergman et al. [284]. 
 
 
     Initially, we evaluated various promoters to tune expression of STB5, as a previous study 
indicated that strong overexpression prevented the strain to grow on glucose [283]. Using a 
plasmid-based CRISPR/Cas9-approach, we replaced the native promoter with that of the Cu2+-
responsive promoter of CUP1 and promoters of CYC1 (weaker), ADH1, TPI1 and PGK1. We 
did not observe a growth arrest on glucose even in the strains where STB5 was regulated by 
strong promoters. However, both Cu2+ induction and utilization of constitutive promoters 
significantly decreased µ(max) and final biomass yields compared to the control in an 
expression induction/promoter strength-dependent manner. The recorded maximum specific 
growth rates are shown in Table 4.  
     Cadiere et al. argued that the negative growth-related effect of STB5 overexpression was due 
to a redox imbalance, as growth was partially resumed when a NADPH-consuming enzyme 
was overexpressed in the strain [283]. Furthermore, plasmid-based overexpression of STB5 in 
a BY4727 background was in a previous study reported to increase the NADPH concentration 
2.5-fold [213]. We measured the NADPH content of the constitutive promoter exchanged 
strains in exponentially growing cultures, however failing to detect any significant difference 
compared to the control in any of the strains.  
 
Indicated target 
genes of Stb5 
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Table 4. Maximum specific growth rates (µ(max) [h-1]) of STB5-promoter exchanged strains (AB12-AB16). 
A) STB5 overexpression mediated by copper induction 
Cu2+ (µM) Control (CEN.PK 113-5D) PCUP1-STB5 (AB12) 
"0"  0.317 ± 0.034 0.344 ± 0.018    
100 0.254 ± 0.014 0.259 ± 0.003  
200 0.284 ± 0.014 0.227 ± 0.008 * 
400 0.181 ± 0.004 0.107 ± 0.021 * 
B) STB5 overexpression mediated by constitutive promoters 
Control  
(CEN.PK 113-5D) 
PCYC1-STB5  
(AB13) 
PADH1-STB5  
(AB14) 
PTPI1-STB5  
(AB15) 
PPGK1-STB5  
(AB16) 
0.326 ± 0.012 0.265 ± 0.006 * 0.239 ± 0.002 * 0.246 ± 0.009 * 0.219 ± 0.014 * 
Asterisks (*) indicate a significant difference (p<0.05; Students t-test, two-sided) compared to the control at the 
same conditions. Strains were grown in minimal media with 2% glucose and 60 mg/L uracil. Values correspond 
to the average of biological triplicates ± standard deviation. 
 
     As an alternative strategy, we investigated how two STB5-overexpressing strains and a 
zwf1∆ mutant, known to be sensitive toward oxidative stress, handled oxidative stress during 
the exponential growth phase by measuring their ability to form viable colonies after a H2O2 
shock.  The proportion of H2O2-shocked cells that survived the treatment (normalized to colony 
count of strains when incubated in regular media) are presented in Figure 21. Interestingly, 
overexpression of STB5 reduced resistance toward oxidative stress, as indicated by similarity 
in behavior of the zwf1∆ strain and PTPI1-STB5. This counterintuitively implies that the flux 
through the PPP is impaired upon STB5 overexpression, as the flux immediately is re-routed 
through this pathway as a primary response to oxidative stress [282]. 
 
 
Figure 21. Survival of the strains CEN.PK 113-5D, zwf1∆ and PCYC1-STB5 and PTPI1-STB5after liquid H2O2-
shock. The values indicate the proportion of surviving cells at each concentration compared to the value 
observed for each strain at 0 mM H2O2. Values are averages of two biological and two technical replicates; error 
bars represent ± standard deviation. Adpated from Bergman et al. [284]. 
 
Even though we were unable to experimentally demonstrate that STB5 overexpression was 
linked to an increased NADPH supply, we decided to investigate if overexpression had an effect 
on FA synthesis. In order to stimulate FA production and generate a drain of NADPH, STB5 
promoter replacements were integrated into the double deletion strain CEN.PK 113-5D 
faa1∆faa4∆. While in faa1∆faa4∆ strains with a strong promoter controlling STB5, the growth 
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rate was reduced in a similar manner as in CEN.PK113-5D (62-72% of that observed for the 
control), the growth rate of PCYC1-STB5 was not significantly altered compared to the control 
(data not shown) – possibly an indication of that a redox-imbalance was alleviated.   
     We decided to harvest samples for FFA analysis at the end of glucose phase as well at 
stationary phase (72 h) as we expected STB5 to have a greater influence on modulating flux in 
glucose phase. As shown in Figure 22A, weaker as well as stronger STB5 overexpression 
resulted in an elevated capacity to produce FFAs in the glucose phase, ranging from 130-139% 
of that observed for the control. The effect did however not correlate clearly with STB5-
expression level, and the differences between the promoter exchanged strains were 
insignificant. At 72 h, stronger overexpression of STB5 led to a decreased ability to produce 
FFAs, while the final titers of PCYC1-STB5 were not significantly different from the control. This 
indicates that effects mediated by Stb5 in the ethanol phase in some way interfere with FFA 
synthesis. 
 
 
Figure 22. Free fatty acid quantification of CEN.PK 113-5D faa1∆faa4∆ strains after glucose was depleted 
(Glucose phase) and at stationary phase (72 h). A) Influence of different levels of STB5 overexpression on fatty 
acid synthetic ability. B) Influence of ZWF1 deletion on fatty acid synthetic ability in the control and PTPI1-
STB5 strain (# indicates that the strain failed to consume the produced ethanol). Strains were grown in minimal 
medium with 2% glucose with the addition of 60 mg/L uracil. Values are averages of three biological replicates, 
error bars ± standard deviation. Asterisks (*) indicate a significant change from the control (p<0.05; Students t-
test, two-sided) at the corresponding sampling point. Adapted from Bergman et al. [284]. 
 
     In order to clarify if the oxidative PPP had a role in providing reducing equivalents for FFA 
synthesis in STB5-overexpression strains, we deleted ZWF1 in the faa1∆faa4∆ control and 
PTPI1-STB5. The results of the FFA quantification are shown in Figure 22B, and the results 
from the glucose phase confirm that the positive effect STB5 overexpression has on FFA 
synthesis is independent of a flux through the oxidative PPP. The zwf1∆ deletion in the PTPI1-
STB5 mutant did not positively affect the final titers, but prevented the strain to resume growth 
after glucose depletion. A noteworthy observation (without direct relation to the topic of STB5) 
is that the oxidative PPP appears to contribute significantly to FFA synthesis during growth on 
ethanol, as the final titers were reduced by 50% compared to the control. If it provides reducing 
equivalents also during glucose phase, this can be compensated via an enhanced flux through 
other routes. In the oleaginous yeast Y. lipolytica, the oxidative PPP has been shown to be the 
main contributor of NADPH during lipid formation [285], but such a relationship has not been 
established in S. cerevisiae. 
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     As overexpression of STB5 using weak (PCYC1) as well as strong promoters (PADH1, PTPI1 and 
PPGK1) produced a similar effect on FA production in the glucose phase (Figure 22A), even 
though the µ(max) of the respective strains differed substantially, we decided to investigate if 
FFA production in the glucose phase could be limited by other factors than NADPH – such as 
the precursor acetyl-CoA. Therefore, we utilized the Xfpk(BB)/Pta(CK) pathway introduced in 
Chapter 3.4 to promote cytosolic acetyl-coA synthesis in strain PTPI1-STB. As we observed 
gpp1∆ to be essential to generate a positive effect on FFA-synthesis (Figure 18B), the 
expression of the XFPK/PTA pathway was evaluated by transforming the control plasmid pSP-
GM1 and pAB10 (Xfpk(BB)/Pta(CK)) into the following faa1∆faa4∆ strains: 1) a non-
modified control , 2) gpp1∆ control and  3) gpp1∆ PTPI1-STB. Figure 23 shows the FFA titers 
obtained at the end of glucose phase normalized to sampling OD600. 
 
 
Figure 23. Influence of additional acetyl-CoA supply on free fatty acid production of CEN.PK 113-
5D faa1∆faa4∆ strains on glucose. The indicated host strains were either transformed with the empty plasmid 
pSP-GM1 or pAB10, encoding a XFPK from B. breve and a PTA from C. kluyveri. Strains were grown in 
minimal media with 2% glucose and harvested at or close to glucose to glucose depletion. Values are averages of 
three biological replicates, error bars ± standard deviation. Asterisks (*) indicate a significant change (p<0.05; 
Student’s t-test, two-sided). Adapted from Bergman et al. [284]. 
 
     Similar to what was observed in Figure 22, overexpression of STB5 had a positive effect on 
FFA synthesis in the glucose phase also in the gpp1∆ background (Figure 23, AB29 vs AB27), 
albeit to a lower extent than observed in the non-deletion background (22% vs. 38% increase). 
Expression of the Xfpk(BB)/Pta(CK) pathway in the gpp1∆ strains had a positive effect in both 
strains, but while the increase was approximately 25% in the control strain, it reached 37% in 
the STB5-overexpression strain.  
     These results indicate that the effects of STB5 overexpression and an increased acetyl-CoA 
supply are not just additive, but act in synergy to increase FFA synthesis. This does in turn 
imply that STB5 overexpression makes more NADPH available than what efficiently can be 
utilized for the desired purpose of FFA synthesis, which instead is consumed via other 
competing cellular processes. 
     With regards to the conflicting results we observed, i.e. that previously published results 
suggest that Stb5 is an activator of the oxidative PPP while our results indicate that flux through 
the pathway is blocked, we wanted to make a more detailed characterization of the effects of 
overexpression, including RNAseq to get a holistic view of the gene expression profile. The 
control strain CEN.PK 113-5D and PTPI1-STB5 (AB15) were cultivated in quadruplicates and 
samples for RNAseq were taken in glucose phase, ethanol phase and during a glucose limited 
steady state (D=0.1 h-1). HPLC and biomass sampling during the exponential glucose phase 
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growth showed that STB5 overexpression led to a 35% decrease in µ(max) (0.25 vs. 0.39 h-1) 
and a significant reduction in glycerol, ethanol and biomass flux even when the parameters 
were normalized to the glucose uptake rate (corresponding to a decrease of 35%, 18% and 17%, 
respectively). 
     An overall PCA plot (Figure 24) of the RNAseq data showed the greatest difference in 
expression profile between all the 6 different sample groups (2 strains and 3 conditions) was 
explained by the sampling condition, in particular between samples taken in exponential phase 
and in ethanol/steady state which corresponds well to the large rearrangement in metabolism 
associated with a shift from fermentative to respiratory growth. Furthermore, the data show that 
STB5 overexpression mediates the greatest gene expression change in glucose phase, which 
appears to shift the expression profile to a state more similar to one of more respiratory 
character. A gene set analysis (not shown) performed with the software PIANO highlights  that 
respiratory processes indeed were induced in strain AB15 during the glucose phase, as well as 
a downregulation of multiple processes related to protein synthesis, which is to be expected as 
the growth rate is known to have a large influence on expression of genes related to ribosome 
and protein biogenesis [286]. 
     STB5 expression was significantly enhanced compared to the control in all conditions, with 
a log2 fold change (LFC) of 4.83, 1.75 and 3.29 in glucose, ethanol and steady state, 
respectively. The native expression levels of STB5 were low at all conditions, with FPKM-
values between 16 and 27, which for example can be compared to that of the glycolytic gene 
PGK1 in the glucose phase, averaging close to 3000.  
 
 
 
Figure 24. PCA plot of RNAseq data from control and PTPI1-STB5 strain. G, E and S corresponds to the 
sampling points (Glucose, Ethanol and Steady state, respectively). Adapted from Bergman et al. [284] 
 
     We performed a reporter transcription factor analysis – matching the transcriptome data to 
a database which lists TFs and their known targets and type of regulation – to find which TFs 
were likely to induce the observed expression changes in the strain overexpressing STB5 
compared to the control. The analysis did not indicate Stb5 as a probable inducer in neither the 
glucose nor ethanol phase, while Stb5 appeared as the most likely candidate to drive the 
observed expression changes during steady state conditions (Figure 25A). This indicates that 
mechanisms are present to counteract the effects of Stb5-mediated regulation in glucose and 
ethanol phase. Adr1, essential for activation of glucose-repressed genes when cells enter the 
diauxic shift [126], stood out as a key positive TF in the glucose phase, together with Msn2, 
Msn4, Pdr1 and Sok2 – transcriptional activators involved in stress response, pleiotropic drug 
resistance and cAMP-dependent protein kinase signal transduction. Of these, only ADR1 
showed a prominent degree of upregulation (Figure 25B). In a recent study by Ouyang et al, 
ADR1 and MSN4 were indicated as direct targets of Stb5, although, ADR1 was reported to be 
negatively regulated [287].  
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Figure 25. Transcriptional analysis of STB5 overexpression in different conditions, where G, E and S correspond 
to the sampling point “Glucose”, “Ethanol” and “Steady State”, respectively. A) Transcription factor (TF) 
reporter analysis, showing the top five scored TFs predicted to drive the down- and upregulated transcriptional 
changes at each of the tested conditions. B) Differential expression of the reporter TF genes in respective 
conditions (padj<0.01). C) Differential expression analysis of genes involved in the PPP, glycolysis, fatty acid 
synthesis and suggested STB5 target genes (padj<0.01). Adapted from Bergman et al. [284]. 
 
     When investigating differentially expressed genes within the central carbon metabolism and 
previously indicted target genes of STB5 in the different sampling conditions (Figure 25C), we 
observed a clear alteration in expression of genes within the PPP in the glucose phase. ZWF1, 
SOL3, RKI1, TAL1 and TKL1 were significantly downregulated, the expression level of GND1 
and RPE1 remained unchanged, while SOL4, GND2, NQM1 and TKL2 were induced upon 
STB5 overexpression. It should however be noted that SOL4, GND2, NQM1 and TKL2 all had 
significantly lower FPKM values than their corresponding paralogs in the glucose phase. When 
the raw read counts for each gene pair were added together and the combined LFC for SOL, 
Transcription  
               factor reporter      
           analysis 
 
Corresponding   
      gene expression of       
          indicated TFs 
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GND, TAL and TKL were calculated with DESeq2, only GND had a slightly positive value 
while all other PPP reactions were affected negatively (significant LFC-values: -0.69, 0.18, -
0.26, and -0.24, respectively). Taking the downregulation of ZWF1 and the “non-materialized” 
downregulation of PGI1 into account, it strongly suggests a reduced capacity of flux through 
the PPP in the glucose phase. 
     Among the other genes indicated to be regulated by Stb5 in response to oxidative stress, 
ALD6 and ILV5 were downregulated, YEF1 remained unchanged while IDP2, GOR1, ALD4, 
ADH6 and YMR315W were upregulated in response to STB5 overexpression in the glucose 
phase. Even though IDP2 had a positive LFC in the DE analysis, it is unlikely that this has a 
large influence on metabolism in the glucose phase due to a low FPKM value. ALD4 was 
strongly upregulated, but the subcellular localization of the corresponding enzyme is within the 
mitochondria and the suggested redox shuttle gene YHM2 was significantly downregulated 
(LFC= -1.31). The DE analysis also shows a weak but positive effect on expression of genes 
with a direct relevance for FA biosynthesis, such as ACC1 and FAS1 (LFC=0.21 and 0.90).   
     STB5 overexpression caused a coordinated upregulation of glycolytic genes (Figure 25C) 
in the ethanol phase, which likely is mediated through an upregulation of the transcription factor 
gene GCR1 highlighted in the TF analysis (Figure 25A and 25B), which is instrumental in 
regulating expression of glycolytic genes [288]. Simultaneously, gluconeogenic genes (FBP1, 
PCK1, PYC1) and the initial gene in the oxidative PPP (ZWF1) were downregulated compared 
to the control, which collectively indicates that the flux through the oxidative PPP was reduced 
also in the ethanol phase (Figure 6C). As observed in Figure 22B, the oxidative PPP appears 
to play a substantial role in providing NADPH for FA synthesis particularly in the ethanol 
phase, which could help to explain the observed negative effect STB5 expression had on FFA 
formation in this phase 
     At steady state conditions, fewer genes of the PPP were significantly deregulated by STB5 
overexpression. ZWF1, SOL4 and RKI1 were not significantly changed, SOL3 and TKL2 were 
downregulated, while GND1, GND2, RPE1 and TAL1 were upregulated. Of the other genes 
indicated to be activated by Stb5 in the study of Larochelle et al., almost all were upregulated: 
ALD6, IDP2, GOR1, YEF1, ALD4, ADH6 and YMR315W. This sheds light on the result of the 
reporter TF analysis, which indicated that Stb5 was likely to drive the observed gene expression 
changes in steady state but not in glucose nor ethanol phase (Figure 25A). 
     The RNAseq analysis shows that some previously indicated target genes of Stb5, such as 
ZWF1 and PGI1, could not be perturbed in the anticipated direction by overexpressing STB5. 
Indeed, Ouyang et al. also failed to pinpoint ZWF1 – encoding the considered rate limiting 
enzyme of the oxidative PPP – as a target gene of Stb5 [287]. These discrepancies could 
potentially have to do with a more complicated regulation of these genes. Possibly, the cellular 
consequences brought about by oxidative stress, such as a reduced NADPH/NADP+ ratio, are 
required for proper binding of Stb5 to its binding motif or subsequent induction. 
     We did observe positive effects of STB5 overexpression on FFA synthesis in the glucose 
phase, which was independent of the flux through the oxidative PPP (Figure 22A and 22B). 
An increased net activity of enzymes encoded by Stb5-target genes that were activated during 
glucose conditions, such ADH6 and YMR315W, and/or reduced consumption of NADPH via 
other reactions, would not have been of help during an oxidative perturbation (Figure 21), as 
it would cause an upstream blockage of the carbon flux at GAPDH, but it could still represent 
a source of NADPH for FA synthesis. However, the RNAseq analysis pointed out that 
expression of ACC1 and FAS1 was upregulated in response to STB5 overexpression, which also 
could lead to a more efficient utilization of cytosolic acetyl-CoA. Unfortunately, the impact of 
these two separate effects cannot be resolved.  
     Previous reports indicated that the NADP+/NADPH ratio is difficult to perturb in a CEN.PK 
background via genetic modifications. In response to overexpression of the NADPH-producing 
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malic enzyme in the cytosol, CEN.PK113-7D counteracted imposed changes by reducing flux 
through the oxidative PPP, which resulted in an unchanged NADPH/NADP+ ratio [289]. 
Furthermore, an increased cytosolic NADPH availability mediated via a deletion of a NADP+-
dependent glutamate dehydrogenase gene GDH1 was found to decrease transcription of ZWF1, 
GND1 and ALD6 [290]. The cellular NADPH/NADP+ ratio is generally held high in order to 
be able to drive biosynthetic reactions, and the cytosolic ratio in CEN.PK 113-7D has been 
reported to be 22.0 and 15.6 during exponential phase and steady state, respectively [186]. This 
supports that an increase in NADPH supply would be particularly damaging in the exponential 
phase. 
     Taken together, we therefore consider it highly likely that the STB5 overexpressing strains 
in our study counteracted an increased NADPH synthesis by partly overriding the Stb5-
mediated regulation by other mechanisms, such as transcriptionally downregulating key 
components of the PPP (Figure 25C), but also by consuming more NADPH, for example via 
enhancing expression of ACC1/FAS1 and elevating FA synthesis. 
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5 Investigating acetylation sites in Fas2 for 
regulatory function 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.1 Studying the function of post-translational acetylation sites 
 
Yeast metabolism is highly regulated, in part via coordinated reprogramming of metabolism on 
a transcriptional level. Furthermore, regulation occurs on the protein level via post-translational 
modifications directly affecting enzymatic activity – a mode of regulation that has the benefit 
of being very fast in response to environmental changes. One group of post-translational 
modification that has been suggested to have a high impact on regulation of metabolism are 
acetylations, a topic briefly touched upon in Chapter 2.2.  
     In S. cerevisiae, around 4000 distinct protein acetylation sites have been identified. 
Compared to various species, the acetylated yeast lysines were found to have a significantly 
higher degree of conservation than non-acetylated lysines, and about 20% of the conserved 
lysines had also been confirmed to be acetylated in fruit fly and human acetylome studies [49]. 
Furthermore, many of the identified acetylations were located in central metabolic enzymes. 
For example, a large proportion of enzymes in glycolysis, gluconeogenesis, and in glycine, 
serine and threonine metabolism were found to be acetylated [49]. Activity of the 
gluconeogenetic enzyme Pck1 was already a decade ago shown to critically depend on an 
acetylation of its lysine residue 514, without which the enzyme fails to support growth of its 
host on non-fermentable carbon sources [179]. However, studies investigating a potential 
regulatory role of the numerous acetylation sites described in reports of the S. cerevisiae 
acetylome are currently missing.  
     There are several ways to evaluate if and how a specific acetylation site has impact on a 
protein function. A general strategy is to expose growing cells to compounds that inhibit 
function of deacetylases. Nicotinamide (NAM) inhibits KDACs of sirtuin type while 
trichostatin A (TSA) inhibits KDACs in general [291, 292]. By purifying a protein of interest 
and studying how the NAM/TSA treatment influenced protein acetylation levels and enzyme 
activity, it can be determined if the PTM has a 1) enzyme-dependent removal, 2) a regulatory 
role in protein function. A similar effect can be achieved by deleting genes encoding certain 
acetyl transferases/deacetylases (or transiently knocking out activity). A drawback of these 
methods is that they only allow to evaluate the function of acetylations introduced or removed 
via specific acetyl transferases/deacetylases, and the influence of acetylations being transferred 
via non-specific mechanism will be overlooked. Additionally, the treatments will affect 
acetylation sites on multiple proteins within the cells, making an in vivo evaluation of enzyme 
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function troublesome. Moreover, if a protein has multiple acetylation sites, it does not allow to 
discriminate between the effects of each individual site on protein function.  
     Within metabolic engineering, knowledge of specific regulatory lysine sites can be used to 
deregulate protein function, e.g. as in the case of the acetyl-CoA synthetase from S. enterica 
described previously [235]. In order to obtain such information, one must introduce specific 
point mutations into the gene sequence representing a codon change and evaluate its 
physiologic impact. An approach based on amber suppression technology allows to genetically 
encode unnatural amino acids such as acetyl-lysines, and thereby directly introducing them into 
the protein sequence during translation. Such an expression system has been successfully 
implemented in S. cerevisiae [293] and requires the expression of an orthogonal pair of 
pyrrolysyl-tRNA synthetase and tRNACUA which detects the amber-codon TAG and introduces 
an acetyl-lysine into the growing protein chain. However, the suppression of the TAG-stop 
codon by tRNACUA might not be complete, resulting in production of truncated proteins of 
interest, and possible off-target effects due to natural amber-codon usage are unavoidable. 
     A simpler method is to replace targeted lysine residues with alternative, native, amino acids 
that can be considered to mimic either the acetylated or non-acetylated state. Several reports 
have utilized the replacement of lysine (K) with glutamine (Q) and arginine (R) to mimic a 
constitutively acetylated and non-acetylated amino acid, respectively [137, 294-297]. The 
molecular structures of the amino acids are shown in Figure 26. Glutamine will similar to an 
acetyl-group abolish the positive charge of the non-acetylated lysine while the replacement of 
lysine with arginine retains a positive charge without being able to be post-translationally 
modified. A benefit of this system is that it should only affect the function of the protein 
investigated, and therefore enables to evaluate enzymatic behavior in vivo.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26. The structure of amino acids with relevance for the KàQ/R residue replacement system. 
 
    The residue replacement system to evaluate function of acetylations has, however, been 
accused of overestimating the effect of protein acetylation [298]. Furthermore, as it assumes 
that the lysine/acetyl-lysine functions in a protein strictly dependent on the electric charge it 
provides. As can be observed in Figure 26, arginine is bulkier than the unmodified lysine 
residue, while glutamine is smaller than the acetylated lysine. Thus, the introduction of either 
of the residues into the three-dimensional protein structure can interfere with function in a steric 
manner. Commonly, it is assumed that a particular site has a high likelihood of being of 
regulatory type if only one of the introduced modifications generates a difference in activity 
while in the other case, protein activity should remain unchanged compared to the control. 
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5.2 Investigation of putative regulatory acetylation of Fas2 (Paper IV) 
 
As mentioned in Chapter 2.3, the study conducted by Henriksen et al. demonstrated that Acc1 
as well as Fas1/Fas2 were acetylated at multiple lysine sites [49]. Based on Henriksen´s et al. 
data, we observed that Fas1 and Fas2 were found to have the highest number of detected unique 
acetylation sites in S. cerevisiae (29 and 50 sites, respectively). The Fas proteins are very large, 
but even performing a normalization to protein length, this represents an acetylation frequency 
of 1.41 and 2.65 per 100 amino acids in Fas1p and Fas2p, respectively. Thus, Fas1 and Fas2 
belong to the top 20% and top 10% of yeast proteins with the highest frequency of acetylation, 
respectively. As FA biosynthesis is highly dependent on acetyl-CoA availability, whose 
concentration in turn influences the acetylation status of proteins, a regulatory mechanism 
controlling FAS activity via acetylation could be envisioned. This type of regulation of FAS 
activity are present in human cells, where an increased level of FAS acetylation has been 
correlated with an elevated degree of protein ubiquitinylation and degradation [51]. 
     Three of the lysine acetylation sites detected by Henriksen et al. in Fas2p (K83, K173 and 
K1551) were confirmed in a study by Kumar et al. in which six different deletion strains (sir2Δ, 
snf1Δ, snf1Δ sir2Δ, gcn5Δ, sir2Δ gcn5Δ, snf1Δ gcn5Δ) were investigated (unpublished). K83 
is located within the malonyl/palmitoyl-CoA transferase (MPT) domain located in Fas2, while 
the larger proportion of the MPT domain is found on Fas1 [299]. K173 is located within the 
acyl carrier protein (ACP) domain of Fas2, while K1551 is located within the ketoacyl synthase 
(KS) domain of Fas2 [38]. Due to the location of these three particular lysines within enzymatic 
domains of the FAS, and the fact that they were confirmed by two independent studies, they 
were selected to be investigated for a regulatory function by using the KàQ/R residue 
replacement system.  
     We replaced the discussed native Fas2 K-residues by introducing Q/R-codons into the FAS2 
gene sequence using the CRISPR/Cas9-technology. Conventional DNA modification strategies 
commonly require that a selective marker gene is introduced alongside the mutation in order to 
identify the correctly transformed cells. When introducing modification into central portions of 
an essential gene – such as FAS2 – this interrupts the gene, thus requiring a temporal expression 
of the wild type gene from elsewhere during the modification process. CRISPR/Cas9 on the 
other hand allows to efficiently insert double-strand breaks into desired location of the gene of 
interest, which subsequently are repaired using the provided DNA fragments carrying the 
mutation to be introduced, eliminating the need for selective markers. 
     The cellular acetyl-CoA concentration has been shown to be the highest during exponential 
phase, while it decreases during the diauxic shift and in ethanol and stationary phase [139]. 
Thus, it is possible that post-translational regulation mediated via acetylation in certain cases is 
growth phase dependent, i.e. occurring in exponential phase while not in ethanol phase. 
Therefore, we investigated how the FAS mutants influenced FA synthesis in glucose phase as 
well as at stationary phase. Additionally, we cultivated the strains directly on ethanol. 
     Single modifications were initially introduced into the strain CEN.PK 113-7D, but the 
mutations did not produce a significant impact on neither growth, cellular FA content nor FA 
composition (data not shown). As the FAS is a highly acetylated protein, we hypothesized that 
the influence of a single amino acid (AA) residue on enzymatic activity might not be sufficient 
to determine a regulatory function. Consequently, we decided to introduce AA exchanges at all 
three lysine sites (K83, K173 and K1551) simultaneously to investigate the effects of the 
combined mutations. Furthermore, as the product of FA synthesis has multiple cellular 
destinations (e.g. phospholipids, triacylglycerols, acetyl-CoA via beta-oxidation), we further 
questioned if it would be feasible to test a regulatory function of acetylation in a strain where a 
small increase or reduction in FF production possibly would be masked by other counteracting 
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Figure 27. Total free fatty acid content (mg/L/OD600) in CEN.PK113-5D faa1∆ faa4∆ strains grown in minimal 
medium, (A) containing 2% glucose harvested around glucose depletion (Glucose) or after 72 h (Stationary) and 
(B) containing 2% (v/v) ethanol harvested at 72 h. The values are means of biological triplicates ± standard 
deviation (except for strain K173Q, which represents duplicate measurements). Significant changes (p<0.05) 
compared to control are marked with an asterisk (*). Adapted from Bergman et al. [300]. 
cellular mechanisms. Therefore, we introduced the AA substitutions in the strain CEN.PK 113-
5D faa1∆ faa4∆, which is unable to reactivate FFAs into acyl-CoA, and likely experience less 
inhibition of FA synthesis.       
     When the single and triple AA substitutions were introduced into the faa1∆faa4∆ strain, 
significant alterations in FFA concentrations and chain length distribution were observed. In a 
first experiment, the strains were cultivated in triplicates in 2% glucose (all strains) or 2% 
ethanol (the control and the triple mutants). For strains cultivated in glucose, samples were 
taken for FFA analysis at the end of the exponential phase and at 72 h, indicated as “Glucose” 
and “Stationary” in Figure 27A, respectively. These results showed that FFA production was 
significantly reduced (p<0.05) in the glucose phase in the strains which had the K173Q and 
triple QQQ mutations, but not in the corresponding K173R and RRR strains. At stationary 
phase, however, majority of the Fas2 mutants showed a significant reduction in FFA synthesis, 
apart from K83R (p=0.053) and K173R. The results for the modified K173 residue would be 
the expected outcome if acetylation of K173 was involved in negatively regulating FAS activity 
in glucose conditions. The opposite behavior was observed when the triple mutant strains were 
cultivated in ethanol: a (non-significant) reduction in FFA synthesis was observed exclusively 
for the triple RRR mutant (Figure 27B), which rather indicates that inability to acetylate the 
investigated lysine residues has a negative effect on FAS activity. 
     In order to obtain more reliable results, we decided to repeat the experiment using 3% 
glucose – resulting in a prolonged glucose phase – and cultivating the strains in quadruplicates. 
The triple mutants were additionally cultivated in 3% ethanol or a total of 3% glucose, where 
2% was supplied via “Feed Beads”, enabling a slow but stable release of glucose over time, 
thus corresponding to a glucose-limited cultivation. This was performed as the three lysine sites 
K83, K173 and K1551 had been observed by Kumar et al. during glucose-limited chemostat 
cultivations, and thus a potential functional impact might have been of particular importance in 
such conditions. 
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Figure 27. Total free fatty acid content (mg/L/OD600) in CEN.PK113-5D faa1∆ faa4∆ strains grown in minimal 
medium, (A) containing 3% glucose harvested around glucose depletion (Glucose) or after 72 h (Stationary) and 
(B) containing 3% (v/v) ethanol harvested at 72 h (Ethanol) or 1% dissolved glucose and 2% glucose supplied in 
feed bead format added after 24 h of culture, harvested after 96 h (Feed Bead). The values are means of 
biological quadruplicates ± standard deviation (except for K173R, which represents triplicate measurements). 
Significant changes (p<0.05) marked with an asterisk (*). Adapted from Bergman et al. [300]. 
     Figure 28 show the FFA quantification of strains cultivated in glucose (28A) and in ethanol 
or using feed beads (28B). The observations made in the first experiment were not reproducible 
in the second. In part, the significant reduction in FFA synthesis observed for strain with 
mutation K173Q did not manifest, while the modifications K1551R, QQQ and RRR all led to 
a significant reduction in FFA production at the end of the glucose phase. Furthermore, no 
significant effect on FFA production was observed at stationary phase, which also is 
contradictory to the initial results. Neither when the triple mutants were cultivated in ethanol or 
using feed beads, significant changes were observed compared to the control.  
     Intriguingly, growth under glucose-limitation (Figure 28B) drastically decreased FFA 
production, as FFA concentrations were as low as 0.4 mg/L/OD600 compared to 15-25 
mg/L/OD600 when glucose or ethanol was used as substrate. Possibly this is related to a reduced 
lipid remodeling during glucose-limited conditions, which is believed to be the primary source 
of FFA species in yeast [12, 16]. 
     Considering results from the first as well as the second experiment, both Q and R 
substitutions often resulted in relatively equal changes in FFA synthesis in mutant strains of 
K83, K1551 and the triple mutants when cultivated on glucose (see Figure 27A and Figure 
28A). This indicates that for these AA substitutions, the residue replacements interfere with 
protein function in an “acetylation-independent manner” and are unsuitable to study the role of 
protein acetylation. For site K173, the Q substitution consequently had a greater negative 
influence on FA synthesis, even if the results were non-significant in the second experiment. 
     An observed difference that was consistent between the first and the second experiment was 
that K173Q, but not K173R appeared to influence the chain length distribution relative to the 
control. Table 5 shows the percentage of C16 and C18 FFA species in the mutants cultivated in 
2 and 3% glucose. Compared to the control, C16 species were reduced from 46% and 53% to 
38% and 46% in glucose and stationary phase, respectively, when cultivated using 2% glucose. 
When cultivated in 3% glucose, C16 species decreased from 64% to 57% in glucose phase, and 
from 53% and 37% in stationary phase, respectively. No significant change in FA chain 
distribution pattern was observed for the K173R mutant cultivated in 2% glucose, while a 
decrease in C16 species was observed when cultivated in 3% glucose, albeit to a much lower 
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extent than its glutamine counterpart. Oddly, while 5 of the 8 Fas2 mutants displayed a 
significantly higher C16 content than the control at stationary phase when cultivated in 2% 
glucose, a majority of the strains exhibited a reduced C16 content when cultivated in 3% glucose.  
 
Table 5. Percentages of C16 and C18 species in FFA samples taken from Fas2 mutants cultivated in either minimal 
medium containing 2 or 3% glucose. The samples were harvested at the end of exponential phase (Glucose) or at 
72 h (Stationary). Significant changes compared to the control (p<0.05) are indicated in bold. 
  
2% glucose 3% glucose  
Glucose Stationary Glucose Stationary  
C16 C18 C16 C18 C16 C18 C16 C18 
Control 46±3 52±3 53±0 45±1 64±1 32±1 53±1 45±1 
83Q 47±3 52±2 57±0 42±0 65±1 33±2 52±1 45±1 
83R 46±1 52±1 55±1 43±1 62±2 35±2 50±1 47±0 
173Q 38±4 59±2 46±2 51±1 57±3 38±2 37±4 59±3 
173R 45±2 53±2 53±1 45±1 63±1 32±1 49±1 49±1 
1551Q 45±4 54±4 55±1 43±1 62±3 35±3 50±0 48±0 
1551R 48±2 51±3 54±0 43±0 65±1 32±1 49±1 48±1 
QQQ 44±2 55±2 53±1 45±1 59±1 37±2 47±1 51±1 
RRR 48±1 49±1 54±1 44±1 63±1 32±1 48±0 51±0 
 
     In the FAS, K173 is located very close to the active site of the ACP domain (Serine180). 
The ACP is instrumental in the FA synthesis process as it is physically attached to the growing 
acyl-chain via the pantetheine arm, and is responsible for the chain transfer to the different 
catalytic centers in the FAS complex [299]. Potentially, the introduction of glutamine at site 
K173 interferes with the transfer of acyl chains to the MPT domain – responsible for releasing 
the free acyl-CoAs. This would in part slow down FA synthesis (Figure 27A), as FAs would 
be trapped within the FAS complex, and simultaneously stimulate a release of C18 acyl chains 
at the expense of C16 species. In order to determine if the observed changes are a result of a 
regulatory acetylation on K173 or a steric alteration of the catalytic chamber when introducing 
a non-charged/smaller AA, further studies are however required. 
     In hindsight, the decision to evaluate merely three acetylated lysine sites in a protein 
complex reported to be able to carry at least 80 was suboptimal. Thus, a more general strategy 
to study protein acetylation presented in subchapter 5.1 would potentially have been more 
advantageous in the case of yeast FAS, assuming that the acetylations were introduced 
enzymatically. Alternatively, a selection of acetylation sites known to be evolutionary 
conserved could have been targeted. For example, by performing sequence alignment of the S. 
cerevisiae and oleaginous yeast Y. lipolytica FAS, we identified 43 out of the 80 acetyl-lysine 
sites detected in S. cerevisiae FAS to be conserved between the two species, out of which 8 
sites were confirmed to be acetylated in Y. lipolytica [131].  
     Yet, the degree of acetylation frequency at the particular sites is likely a stronger indicator 
of whether the modifications have a physiological role or not. An acetylation site is unlikely to 
have a regulatory impact if too few proteins carry the modification at a single time point to 
significantly influence its activity. Weinert et al. estimated that 95% of the acetylation sites in 
S. cerevisiae were of low-stoichiometry, defined as that <1% of the lysine-site in proteins are 
occupied by an acetyl-group [50]. A recent study investigating acetylation frequency in human 
cells showed a similar pattern, and furthermore demonstrated that the acetylation frequency of 
various functionally characterized sites are of low-stoichiometry in vivo [301]. When the data 
of Weinert et al. were investigated, only three acetylation sites detected within Fas2 were 
suggested to be of high-stoichiometry (>1%): K573, K1423 and K1551. These are therefore 
good candidates for a potential further analysis. 
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6 Conclusions and perspectives 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The overall goal of this thesis was to investigate methods and system parameters with potential 
to improve production of or shed light on FA synthesis in the commonly utilized cell factory S. 
cerevisiae. This entailed to evaluate a more energy- and carbon-efficient route to produce the 
FA precursor acetyl-CoA (Paper I and II). Furthermore, we investigated if overexpression of 
a TF related to NADPH biosynthesis could be used as strategy to boost cofactor-expensive FA 
synthesis (Paper III). Lastly, we also sought to explore if FAS activity was regulated by 
acetylation – knowledge which potentially could be used to deregulate FA synthesis (Paper 
IV). It should nevertheless be highlighted that the knowledge assembled within the different 
projects of this thesis has potential to be used in other applications. The following subchapters 
will discuss the overall conclusions gained from working with the mentioned topics and put 
them into a more general context.  
 
6.1 Acetyl-CoA supply via the XFPK/PTA pathway 
 
Conclusions 
 
When a comparison of various routes for providing cytosolic acetyl-CoA in S. cerevisiae is 
made, the XFPK/PTA pathway stands out as the one that individually provides the best 
theoretical yields for several production processes relying on acetyl-CoA as precursor, 
including FAs [43]. The theoretical yield is based on an assumption of 100% flux efficiency 
via the targeted pathway, and therefore does not consider aspects such as kinetic and 
thermodynamic constraints. In Paper I, we identified several efficient XFPKs with varying 
substrate specificity, information that can be used to optimize flux through a heterologous 
XFPK/PTA pathway in yeast. We later on showed that co-expression of XFPK/PTA indeed 
had a significant positive influence on FA synthesis in the glucose phase. However, during the 
course of the project, we recognized aspects of XFPK/PTA expression in S. cerevisiae imposing 
limitations on yield. 
     The first observation is that S. cerevisiae possesses a strong enzymatic ability to degrade the 
XFPK product AcP to acetate. Excess acetate formation was highlighted already in a study 
expressing the XFPK from B. lactis by Sonderegger et al. [245], but not discussed as 
constituting a problem in the more recent studies using the XFPK from A. nidulans [32, 45]. 
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This makes sense when observing how limited the catalytic efficiency of the Xfpk(AN) enzyme 
is in comparison to that of enzymes from the Bifidobacterium genus. One of the major 
theoretical advantages of utilizing the heterologous Xfpk enzyme is its ability to bypass the 
ATP consumption during acetate to acetyl-CoA formation. Thus, the requirement to activate 
additionally formed acetate to acetyl-CoA using endogenous Acs enzymes should constitute a 
distinct problem when attempting to optimize acetyl-CoA supply and subsequent product 
formation. In Paper II, we showed that the excess acetate formation resulting from expression 
of the XFPK is likely to increase proton decoupling, leading to a decreased biomass yield and 
respiratory demand in batch culture. Furthermore, even in the absence of acetate accumulation 
in chemostat cultivation, XFPK expression led to a significant decrease in biomass yield and a 
concurrent increase in O2 consumption, further emphasizing that the ATP demand is increased 
when acetate is converted to acetyl-CoA.  
     We confirmed the glycerol-3-phosphatases Gpp1 and Gpp2 to be responsible for a large 
proportion of the formation of acetate from AcP. However, deletion of both GPP1 and GPP2 
increases lag time, severely decreases µ(max), and at the same time significantly increases 
acetate accumulation in the strains. These results verified the importance of glycerol formation 
in maintenance of redox homeostasis, and also showed that the purpose of preventing excessive 
acetate formation is defeated when deleting both GPP1 and GPP2. Thus, our recommendation 
is that that the most influential of the two enzymes – Gpp1 – is targeted for removal when the 
XFPK/PTA pathway is expressed.  
     A second parameter that prevents an efficient flux through the XFPK/PTA pathway is 
related to the reversibility and/or the low flux through the PTA reaction. When a XFPK and 
PTA were co-expressed in a wild type strain – results of which were presented in Chapter 3.4 
– acetate accumulation was not significantly altered compared to expression of XFPK alone. 
Thus, the reaction to convert AcP to acetyl-CoA must have been significantly slower than the 
endogenous hydrolysis process to acetate. Furthermore, co-expression of XFPK/PTA resulted 
in a reduced final biomass yield compared to expression of XFPK alone, both in wild type and 
gpp1∆gpp2∆ background. This indicates that the reversibility of the PTA reaction results in a 
futile cycle, where AcP is degraded to acetate via endogenous routes, ATP is consumed during 
acetate activation, and PTA uses acetyl-CoA to reform AcP. The net result is a consumption of 
ATP, that should negatively affect growth. 
     The thermodynamic equilibrium constraints of the PTA reaction dictate that it is likely to 
form AcP from acetyl-CoA when the concentration of AcP is low. Such a situation is probable 
to occur after glucose is depleted, and the concentration of sugar phosphates – i.e. the substrate 
of XPFK – decreases. Indeed, this behavior would explain the observation that even if co-
expression of XFPK/PTA generated an increased ability to produce FFA in the glucose phase 
in a gpp1∆ mutant, the expression had a negative effect on the final FFA titers. In view of this, 
in order to ensure that the XFPK/PTA pathway promotes synthesis of FA (or other acetyl-CoA 
derived products), a continuous supply of AcP must be secured. This indicates that a two-stage 
fermentation process, which normally occurs in batch cultures, should be avoided, for example 
by employing a fed-batch process. 
 
Perspectives 
 
     Taken together, in order for the XFPK/PTA pathway to reach its full potential as an efficient, 
acetyl-CoA providing pathway in yeast, more work is required. To decrease acetate formation 
further, glycerol-3-phosphatases from heterologous sources could be screened for an ability to 
catalyze the vital function of glycerol formation while displaying a minimal AcP-hydrolytic 
activity. Such candidates could be used to replace the native enzymes. Furthermore, engineering 
of PTA to display stronger acetyl-CoA forming behavior would be highly beneficial for the 
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overall pathway flux. Following such optimization work, interesting areas of XFPK/PTA 
utilization are highlighted in the following paragraphs. 
     The stoichiometric analysis performed by van Rossum et al. showed that an ultimate strategy 
to provide cytosolic acetyl-CoA for FA synthesis is a combinatorial approach of XFPK/PTA 
flux (65%) and ATP-neutral pyruvate to acetyl-CoA flux (35%) [43]. As previously mentioned, 
such an approach was successfully utilized by Meadows et al. to produce farnesene, resulting 
in an process with increased yield, productivity as well as decreased oxygen consumption [276], 
The study clearly demonstrates the broad applicability and benefit of the XFPK/PTA pathway 
in optimization of microbial catalyst for acetyl-CoA derived production. This study utilized the 
XFPK from L. mesenteroides also investigated within this thesis, which we observed had a 
relatively weak ability to convert F6P to AcP. Their procedure to select the best performing 
XFPK/PTA couple was to perform growth complementation of an acs2∆ mutant on glucose. 
This likely could have hidden more active XFPK candidates as an increased acetate-
accumulation likely would have restricted the growth of such strains. In order to optimize 
redirection of the carbon flux when glucose is used as feedstock, we suggest to utilize an 
enzyme with strong affinity toward F6P (e.g. Xfpk(BB)), as F6P then is present at higher 
concentration than X5P.  
     On the other hand, candidates with a more pronounced affinity for X5P would be beneficial 
in order to process pentose sugars such as xylose. Pentose sugars are a common constituent of 
lignocellulosic material, and may constitute up to 20% of the total sugar content [302]. In order 
for microbial catalysts to truly constitute a climate neutral and sustainable route of chemical 
production, full utilization of these resources is essential. Naturally, S. cerevisiae does not grow 
on xylose, leading to a substantial resource waste when lignocellulosic material is fermented. 
Consequently, during the last two decades plenty of resources have been invested to engineer 
yeast for xylose fermentation [303]. Sonderegger et al. evaluated the use of the XFPK from B. 
lactis to promote ethanol fermentation on xylose [245]. Flux through the redox neutral 
XFPK/PTA-pathway relieves a redox imbalance otherwise resulting from the sequential 
activity of a NADH-forming heterologous xylitol dehydrogenase and GAPDH, which under 
normal circumstances limits the attainable ethanol yield. As the strains expressing Xfpk(BL) 
accumulated excess acetate – a severe inhibitor of xylose fermentation – the choice was made 
to rely on a weak endogenous XFPK-activity detected in S. cerevisiae, even though suboptimal 
flux through the pathway was observed [245]. Thus, the knowledge of the role of Gpp1 and 
Gpp2 in AcP hydrolysis should bring substantial benefit for utilizing a XFPK/PTA-pathway in 
ethanol fermentation of xylose. If considering FA synthesis from xylose, it would be interesting 
to evaluate a xylose activation strategy based on the redox neutral xylose isomerase (XI) 
directly converting xylose to xylulose [303], in combination with the XFPK/PTA-pathway. 
This would enable a redox neutral route to acetyl-CoA, which is preferential compared to a 
NADH-forming scenario according to the principles discussed in Chapter 3.1. However, ATP 
and reducing power would still be required to be produced via other routes.  
     An additional potential application of XFPK expression is related to the intracellular levels 
of the sugar phosphate E4P, which we in Paper II showed was increased more than 5-fold in 
the strain expressing Xfpk(BB). Aromatic chemicals are routinely produced from fossil fuels, 
and have large application areas within the chemical, pharmaceutical and food industries. Many 
metabolic engineering strategies have been designed to make their renewable synthesis more 
efficient [304]. Biosynthesis of the aromatic compounds proceeds via the shikimate pathway 
and is initiated with the formation of dehydroshikimate via condensation of the glycolytic 
intermediate PEP and the PPP intermediate E4P, of which E4P has been shown to be the 
limiting substrate [305]. Thus, expression of a XFPK candidate with high affinity for F6P 
resulting in formation of E4P and AcP is likely to increase formation of dehydroshikimate and 
metabolites derived thereof. 
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6.2 Increasing NADPH supply to stimulate FA synthesis 
 
Conclusions 
 
As a second part of this thesis, we evaluated if FA synthesis could be positively modulated by 
a strategy aimed to increase supply of NADPH, used in extensive amounts during FA synthesis. 
Increasing NADPH supply has been shown to be successful in promoting FA synthesis, in 
particular when redirecting flux towards the oxidative PPP. In Paper III, we overexpressed 
STB5 – encoding a transcription factor known to regulate multiple genes related to NADPH 
biosynthesis in response to oxidative stress – with the hypothesis that the flux through the 
oxidative PPP and other NADPH-producing reactions would increase, and as a consequence 
stimulate FA synthesis. Even though we did observe a moderate positive effect of STB5 
overexpression on FA synthesis in the glucose phase, this effect was shown to be independent 
of flux through the oxidative PPP. This agreed with the observation that strains overexpressing 
STB5 had a reduced ability to handle H2O2 stress. 
     Transcriptome profiling confirmed that strong STB5 overexpression appeared to cause a 
counterintuitive phenotype with reduced flux through the oxidative PPP in batch phase while a 
larger proportion of the suggested Stb5 target genes were activated in glucose-limited 
conditions. Previous studies performed in CEN.PK strains has also showed that flux through 
the oxidative PPP or transcription of genes such as ZWF1, GND1 and ALD6 were decreased in 
response to genetic alterations increasing NADPH supply [289, 290]. Furthermore, the apparent 
inability of Stb5 to activate expression of ZWF1 and downregulating PGI1 the critical genes to 
moderate a switch from glycolytic to oxidative PPP flux – suggests that oxidative stress 
(in)directly is required for Stb5 to transcriptionally regulate these genes. 
     Overexpression of STB5 to elevate NADPH levels is a metabolic engineering strategy with 
broad applicability. During the preparation of the Paper III, three other studies were published 
that investigated the use of STB5 overexpression as means to positively influence synthesis of 
products depending on NADPH or a high PPP flux, some with moderate success [306-308]. 
None of the mentioned groups investigated which genes actually were activated in response to 
STB5 overexpression and relied fully on the transcriptional regulation profile reported in the 
literature. Our study highlights that engineering NADPH metabolism via STB5 overexpression 
has systemic effects if NADPH is not consumed efficiently.  
     Seen in the light of our results and those observed by others, it appears as if CEN.PK strains 
efficiently counteract an elevated NADPH/NADP+ ratio by transcriptionally downregulating 
some of the most influential genes in NADPH biosynthesis. Thus, increasing NADPH supply 
must be tightly balanced with improving consumption in the targeted pathway in order to avoid 
systemic negative effects. Indeed, we observed improved growth of a strain expressing STB5 
under the weak PCYC1 promoter when FA synthesis was promoted in a faa1∆faa4∆ strain. 
 
Perspectives 
 
In general, the optimization of metabolic engineering strategies is dependent on establishing a 
redox balanced formation of product. In case of FA synthesis, this would necessitate a bypass 
of NADH formation in glycolysis, while producing two molecules of NADPH per acetyl-CoA 
formed. Indeed, this could be achieved by forcing flux through the oxidative PPP and from 
thereon directly to acetyl-CoA synthesis, e.g. by a X5P-specific XFPK/PTA pathway.  
     Overexpression of STB5 as a metabolic engineering strategy to enhance flux through the 
oxidative PPP – which was our intention – did not prove to be a particularly robust or effective 
method. In this respect, overexpression of the desired target genes by direct modulation of 
promoter activity [15] is likely to be more efficient. In addition, it would probably prevent a 
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subsequent transcriptional inactivation of the genes in response to an increased 
NADPH/NADP+ ratio. Another alternative could be to downregulate the activity of the 
glycolytic gene TPI1, as a block of this particular reaction has been shown to force carbon flux 
through the oxidative PPP [309]. Such a strain would also constitute an interesting host to 
evaluate the XFPK/PTA pathway for enhanced acetyl-CoA supply, as reduced activity of Tpi1 
also was shown to increase F6P/X5P levels. 
     An inherent drawback of enhancing cofactor supply is that it is an unspecific approach, as 
anabolic reactions in general are dependent on NADPH. Thus, both NADPH and cellular 
precursors will be consumed by other processes. Seen in this respect, increasing cofactor supply 
has the greatest potential when other parameters of production have been optimized, and 
NADPH supply is truly limiting. Furthermore, deleting competing non-essential enzymes 
consuming NADPH is an alternative, as indicated by the successful strategy to delete the 
NADP+-dependent glutamate dehydrogenase GDH1 for increasing fatty alcohol titers [17]. 
     Currently, the achieved product-on-substrate yields of FA synthetic processes in S. 
cerevisiae are relatively low compared to the theoretical ones [310], which likely is why low 
carbon efficacy of the production host has not yet emerged as a pronounced problem. When 
researchers get closer the theoretical limit, an elevated flux through the oxidative PPP would 
however constitute a problem due to the carbon loss it is associated with. Lipid production in  
the oleaginous yeast Y. lipolytica was for example recently pushed closer to the theoretical limit 
by engineering an enhanced NADPH supply via non-CO2 emitting sources by expressing 
heterologous, NADP+-dependent versions of GAPDH and ME [311]. 
     An ideal way to produce FAs is however through a process that does not require NADPH at 
all, but rather depends on NADH provided via glycolysis. This can be achieved by employing 
enzymes catalyzing β-oxidation in a reverse approach [312]. The process utilizes acetyl-CoA 
instead of malonyl-CoA for chain elongation – reducing ATP consumption – and NADH 
instead of NADPH as a source of electrons. Thus, this allows for a more energy and resource 
efficient production of FAs, and the system has been utilized in E. coli to efficiently produce 
S/MCFAs, reaching titers of up to 1-2 g/L [313, 314]. The establishment of the reversed β-
oxidation in yeast has unfortunately proved to be challenging [315, 316]. Hopefully the key 
bottlenecks in the system can be identified to unlock this strategy also for use in S. cerevisiae. 
 
6.3 Post-translational regulation of FAS 
 
Conclusions & Perspectives 
 
The identification of regulatory acetylation sites on enzymes poses an opportunity to deregulate 
connected cellular processes. Due to proximity of acetyl-CoA and FAS in the metabolic 
network, we hypothesized that degree of protein acetylation indeed could have a direct role in 
regulating enzyme activity. In Chapter 5, results of our investigation of three acetylation sites 
(K83, K173, K1551) detected within Fas2 had a potential regulatory role were presented. 
     The results of our study were not conclusive, partly because the results produced were not 
reproducible between experiments conducted, and in part because both AA substitutions 
appeared to influence enzyme behavior through a steric mechanism for two of the three sites. 
Nevertheless, the behavior of the K173 mutants, where AA changes were introduced in close 
proximity to the active site of the ACP-domain (S180) – consequently showed a larger negative 
influence on FFA synthesis for mutant K173Q (mimicking an acetylated residue) compared to 
K173R mutant. Furthermore, the K173Q mutation specifically generated a reproducible and 
significant decrease in FA species with chain length C16 at the expense of C18. The phenotype 
could potentially be explained by a reduced ability of ACP to efficiently transfer acyl-CoA 
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species to the MPT domain. More studies have to be performed in order to determine if any of 
the investigated residues have a regulatory role. 
     A study that investigated the degree of acetylation stoichiometry in S. cerevisiae suggests 
that very few of the acetylation sites detected in FAS have an important physiological function 
[50]. It is estimated that only three detected acetylation sites in Fas2 (and none in Fas1) have a 
higher frequency of occupancy than 1% - K1551 being one of them. Thus, if further studies are 
performed to characterize the influence of acetylation sites in yeast FAS function, sites with 
high acetylation frequency and/or those which are found to be evolutionary conserved among 
species are likely the best candidates to proceed with. 
 
6.4 S. cerevisiae as a cell factory for fatty acids 
 
The subjects explored within this thesis did not in themselves result in a S. cerevisiae cell 
factory displaying high FA yield and titers. A take-home message from the work conducted is 
that when providing additional amounts of acetyl-CoA or NADPH for FA synthesis, care must 
be taken to ensure that the produced precursors and cofactors are efficiently utilized at the point 
of production. Therefore, simultaneous engineering efforts to force the flux through Acc1 and 
the FAS complex and reduce competing pathways are required to maximize the benefit of 
strategies targeting an increased acetyl-CoA and/or NADPH supply to produce more FA. 
     Using the detailed knowledge gained within the thesis, the strategies could with little effort 
be implemented in platform strains already producing large quantities of FAs or lipids in order 
to optimize production. For example, two yeast strains were recently constructed in which 
ethanol formation was abolished to increase production of FAs or metabolites derived of acetyl-
CoA, which potentially would benefit further from expressing the XFPK/PTA pathway [15, 
249]. 
     The progress in transforming S. cerevisiae to a cell factory for FAs and FA-derived 
chemicals has advanced tremendously just during the past five years, enabling greatly elevated 
product titers of various FA derived products [310]. Recent achievements in titer are 33.4 g/L 
FFA [15], 1.76 g/L TAGs [18]) and 6.0 g/L fatty alcohols [17]. The corresponding product-on-
substrate yields for the processes were reported to be 30%, 27% and 18% of the theoretical 
maximum, respectively. These developments show that it is possible to transform a non-
oleaginous yeast into an efficient producer of FAs, and that the production parameters likely 
will be pushed even further in a near future. Hopefully, the work presented in this thesis will 
aid in this process. 
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